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1 INTRODUCTION 
1.1 The Ras Protein 
1.1.1 Ras - A Molecular Switch within Signal Transduction 
Three different ras genes are found in mammals encoding the four highly homologous 
proteins H-Ras, N-Ras, K-Ras4A and K-Ras4B. These 21 kDa proteins consist of 188-189 
amino acids and play a vital role in cell signalling events. Except the so-called hyper 
variable region (HVR), which compromises the 25 carboxy terminal amino acids, the Ras 
proteins show high sequence homology. In order to be biologically active they are 
posttranslational modified at the cysteine residue of the so-called CAAX-box (C is a 
cysteine, A is an aliphatic amino acid, X is any amino acid) by the attachment of lipophilic 
groups and thereupon membrane-anchored (Williamson et al. 1984). 
Altering between an inactive GDP- and an active GTP-bound conformation Ras and the 
members of the superfamily act as molecular switches (Figure 1.1), whereby two classes of 
regulatory proteins determine the lifetime of these two states: guanine nucleotide exchange 
factors (GEFs) and GTPase activating proteins (GAPs).  
 
 
 
Figure 1.1: The molecular switch of Ras. Bound to GDP Ras is in its inactive form. Upon the stimulated 
exchange of GDP against GTP Ras becomes activated and is now able to interact with its effectors. The 
signal is terminated by the hydrolysis of the bound GTP. Ras turns back into its GDP-bound state and can no 
longer interact with effectors. 
 
The resting GDP-bound state of Ras becomes activated by the stimulated exchange of 
GDP against GTP. This reaction is intrinsically very slow and can be accelerated by 
several orders of magnitude. GDP dissociates in less than one second from the protein in 
complex with its GEF. Subsequently GTP, the most abundant nucleotide in the cell enters 
the binding pocket followed by the release of the exchange factor. In its active state Ras is 
now able to interact with effector molecules activating the corresponding cellular response 
(see e.g. Herrmann 2003). Signalling can be switched off by the hydrolysis of the bound 
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GTP at the γ-phosphate. Ras itself exhibits intrinsic GTPase activity for this reaction, 
which is very slow with 0.028 min-1 at 37 °C and can be accelerated by a factor of 105 in 
the presence of GTPase activating proteins (Scheffzek et al. 1997 1996). Upon the release 
of inorganic phosphate Ras is in its inactive state again and can no longer interact with 
effector molecules. 
Ras is the founding member of the superfamily of Ras-related guanine nucleotide binding 
(GNB) proteins, which can be subdivided into the five major subfamilies Ras, Rho, Rab, 
Ran and Arf (Wennerberg et al. 2005). They have the common ability to bind GDP and 
GTP with high selectivity and high affinity, which is in the order 10 pM for Ras strongly 
dependent on the presence of Mg2+-ions (John et al. 1990, Neal et al. 1990,  
Schmidt et al. 1996). About 100-150 different GNB proteins are present in a single cell and 
regulate a multitude of signal transduction and transport processes (Wennerberg et al. 
2005). The different subfamilies and their specific function within the cell are summarized 
in Table 1.1.  
 
Table 1.1: Subfamilies of the Ras-related GNB proteins, their members and cellular function. 
Subfamily Members Cellular Function 
Ras 
 
Rat sarcoma 
 
Ras, Rap, Rit, Rem, TC21, 
Rad, Gem, Rheb, Ral, Rerg 
proliferation, 
differentiation, apoptosis 
Rho 
 
Ras homologous 
 
Rho, Rnd, Rif, Rac, Cdc42, 
TC10, TCL, Wrch 
cytoskeleton, proliferation, 
gene expression 
Rab Ras-like proteins in brain Rab vesicular transport 
Ran Ras-like nuclear protein Ran nuclear transport 
Arf ADP-ribosylation factor Arf, Sar, Arl, Ard vesicular transport 
 
 
Ras initiates different signal cascades, which control cell differentiation, proliferation or 
apoptosis by transducing extracellular ligand-mediated stimuli to the nucleus. The most 
prominent and best understood Ras-mediated pathway is the mitogen-activated protein 
kinase (MAPK) cascade, which receives stimuli from growth factors and hormones, which 
are transmitted to the cell by tyrosine kinase receptors (Burgering and Bos 1995). Binding 
of the external ligand to its receptor tyrosine kinase (RTK) leads to the phosphorylation 
and dimerization of the receptor. The activated RTK becomes phosphorylated at specific 
tyrosine residues in its intracellular domain followed by the binding of the sequence 
homology 2 (SH2) domains of adaptor proteins like Grb2 (growth-factor-receptor bound 
protein 2) to the phosphorylated residues. These proteins also contain a SH3 domain 
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capable of binding proline rich motifs in proteins like SOS (son-of-sevenless), which is a 
guanine nucleotide exchange factor of Ras. SOS is recruited to the plasma membrane, 
binds to Ras and catalyzes the exchange of GDP against GTP. Ras, now in its active 
conformation associates with its downstream effector Raf, a serine/threonine kinase. Upon 
activation of its kinase activity Raf phosphorylates and activates the MAPK kinase 
(MAPKK) MEK, which in turn catalyzes the phosphorylation and activation of ERK, 
another MAPK. Consequently ERK both activates its cytosolic substrates and translocates 
to the nucleus, where different cellular events such as proliferation, differentiation or 
apoptosis are stimulated. It has to be noted here that Ras is not only involved in one linear 
signalling pathway, but rather part of a complex network of signal transduction events 
(Schubbert et al. 2007). It can be activated by several signals and relays the information to 
more than one downstream effector as revealed by experiments with effector region 
mutants of Ras: whereas certain pathways are blocked others are not affected (White et al. 
1995, Qui et al. 1995 1997, Koshravi-Far et al. 1995). 
 
1.1.2 Three Dimensional Structure of Ras 
The highly flexible C-terminus of Ras impairs crystal packing of the full length protein. 
Since this region is not essential for the biochemical properties of Ras (John et al. 1989), 
but only for its biological activity, versions truncated at either position 166 or 172 have 
been successfully crystallized. Correspondingly, biophysical investigations are mainly 
carried out with truncated Ras. All members of the Ras superfamily share the same overall 
structural fold, the so-called G domain, which is responsible for the basic processes such as 
nucleotide binding and hydrolysis. This core domain consists of a central six-stranded β-
sheet and five α-helices located on both sides of the sheet (Vetter and Wittinghofer 2001). 
It contains six conserved sequence elements involved in either coordinating the guanine 
base (G motifs) or the magnesium ion and/or the phosphate groups (PM motifs). The PM1 
motif 10GxxxxGK(S/T)17 encircles the β- and γ-phosphate of the bound nucleotide and is 
for that reason also called phosphate binding loop or P-loop (Saraste et al. 1990). The 
invariant lysine16 adopts a ring-like structure and twines around the β-phosphate. A 
positively polarized environment is created for the negatively charged phosphate groups by 
the main chain nitrogens of residues 13–16 pointing towards the phosphates and the side 
chain of lysine16. Serine17 coordinates the magnesium ion via its side chain hydroxyl group 
and additionally forms a hydrogen bond with the β-phosphate via its main chain NH 
(Saraste et al. 1990). The totally conserved threonine35 residue represents the PM2 motif. 
In the triphosphate form its side chain interacts with the magnesium ion and the main chain 
NH forms a hydrogen bond with the γ-phosphate. This residue is key player within the 
conformational switch process upon hydrolysis (see section 1.1.3.2) along with glycine60 of 
the PM3 motif 57DxxG(Q/H/T)61, which forms a main chain hydrogen bond with the  
γ-phosphate (Vetter and Wittinghofer 2001). Within the latter motif aspartate57 is 
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connected to the γ-phosphate through a water molecule and glutamine61 plays a crucial role 
in the hydrolysis mechanism by the stabilization of the transition state (see section 1.1.3.3). 
Figure 1.2 shows the ternary and primary structure of Ras. 
 
 
 
Figure 1.2: Primary and ternary structure of Ras.  (A) Ribbon plot of wild type Ras complexed to 
GppNHp. Conserved sequence elements around the nucleotide are colored orange. The two switch regions 
are shown in blue. (B) Schematic representation of the location of the conserved sequence elements in the 
primary structure, color coded analogous to (A) (modified from Wittinghofer and Waldmann 2000). 
 
As mentioned above nucleotide binding is very strong in Ras proteins, which is reflected 
by the large number of polar interactions between GppNHp and the nucleotide binding site 
in wild type Ras (Figure 1.3).  
 
 
 
Figure 1.3: Interactions between selected residues in Ras with GppNHp bound (taken from 
Wittinghofer and Waldmann 2000). 
 
Only members of the Ras superfamily share the G1 motif, which is either tyrosine or 
phenylalanine (Phe28 in the case of Ras). This residue is orientated orthogonal to the 
guanine base and forms strong hydrophobic interactions supported by lysine117 from the 
G2 motif (116(N/T)KxD119). This motif provides additional ionic interactions and hydrogen 
bonds. The side chains of the G3 motif with only the alanine residue being totally 
conserved is not involved in any binding of the nucleotide by its side chains. By stabilizing 
amino acids from other G motifs, e.g. lysine147 stabilizes the G1 motif, it functions as 
helper for nucleotide binding. The strong hydrogen bond formed between the main chain 
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of alanine146 and O6 of the base is responsible for the specificity for guanine nucleotides 
(Rensland et al. 1995). 
 
1.1.3 The Switch Mechanisms and Conformations 
1.1.3.1 Structural Differences 
Switching from the inactive state to the active one and vice versa is accompanied by 
structural changes within two adjacent regions of the protein, namely switch I (residues  
30-40) and switch II (residues 60-76) (Milburn et al. 1990). These residues have been 
shown to be highly flexible by NMR and EPR studies (Ito et al. 1997, Farrar et al. 1997). 
The universal switch mechanism involves the invariant Ras residues Thr35 and Gly60, 
which are hydrogen bonded to the γ-phosphate oxygens of the bound nucleotide via their 
main chain NH-groups. In the so-called ‘loaded-spring” mechanism the release of the  
γ-phosphate upon hydrolysis allows the switch regions to adopt a more relaxed 
conformation (Vetter and Wittinghofer 2001). The inactive and the active conformation of 
wild type Ras are shown in Figure 1.4.  
 
 
 
Figure 1.4: Wild type Ras in its inactive and active conformation. Shown are the crystal structures of 
Ras(wt)·Mg2+·GDP (left, pdb 4q21) and Ras(wt)·Mg2+·GppNHp (right, pdb 5p21). The invariant residues 
threonine35 and glycine60 are highlighted in blue.  
 
1.1.3.2 The 'Switch On' Reaction 
The 'switch on' reaction, the exchange of GDP against GTP is increased by guanine 
nucleotide exchange factors, which can be subgrouped into two different classes 
(Downward et al. 1996). The first group compromises RasGEFs, which are activated by 
second messengers like Ca2+, Ca2+-calmodulin or diacylglycerol (Shou et al. 1992, 
Martegani et al. 1992). The second class is represented by SOS (son-of-sevenless), which 
possesses a proline-rich region for the interaction with the SH3 domain of adapter 
molecules like Grb2 (Li et al. 1993). Two regions are conserved in all Ras-specific GEFs: 
the Cdc25-like domain, necessary and sufficient for nucleotide exchange (Lenzen et al. 
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1998) and the so-called Ras exchange motif (REM), which is located in a variable distance. 
This domain is mainly responsible for the stability of the catalytic domain (Fam et al. 
1997). The GEF stimulated nucleotide exchange reaction is a multistep mechanism 
involving binary and ternary complexes between the Ras protein, the nucleotide and the 
exchange factor. In SOS the Ras exchange motif and the Cdc25-like domain are adjacent 
to each other and built the so-called SOScat region, compromising about 500 residues. The 
structure of the complex between SOScat and nucleotide-free Ras was solved by Boriak-
Sjodin et al. (1998) providing more detailed mechanistic insight into the exchange reaction. 
SOS mainly interacts with the switch regions, the P-loop and helix α3 of Ras. Selected 
interactions are shown in Figure 1.5 and compared to the structure of wild type 
Ras·Mg2+·GppNHp. The Ras-nucleotide interaction is affected in two ways due to the 
action of SOS. First of all the affinity for the nucleotide is weakened due to the disruption 
of crucial interactions with the nucleotide, the magnesium ion and the phosphate group. 
The tight binding of SOS induces a structural rearrangement in the backbone of switch II.  
 
 
Figure 1.5: Interactions in the nucleotide-binding site compared between active wild type Ras alone 
and its complex with SOS. (a) Selected interactions between Ras and a GTP analogue (pdb 5p21). (b) 
Selected interactions between Ras and SOS are shown in the same orientation as in (a). Only helix αH and 
selected side chains of SOS are shown. (c) The nucleotide-binding site on the surface of Ras in a Ras–GTP 
analogue (pdb 5p21) is shown. The side chain of Tyr 32 was deleted from the surface calculations for clarity. 
(d) The surface of Ras in the Ras–SOS complex is shown with the backbone of SOS (N-domain deleted) as a 
green ribbon. Ras is in a slightly different orientation from that in (c). In (b) and (d) the nucleotide is shown 
for reference only (taken from Boriak-Sjodin et al. 1998). 
 
As a consequence alanine59 occupies the magnesium binding site and the glutamate62 side 
chain interacts with both the NH of glycine60 and side chain of lysine16. Secondly, the 
release of the bound nucleotide is facilitated. The nucleotide binding site opens up by the 
insertion of a helical hairpin (helix αH of SOS), which forces switch I to flip out of its 
position in the GTP-bound conformation. The stabilizing interaction of phenylalanine28 
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with the nucleotide is now missing. Magnesium and phosphate binding is additionally 
disturbed by the side chain interaction of leucine938 with serine17 in Ras and the carboxyl 
group of glutamate942, which is located, where the α−phosphate is found in the nucleotide-
bound form. In summary switch I is pushed away from its normal position, whereas switch 
II is pulled towards the nucleotide binding site. This mode of GEF action has been termed 
‘push-and-pull mechanism’ (Vetter and Wittinghofer 2001). It has to be mentioned that an 
additional binding site distal to the binding site of nucleotide free Ras in SOScat, which is 
specific for Ras·GTP was identified by Maragrit et al. (2003). They solved the crystal 
structure of the ternary Ras·GppNHp:SOScat:Ras(nucleotide-free) complex. The interaction 
of Ras·GTP with SOS resembles the interaction of active Ras with its effectors. Due to its 
binding the REM motif is oriented differently and the number of interaction sites between 
nucleotide-free Ras and the active site of SOS is increased.  
 
1.1.3.3 The 'Switch off' Reaction 
Since oncogenic activation lacks the intrinsic as well as the GAP accelerated GTPase 
reaction (see section 1.1.6) the 'switch off' reaction is of high biochemical and medicinal 
interest. Ras signalling can be terminated by either its intrinsic or its GAP mediated 
GTPase activity. Both reactions are not understood in detail to date. The main discussion is 
about the nature of the phosphoryl transfer, which might be associative or dissociative 
(Wittinghofer 2006). The intrinsic GTPase reaction is proposed to rely on a substrate-
assisted mechanism, where the γ-phosphate group itself acts as a base and activates the 
nucleophilic attack of the water molecule (Schweins et al. 1995). The GAP-mediated 
hydrolysis reaction has been subject to discussions for a long time. In one assumption the 
role of GAP was confined to catalyzing a rate-limiting isomerization in the Ras protein. 
Ras only becomes activated through the action of GAP and is itself an efficient GTPase 
(Rensland et al. 1991). In a second model GAP is directly involved in the hydrolysis 
reaction, providing crucial residues and stabilizing the transition state. Figure 1.6 gives a 
detailed view of the interaction between Ras and RasGAP. The so-called 'arginine-finger 
hypothesis' with a conserved arginine residue of GAP being such a residue has been 
supported by several experimental data. It has, for example been shown to be necessary for 
GAP catalysis, but not for binding of GAP (Ahmadian et al. 1996 1997). Scheffzek et al. 
(1997) solved the structure of the Ras-GDP-AlF3-GAP-334 complex mimicking the 
transition state of the hydrolysis reaction. Indeed, Arg789 of GAP represents a key residue 
in hydrolysis. Its side chain (the ‘arginine-finger”) points into the active site of Ras and 
coordinates an oxygen of the γ-phosphate group and the β,γ-bridging oxygen. Its carbonyl 
oxygen is hydrogen bonded to the side chain NH of Ras Gln61, which also forms hydrogen 
bonds to the attacking water molecule along with Thr35 (see Figure 1.6). This mechanism is 
not common to all Ras-like proteins, e.g. RanGAP and RapGAP do not provide an arginine 
finger (Seewald et al. 2002, Scrima et al. 2008). 
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Figure 1.6: Details of the interaction between Ras and RasGAP: structural view on the active site.  
Critical residues of Ras (yellow) and GAP-334 (red) are shown in ball and stick (taken from  
Scheffzek et al. 1997). 
 
 
1.1.4 Association of Ras with Effectors 
1.1.4.1 Structural Principles 
In spite of the fact that all known Ras effectors differ in their function and show no 
remarkable sequence homology, they do have a common region of roughly 100 amino 
acids responsible and sufficient for the interaction with Ras, termed Ras binding domain 
(RBD) or, in the case of AF6 and RalGDS Ras association (RA) domain (Ponting and 
Benjamin 1996). NMR and X-ray analyses of the RB or RA domains of the Ras effectors 
Raf (Emerson et al. 1995), RalGDS (Huang et al. 1997, Kigawa et al. 1998, Geyer et al. 
1997, Vetter et al. 1999), AF6 (Steiner et al. 2000) and Byr 2 (Gronwald et al. 2001) 
revealed that they all share the same topology, the ubiquitin fold (ββαββαβ). They interact 
in a similar manner with Ras (Nassar et al. 1995 1996, Huang et al. 1998, Walker et al. 
1999, Pacold et al. 2000, Scheffzek et al. 2001), forming an intermolecular β-sheet by the 
antiparallel co-alignment of RBD β2 and Ras β2 within the switch I region. Additionally 
residues flanking the so-called effector region of Ras (residues 32-40) contribute to the 
interaction. Despite this common interaction pattern in Ras-effector complexes the binding 
affinities can differ up to 100-fold ranging between 20 nM and 2 µM (Wohlgemuth et al. 
2005), which indicates precise adjustments within the interface for distinct specificities. 
Recently a different type of Ras-effector interaction involving switch II of Ras has been 
reported (Stieglitz et al. 2008). In NORE 1 (novel Ras effector) the RA domain is not 
sufficient for the association of Ras. Additional residues provided by the N-terminal 
extension of the RA fragment are necessary. Residues cysteine220 and leucine221 build 
strong hydrophobic interactions with Ras switch II residues tyrosine64 and methionine67.  
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1.1.4.2 Interaction between Ras and Raf-RBD 
The structure of Ras and the RBD of Raf has not been solved so far, but the crystal 
structures of the Ras analogues Rap1A and Raps (Rap(E30D,K31E)) in complex with Raf-
RBD (Raf residues 51-131) are available (Nassar et al. 1995 1996). The overall sequence 
homology between Raps and Ras is 50% and in the interface region 95%. Raps residues 
33-41, almost matching switch I are involved in the interaction with Raf-RBD. However, 
mutations in the switch II region, e.g. D57A and A59T of Ras also impair binding of Raf-
RBD (Shirouzo et al. 1994). An additional region in Raf, the so-called cysteine rich 
domain (CRD) compromising residues 139-154 influences the Ras-Raf interaction (Gosh 
et al. 1994, Gosh and Bell 1994). It requires an intact switch II region for its binding 
activity (Drugan et al. 1996). Peptides compromising residues of the Raf-RBD, which do 
not contribute to the interaction with Raps in the crystal structure have been shown to have 
an inhibitory effect on Ras-Raf association (Barnard et al. 1995). The Ras-Raf-RBD 
complex is highly dynamic, exhibiting both fast association and dissociation (Gorman et al. 
1996). The association between Ras and Raf-RBD can be described by a minimal model 
compromising a two-step binding mechanism resulting in a hyperbolic dependence of the 
observed rate constants on increasing concentrations of Raf-RBD (Sydor et al. 1998, 
Linnemann et al. 1999). First a loosely bound encounter complex is formed, which 
subsequently isomerizes into a tight binding complex. A dissociation constant K1 = k-1/k1 
of 12 µM, a k2-value of 415 s-1 and an overall affinity of 0.05 µM is derived for the 
association between wild type Ras and Raf-RBD (Spoerner et al. 2001). Studies on the 
kinetics with 10 different RBDs and Raf demonstrated that the rate constants are conserved 
during evolution (Kiel et al. 2004). Since the Ras-Raf-RBD interface mainly constitutes of 
electrostatic interactions (Nassar et al. 1996, Zeng et al. 1999, Wohlgemuth et al. 2005, 
Kiel et al. 2005, Kiel and Serrano 2006) it is proposed that the formation of the initial low 
affinity complex is mainly driven by electrostatics and allows Ras to discriminate binding 
partners very quickly (Goldfinger 2008) before isomerizing to the higher affinity complex. 
Experimental data of the association between NORE1 and Ras support this assumption. 
Whereas the on-rate of the association is similar compared to Raf-RBD the off-rate is 
much lower probably to the additional interaction provided by the N-terminal extension 
with Ras switch II (Stieglietz et al. 2008). 
1.1.4.3 Partial Loss-of-Function Mutants 
Certain mutations in the effector region of Ras lead to so-called partial loss-of-function 
mutants, which only interact with a subset of the known Ras effectors (White et al. 1995, 
Akasaka et al. 1996).  These mutants have intensively been used to investigate the role of 
Ras in certain signalling pathways (Joneson et al. 1996, Koshravi-Far et al. 1996, 
Rodriguez-Vicinia et al. 1996 1997, Wolthuis et al. 1996, Vavvas et al. 1998). Threonine35 
is a highly conserved residue in the switch I region of Ras. In Ras-effector complexes it is 
involved in the coordination of the crucial metal ion via its side chain hydroxyl group and 
of the γ-phosphate of the bound nucleotide via its main chain NH (Nassar et al. 1995 1996, 
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Vetter et al. 1999). Mutation to serine blocks the association with Byr or RalGDS, whereas 
the Raf signalling pathway is not affected. Kinetic stopped flow analysis showed that the 
interaction of Ras(T35S) and Raf-RBD follows a two-step mechanism as described above 
for wild type  Ras, but the affinity for Raf-RBD is diminished by a factor of approximately 
60 (Spoerner et al. 2001). In contrary the same experiments with the corresponding alanine 
mutant indicate a different effector-binding conformation, which does not involve a rate-
limiting step. The association kinetic switches into a one step mechanism with linear 
dependence on the concentration of Raf-RBD (Spoerner et al. 2001). The effector can still 
be bound by the mutant leading to the weak complex, but the rate limiting step, the 
isomerzation to the high affinity complex is missing (see Figure 1.7).  
 
 
 
Figure 1.7: Kinetics of the association between wild type and mutant Ras·mantGppNHp and Raf-RBD. 
Plot of the observed rate constants against the effector concentration (taken from Spoerner et al. 2001). 
 
 
1.1.5 31P NMR Spectroscopy - The Bound Nucleotide as Probe 
1.1.5.1 31P NMR Spectroscopy  
The 31P isotope is a NMR active nucleus with a spin number of I = 1/2 and a natural 
abundance of 100%. 31P NMR spectroscopy represents a quite attractive method for the 
study of GNB proteins since the only phosphorus atoms present arise from the bound 
nucleotide, which is located directly in the active site of Ras. The conformational switch 
from the inactive to the active state is accompanied by structural changes within regions, 
which are directly involved in nucleotide binding. These structural differences are directly 
reflected by changes in the NMR parameters, such as chemical shift values, line widths or 
relaxation characteristics of the phosphorus atoms in the nucleotide. The 31P chemical 
shifts of phosphorus compounds can extend over a range of approximately 100 ppm 
creating spectra with only few overlap. The areas of the observed peaks can be used as a 
direct measure of relative populations of for example different conformational states. The 
major drawbacks are the high amount of protein one needs and the quite long aquisition 
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time due to the low sensitivity of 31P (6.64% of 1H) and its long relaxation time. The NMR 
sample commonly consists of 500 µL protein solution with a concentration in the 
millimolar range. In order to obtain a spectrum with sufficient quality a typical aquisition 
compromises about 2000 scans and takes about four hours. 
 
1.1.5.2 Conformational Dynamics in Active Ras 
As mentioned above the only phosphorus atoms present in the Ras protein are the ones 
from the bound nucleotide. Consequently one would expect three distinct signals 
representing the three phosphate groups in active Ras. 31P NMR spectroscopic 
investigations on Ras bound to its physiological triphosphate nucleotide GTP gives one 
signal per phosphate group, when recorded at room temperature (Rösch et al. 1986). A 
different picture is obtained in experiments at lower temperatures with Ras complexed to 
the GTP-analogues GppCH2p or GppNHp (see Figure 1.8 (B), (C)), commonly used in 
biochemical studies due to their reduced rate of hydrolysis.  
 
 
 
 
Figure 1.8: GTP (A) and its slowly hydrolyzing analogues GppCH2p (B), GppNHp (C) and GTPγS (D). 
These analogues are commonly used in biochemical studies of the active form of Ras due to their reduced 
rate of hydrolysis. Substitutions compared to the physiological nucleotide are highlighted in red. 
 
At least two distinct conformational states, called state (1) and state (2) represented by 
different 31P NMR chemical shift values for the α- and γ-phosphate groups can be found in 
active wild type Ras (see Figure 1.9) with a relative population of state (2) over state (1) of 
1.9 at 278 K (Geyer et al. 1996, Spoerner at al. 2001 2005a). These states are in dynamic 
equilibrium with exchange rates in the millisecond time scale at room temperature. At 
higher temperatures the exchange between these two conformational states becomes fast 
and consequently only one peak is observed for each phosphate group with a chemical shift 
at the population averaged position. The coexistence of both states was also revealed by 
solid-state 31P NMR- spectroscopic investigations on Ras crystals (Stumber et al. 2002, 
Iuga et al. 2004) or precipitated Ras (Ader et al. 2007). 
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As shown in Figure 1.9 state (2) becomes stabilized, when Ras is complexed to the RBDs 
of its effectors (Geyer et al. 1996 1997, Gronwald et al. 2001, Linnemann et al. 1999, 
Spoerner et al. 2001 2004 2005a). For that reason state (2) is also known as the effector 
binding state and is strongly assumed to resemble the structure adopted by Ras in complex 
with its effectors. In contrast state (1) shows drastically reduced affinity for effector 
molecules as studied by calorimetric and fluorescence-based methods as well as 31P NMR 
spectroscopy (Spoerner et al. 2001 2004 2007). The affinity of state (1) to Raf-RBD is 
smaller by a factor of approximately 20. For that reason state (1) was initially referred as 
the so-called weak effector-binding state. Recent results demonstrated that conformational 
state (1) is selectively recognized by the exchange factor SOS (Kalbitzer et al. 2009) as 
revealed by strong line broadening of the 31P resonances of wild type Ras·Mg2+·GppNHp 
upon complex formation with SOS.  
 
 
 
 
Figure 1.9: Main functional states of Ras·Mg2+·GppNHp as detected by 31P NMR spectroscopy.  31P 
NMR spectra of (a) wild type Ras and (b) the partial loss-of-function mutant Ras(T35S) complexed to 
Mg2+·GppNHp. Spectra (c) and (d) show Ras(T35)·Mg2+·GppNHp in complex with SOS(W729E) and Raf-
RBD, respectively (taken from Kalbitzer et al. 2009). 
 
Consequently state (1) is expected to be structurally closer related to the conformation of 
Ras in complex with GEFs. In the crystal structure of Ras(G60A)·Mg2+·GppNHp (Ford et 
al. 2005), which exists in conformational state (1) from the spectroscopic view switch I 
adopts a position similar to the one found in Ras in the complex with SOS supporting the 
above suggestion. Threonine35, totally conserved in all members of the Ras superfamily, is 
involved in the coordination of the Mg2+ via its side chain hydroxyl group and contacts the 
γ-phosphate group with its main chain NH in active wild type Ras. Both interactions are 
missing in the crystal structure of Ras(G60A)·Mg2+·GppNHp (Ford et al. 2005). Replacing 
this threonine residue against serine or alanine gives mutants predominately existing in 
conformationals state (1) (Spoerner et al. 2001). Whereas upon addition of effector-RBDs 
the dynamic equilibrium shifts towards state (2) in the case of the serine mutant, in the 
spectra of the alanine mutant solely broadening of the resonance lines can be observed. 
This difference in effector binding between the two mutants was also revealed by stopped 
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flow experiments with Ras loaded with a fluorescently labelled nucleotide (see section 
1.1.4.3). Figure 1.9 shows the main conformational states of active wild type Ras and the 
mutant Ras(T35S). 
In GTPγS, another slowly hydrolyzable analogue for GTP the γ-phosphate group is 
modified by the replacement of an oxygen atom against sulfur (see Figure 1.8 (D)). When 
bound to wild type Ras only one conformational state corresponding to state (2) in 
complex with Mg2+·GppNHp or Mg2+·GppCH2p is prevalent (Spoerner et al. 2007). In 
contrast in the 31P NMR spectra of the Ras mutants T35A and T35S two sets of resonances 
are visible for the β- and γ-phosphorus atoms when GTPγS is bound (see Figure 1.10).  
 
 
 
 
Figure 1.10: 31P NMR spectra of wild type and mutant Ras complexed to the GTP analogue GTPγS 
(modified from Spoerner et al. 2007). 
 
These states have been identified to represent substates of conformational state (1) 
interconverting in the millisecond time scale with a free activation energy  
∆G1a1b = 41 kJ mol-1 and a K1a1b value of 0.5. In the case of the serine mutant a third line 
corresponding to the one in wild type Ras is visible for the γ-phosphorus. Saturation 
transfer experiments revealed that state (1b) is also present in wild type Ras but as 
aforementioned very little populated and thus not visible. In good agreement with previous 
results obtained with the GppNHp and GppCH2p complexes only the serine, but not the 
alanine mutant can be shifted towards conformational state (2) in the presence of different 
RBDs. As already mentioned the 31P NMR spectrum of Ras(wt) complexed to its 
physiological nucleotide GTP gives one resonance line for each phosphate group (Rösch et 
al. 1986), representing conformational state (2). 31P NMR experiments at higher fields 
clearly reveal the existence of second set of resonances only little populated for 
Ras(wt)·Mg2+·GTP at 278 K (Spoerner et al., unpublished results). The second 
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conformational state is identical to the one found in the partial loss-of-function mutants 
Ras(T35A) and Ras(T35S). 
In summary active wild type Ras is in dynamic equilibrium between at least two 
conformational states with K12 values depending on the bound nucleotide. One state 
becomes stabilized by effector binding, whereas the other one is required for the 
interaction of GEFs. The coordination of the γ-phosphate group by threonine35 is strongly 
suggested to be transient in solution indicating a high flexibility of the sidechain and/or the 
loop containing Thr35 (Bellew et al. 1996, Halkides et al. 1996). Supporting data is derived 
from the crystal structure of Ras(T35S)·Mg2+·GppNHp, where the switch regions are not 
visible (Spoerner et al. 2001). Additionally it could be shown that both states differ in their 
GTPase activity with the latter one being faster in conformational state (2) (M. Spoerner, 
unpublished results). Relaxation measurements on wild type Ras·Mg2+·GppNHp indicate 
that the major part of the catalytic domain of the Ras GTPase is involved in this 
conformational exchange (O´Connor and Kovrigin 2008).  
 
1.1.5.3 31P High Pressure NMR Spectroscopy on Ras(wt)·Mg2+·GppNHp 
Conformational dynamics are of high interest when studying the function of proteins. In 
solution multiple conformational states have to coexist for a given protein allowing the 
quick response to changes in its environment. In order to obtain a complete picture of the 
function and dynamics in a protein it is not sufficient to study solely the main 
conformation, which is usually obtained in crystallography. Different approaches 
disturbing the environment, such as changing the pH value, the temperature or the addition 
of chaotropic substances like guanidine hydrochloride are followed in order to force the 
protein to turn into its structural substates. The main drawback within these methods is the 
fact that the whole system may be influenced. High pressure NMR represents a novel tool 
for the characterization of structural subensembles (Kremer 2006, Akasaka 2006). The 
increased sensitivity of NMR allows for the investigations of the pressure effects in 
macromolecules at atomic resolution, e.g. the detection of intermediate states (Kachel et al. 
2006). Transitions between different conformational states are accompanied by changes in 
the specific volume (Akasaka and Li 2001). Excited states are generally solvated to higher 
extend and exhibit a smaller specific volume. Under high pressure structures with smaller 
specific volumes ∆V0 are stabilized and consequently low populated excited states can be 
detected. The structure of the substate of interest is hereby only slightly affected but rather 
the relative populations between the different conformations allowing for structural 
characterization. In order to distinguish real structural changes from chemical shift 
differences induced by pressure the proton chemical shift dependence on pressure was 
investigated in random coil model peptides giving an amino acid specific pressure 
coefficient (Arnold et al. 2002). Unfortunately such data are missing for the amide nitrogen 
chemical shifts to date, but work is currently ongoing at the department.  
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As described in section 1.1.5.2 active Ras exists in an equilibrium between different 
conformational states. Increasing pressure on wild type Ras complexed with GppNHp 
shifts the dynamic equilibrium towards conformational state (1) in a reversible manner as 
shown by 31P NMR spectroscopy (Kalbitzer et al. 2009). At a pressure of 200 MPa the 
relative population of conformational state (2) over (1) decreases from 1.9 to 0.44 at 
278 K. The difference of the specific volumes between the two conformational states was 
calculated to be ∆V0 = 17.2 ml mol-1.  
 
1.1.6 Targeting Ras in Antitumoral Therapy 
1.1.6.1 Oncogenic Ras Mutants 
In many human malignancies Ras is found mutated (Bos 1989) ranging from 95% in 
pancreas carcinomas (Almoguera et al. 1988), 65% in colon cancer (Burmer and Loeb 
1989), 46% in endometrial carcinomas (Enomoto et al. 1990) to 16% in carcinomas of the 
bladder (Visvanathan et al. 1988). The reason therefore is a point mutation at either 
position 12, 13 or 61 (Seeburg et al. 1984, Karnoub and Weinberg 2008). As a result the 
protein is locked in its active GTP-bound conformation due to the loss of both, its instrinsic 
and GAP accelerated GTPase activity, which contributes to uncontrolled cell growth and 
thus to tumor formation (Bos 1989). The structural basis for the oncogenic potential of a 
mutation at either position 12, 13 or 61 in Ras in explained in Figure 1.11.  
 
 
 
 
Figure 1.11: Structural basis for the oncogenic potential of Gly12, Gly13 and Gln61 mutants of Ras. Close 
approach of the finger loop of GAP-334 to loops L1 (P-loop) and L4 of Ras. In position 12 of Ras, normally 
glycine, an alanine side chain has been introduced (gray) into the model to show that even small substitutions 
would be within van der Waals distance (gray sphere) to Gln61 (NH2, blue sphere) and Arg789 (CO, red 
sphere), glycine13 is more remote from GAP-334 (from Scheffzek et al. 1997). 
 
As described in section 1.1.3.3 Arg789 of GAP is coordinated to the side chain of Ras Gln61 
via its carbonyl oxygen explaining the oncogenic potential of mutations at position 61. 
Glycine12 mutants bind to GAPs with similar affinity as does the wild type protein. 
Consequently the mutation can be tolerated in the ground state of the formed complex. A 
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different picture is obtained in the transition state. The glycine residues of Ras at positions 
12 and 13 are in close proximity to the finger loop. Any substitution at these positions, 
even the smallest possible one against alanine sterically interferes with the interaction 
between Arg789 and Gln61. The structural basis for the oncogenic potential of a mutation at 
either position 12, 13 or 61 in Ras in explained in Figure 1.11. 
 
1.1.6.2 General Strategies 
In the late 80ies it became more and more apparent that aberrations in signalling pathways 
contribute to many diseases such as cancer. Consequently a lot of effort has been put into 
the development of drugs targeting cell signalling events. This type of disease management 
is termed signal-transduction therapy (Levitzki 1994). In the case of Ras signalling four 
approaches have been reported for the interruption of aberrant signalling (Figure 1.12) and 
will briefly be discussed. 
 
Inhibition of Membrane Attachment 
As mentioned in section 1.1.1 posttranslational modifications of Ras are necessary in order 
to obtain biological activity. The first process is catalysed by the enzyme 
farnesyltransferase, which thioalkylates a cysteine residue within the CAAX (CVLS in 
Ras) box with a C15 prenyl group followed by C-terminal proteolysis and methylation and 
the attachment of a C16 palmitoyl group. Inhibition of this posttranslational modification 
renders the protein inactive due to the impaired membrane attachment (Gelb et al. 2006). 
The main target of inhibitors in this approach is represented by the enzyme farnesyl 
transferase (Basso et al. 2006). Tetrapeptides mimicking the CAAX-box represented the 
first inhibitors (Reiss et al. 1990), followed by peptidomimetics and finally non-peptide 
inhibitors. An example for the latter is given by BMS-214662 with an IC50-value of  
1.35 nM (Hunt et al. 2000, Rose et al. 2001, Cortes et al. 2005). This compound is subject 
to anticancer clinical trials at the moment. 
 
 
 
 
Figure 1.12: General strategies for the inhibition of Ras signalling and selected examples for inhibitors. 
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Induced GTPase Activity 
A key process within the Ras cycle is the 'switch off' reaction, which is missing in the case 
of oncogenic mutants (Bos et al. 1989). Originally designed as a slowly hydrolyzable GTP-
analogue like GppNHp, GppCH2p or GTPγS diaminobenzophenonephosphoroamidate-
GTP (DABP-GTP) was found to be efficiently turned over to the corresponding 
diphosphate form and DABP-Pi by Gsα (Zor et al. 1997). Similar results have been 
obtained with active Ras (Ahmadian et al. 1999), where the rate of hydrolysis is even 10-
fold higher compared to the physiological nucleotide GTP in wild type Ras. Moreover it 
was shown, that the rate of hydrolysis in the oncogenic mutants Ras(Q61N) and 
Ras(G12V) complexed to DABP-GTP can be accelerated up to 220- and 720-fold, 
respectively (Ahmadian et al. 1999). The crystal structures of Ras(G12V) and Ras(G12P) 
complexed to DABP-GTP have been solved and can provide tools for the structure-based 
design of anti-Ras drugs.  
 
Inhibition of the Nucleotide Exchange of GDP against GTP 
Since oncogenic mutants of Ras are locked in their active GTP-bound conformation 
another promising approach contains the inhibition of the GDP-exchange reaction. The 
Schering-Plough Research Institute has reported on compounds capable of inhibiting the 
exchange reaction in the low µM range (Taveras et al. 1997). These compounds form a 
noncovalent complex with Ras·GDP (Ganguly et al. 1997). The interaction of one of these 
compounds SCH-54292 with Ras·GDP was investigated in more detail by NMR 
spectroscopy (Ganguly et al. 1998) revealing the binding site to be close to the switch II 
region. An important role is adapted by the hydroxylamine group, which is located in close 
vicinity to both the magnesium ion and the β-phosphate group. Since the sugar moiety of 
the compound was pointing outside the binding pocket indicating no contribution to the 
binding, compounds missing the sugar moiety (Colombo et al. 2004, Peri et al. 2005) were 
designed and tested. However, the detailed modes of binding and inhibition are still under 
investigation.  
 
Inhibition of the Interaction with Effector Molecules 
In order to prevent aberrant signalling in oncogenic Ras the direct inhibition of the 
interaction with effector molecules represents another interesting approach. The 
development of inhibitors directly interfering with the Ras-Raf association is quite 
challenging due to the large surface area covered by the interaction site (Downward 2003). 
Sulindac, a nonsteroidal anti-inflammatory drug applied in the treatment of many cancers 
was found to inhibit the growth of tumors containing activated Ras to a higher degree than 
of those harbouring the wild type ras gene (Thompson et al. 1997). Its active metabolite 
sulindac sulfide has been shown to potently interfere with the Ras-Raf interaction due to its 
binding activity for active Ras (Herrmann et al. 1998). Ind12, a compound derived from 
sulindac also interferes with the Ras signalling pathway, but its mode of action remains 
unclear (Karaguni et al. 2002). The screening of a 189 compound library structurally based 
on sulindac yielded eight promising hits exhibiting a up to 30 times higher potency in the 
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cytotoxicity assay than sulindac (Müller et al. 2004). These compounds were further tested 
concerning their impact on the Ras-Raf interaction and yielded half inhibitory 
concentrations between 100 µM to 450 µM with the exception of compound 5h, which 
gave an IC50 value of 30 µM (Waldmann et al. 2004). The binding of this compound and 
sulindac sulfide was further investigated in [1H, 15N]-HSQC-NMR titration studies with 
wild type Ras·Mg2+·GppNHp. Due to the fact that both switch regions are not visible in the 
[1H, 15N]-HSQC spectrum of wild type Ras·Mg2+·GppNHp (Ito et al. 1997) the exact 
binding position remains unknown, but it is strongly suggested that the binding of both 
compounds takes place in the switch I region.  
In conclusion one can say that Ras is an extensively studied target in anticancer therapy. 
Several research groups and companies work on the development of inhibitors for 
oncogenic Ras signalling following different approaches. None of them has succeeded yet, 
but investigations are going on. In the following two paragraphs two additional approaches 
are presented, which have also been subject to investigations in the present work. 
 
1.1.6.3 Peptides with Consensus Ras Binding Sequences 
Using contact epitope scanning and site directed mutagenesis peptides based on the 
primary sequence of Raf-RBD have been investigated concerning their inhibitory effect on 
the interaction with Ras·GTP by Barnard et al. (1995). Out of nineteen tested peptides, two 
containing c-Raf-1 residues 91-105 and 118-143 potently interfered with Ras association. 
Further studies revealed that the peptide compromising Raf-residues 91 to 105 could be 
truncated to seven amino acids without the loss of the inhibitory effect (Barnard et al. 
1998). The most potent peptide consisting of Raf residues 95-CCAVFRL-101 is located 
~15 Å away from the binding interface in the Raps-Raf-RBD complex (Nassar et al. 1996). 
Figure 1.13 the calculated complex structure of Ras and Raf-RBD is depicted  
(Zeng et al. 1999 2001). 
 
 
 
Figure 1.13: Complex structure of Ras-Raf-RBD obtained from a molecular dynamics simulation. The 
effector loop, the interaction surface and the switch II region in Ras are coloured green, pink and red, 
respectively. The Ras Binding Helix of Raf is colored brown. The inhibitory peptide CCAVFRL is 
highlighted blue in the structure (taken from Zeng et al. 2001). 
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Modifications of single amino acids in the shortened peptide yielded stronger inhibitors for 
Ras-Raf association in vitro. The strongest effect was observed by increasing the 
hydrophobicity at postion 97. Mutations at positions 98, 99 and 100 were tolerated, 
whereas N-methylation at position 96, 97 or 98 led to a complete loss of the inhibitory 
effect. This indicates the need of a specific conformation to be fulfilled by the seven amino 
acid peptide in order to be an active inhibitor. The main question remaining is about the 
mode of action of the peptide. Since it is also capable of inhibiting the interaction between 
active Ras and the RBD of RalGDS it is strongly suggested that the peptide binds 
specifically to the Ras protein (Barnard et al. 1998). 
 
1.1.6.4 Stabilization of the Weak Effector-Binding Conformation in Active Ras 
As described in paragraph 1.1.5 31P NMR spectroscopy reveals the existence of a dynamic 
equilibrium between at least two distinct conformational states in Ras bound to the GTP 
analogue GppNHp. One of these states shows drastically reduced affinity for effector 
molecules. Shifting the equilibrium towards this so-called weak-binding state by its 
stabilization with suitable ligands thus represents an additional novel approach in 
antitumoral therapy. Zn2+-cyclen has been reported to selectively recognize state (1) 
(Spoerner et al. 2005c) and to be capable of shifting the equilibrium completely towards 
the weak effector-binding state in wild type Ras·GppNHp (Figure 1.14).  
 
 
 
Figure 1.14: Stabilization of the weak effector-binding state in wild type Ras·Mg2+·GppNHp by the 
small molecule Zn2+-cyclen (from Spoerner et al. 2005c). 
 
For that reason Zn2+-cyclen serves as a lead compound for the development of a novel 
class of Ras inhibitors. The binding of this substance in the protein has been investigated in 
more detail by paramagnetic relaxation enhancement and chemical shift perturbation 
studies using a paramagnetic and a diamagnetic derivative of cyclen (T. Graf 2006). Three 
different binding position have been identified in the partial loss-of-function mutant 
Ras(T35A)·Mg2+·GppNHp, whereby one is close to the γ-phosphate group of the bound 
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nucleotide. The other two binding sites have been found to be located close to histidine27 
and phenylalanine28 and at the negatively charged loop compromising amino acids 
aspartate105 to methionine111.The binding constant for each position was determined 
yielding millimolar affinity with the one in the active site exhibiting the lowest affinity. 
Additionally a model of the ligand binding site at the active centre was obtained using the 
docking programe HADDOCK (T. Graf 2006). In Figure 1.15 the obtained structure is 
directly compared with the active conformation of wild type Ras·Mg2+·GppNHp. 
Compared to the wild type protein a more opened structure is adopted by 
Ras(T35A)·Mg2+·GppNHp accompanied by changes in both switch regions and the P loop. 
The amide protons of the cyclen scaffold are in hydrogen bonding contact to glycine12, 
aspartate33, alanine35 and alanine59. Tyrosine32 of the effector loop has changed its position 
considerable as indicated in Figure 1.15.  
 
 
 
Figure 1.15: Comparison of the crystal structure of a) wild type Ras·Mg2+·GppNHp (pdb 5p21) with b) 
the calculated structure of the complex between Ras(T35A)·Mg2+·GppNHp and Cu2+-cyclen (T. Graf 
2006,  Rosnizeck et al., accepted). 
 
Based on the range of the 31P NMR chemical shift differences of the γ-phosphorous 
resonances Geyer et al. (1996) proposed that Tyr32 is extensively involved in the transition 
between the two active Ras conformations. This is supported by the finding that the 
mutation of tyrosine32 against arginine shifts the dynamic equilibrium towards the weak-
binding state. The residue also differs strongly in its orientation in the crystal structure of 
wild type Ras complexed to GppNHp and GDP, respectively. Generally 
Ras(T35A)·Mg2+·GppNHp complexed with Cu2+-cyclen is structurally closer related to the 
conformation of inactive Ras(wt)·Mg2+·GDP or the mutant Ras(G60A)·Mg2+·GppNHp 
(Ford et al. 2005), which is from the spectroscopic view in conformational state (1) than to 
wild type Ras·Mg2+·GppNHp alone or in its complexes with effector molecules.  
 
 
Chapter 1                                                                                                           Introduction 
 
 
- 21 - 
1.2 Identification and Characterization of Ligand Binding 
by NMR Spectroscopy 
1.2.1 Integration of NMR in the Drug Development Process 
NMR has become a more and more attractive tool in any stage of drug development, which 
is reflected by the large number of reviews available (see e.g. Pellecchia et al. 2008). The 
reason therefore can be found in the strong progress in the field of hard- and software 
development, such as high field spectrometers, cryogenic probes and modern software 
packages for data evaluation (Güntert 2009), respectively. Additionally the sensitivity of 
NMR has improved by modern pulse sequences, such as the TROSY-spectroscopy (Zhu 
and Yao 2008) and more and more information about interactions is available due to the 
extended use of different NMR parameters, such as residual dipolar couplings (RDCs) 
(Bax and Grishaev 2005, Bouvignies et al. 2005) and cross correlated relaxation (CCR) 
rates (Reif et al. 1997). Moreover combinatorial chemistry approaches deliver large 
amounts of substances with high diversity, which can be tested in the early stage of drug 
design in order to obtain initial hits. Automation is straight forward in NMR spectroscopy 
by now allowing for high throughput applications. In general advantages of the method can 
be found in its high sensitivity and the possibility to investigate biomolecules under 
physiological conditions without disturbing the sample.  
Structural characterization of the target molecule by NMR spectroscopy represents several 
advantages over conventional X-ray crystallography, such as the possibility to gain 
information about the dynamics of the protein by relaxation experiments (Kay 1998) or the 
solvent accessibility by examining amide proton exchange rates for example (Gemmecker 
et al. 1993, Dyson et al. 2008), both necessary for the identification of druggable areas in 
the protein. As soon as the target is identified and sufficiently characterized primary 
screening is employed in order to identify so-called hits. Binding activity of a ligand can 
either be detected in receptor- or ligand-based methods by monitoring changes of NMR 
parameters of either the receptor in the presence of the ligand or vice versa. Initial methods 
were based on the observation of the chemical shifts or line width of the target resonances 
in 2D NMR spectroscopy, which was very time and sample consuming. Meanwhile 1D 
spectroscopy observing the ligand signals is applied in most of the cases. The advantages 
are obvious. There is no need of isotope labelling, data collection time is reduced as well as 
the amount of protein one needs. Several primary NMR screening techniques have been 
reported, such as WaterLOGSY (Dalvit et al. 2001), transferred NOE (Meyer et al. 1997), 
NOE pumping (Chen and Shapiro 1999 2000) or STD (saturation transfer difference) 
spectroscopy (see section 1.2.2). In all these methods weak binders are identified, which 
have to be further characterized in terms of their binding position and further modified 
concerning their binding affinity by for example INPHARMA (Sánchez-Pedregal et al. 
2005) or SAR (structure activity-relationship) by NMR (Shuker et al. 1996, Hajduk 2006). 
In the latter approach fragments binding to nearby sites in the protein are identified by 
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[1H, 15N]-HSQC experiments and optimized concerning their binding properties. Both 
fragments are then linked together with the aim to give a high affinity ligand.  
 
 
1.2.2 Saturation Transfer Difference Spectroscopy 
1.2.2.1 The Transferred NOE-Effect 
Macromolecules and small molecules differ in their nuclear Overhauser enhancement 
(NOE) characteristics due to their different correlation times τc. Low molecular mass 
substances have short correlation times (τc < 10-10 s) and therefore exhibit positive or very 
small negative NOEs, while large molecules have long correlation times (τc > 10-8 s) and 
consequently strongly negative NOEs. In the complex with a protein the ligand adopts the 
correlation time of the macromolecule and consequently its NOE characteristics. This 
observation is termed the transferred NOE (trNOE) effect (Balaram et al.1972a 1972b) and 
reflects the bound state of the ligand. As soon as the ligand dissociates from the target it 
carries the information of binding into solution, where it can be detected by the loss of 
signal intensity (Clore and Gronenborn 1982 1983). The trNOE effect has successfully 
been used for the identification of binding compounds in screening experiments (Meyer et 
al. 1997). One major problem occurs in the case of aggregation of the ligand molecules, 
which results also in negative NOEs not obtained due to the binding of the macromolecule. 
Akasaka (1979) found that selective saturation of the muscle protein myosin also 
influenced the signal intensity of the ligand ADP due to the transfer of saturation from the 
protein to the bound ligand via intermolecular cross relaxation. In saturation transfer 
difference (STD) spectroscopy (Klein et al. 1999, Mayer and Meyer 1999), which relies on 
the trNOE effect, magnetization is transferred from the protein to the bound ligand, which 
‘remembers” the saturation in its free state, where it is detected. Comparison with a 
standard experiment directly reveals binding ligands.  
 
1.2.2.2 The STD NMR Experiment 
Saturation transfer difference spectroscopy consists of two experiments. In the first one, 
the off-resonance experiment, a common spectrum is recorded with an irradiation 
frequency of about 30 ppm, which is far away from the signals of any compound in the 
sample. In the second experiment (the on-resonance experiment) magnetization is 
introduced into the protein by selective radio frequency pulses and spreads through the 
entire molecule via spin diffusion (Kalk and Berendsen 1976). Binding to the protein leads 
to a transfer of magnetization from the macromolecule to the ligand, which in turn results 
in a loss of signal intensity of the ligand resonances in the on-resonance spectrum. 
Subtraction of the on-resonance spectrum from the off-resonance (or reference) spectrum 
gives the difference spectrum. Only signals from ligands with binding activity appear in 
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the difference spectrum. A schematic representation of the experiment is given in  
Figure 1.16. It is clear that the on-resonance spectrum has to ensure that only the protein 
resonances will be saturated. Due to their strong line broadening protein resonances are 
also present outside the spectral window of the ligand in the negative ppm range or at ppm-
values > 10. Commonly on-resonance irradiation is performed at around -1 ppm, but at 
least 1.2 ppm away from the closest ligand signal. It has to be noted that the size of the 
signal in the difference spectrum cannot be used as a direct measure of binding affinity. It 
strongly depends on the off-rate of the bound ligand from its complex with the protein, the 
saturation time and the excess of ligand in the sample. In the difference spectrum also the 
signals from the protein appear. In order to prevent an overlap of the protein resonances 
with the ones from the ligand a relaxation filter, the so-called T1ρ-filter can be integrated in 
the pulse sequence. The STD scheme can in principle be implemented to any NMR 
experiment (Nagaraja 2006). STD NMR spectroscopy offers several advantages. Neither 
the ligand nor the protein needs to be labelled. Likewise there is no upper size limitation 
for the protein, since saturation is rather more efficient the larger the receptor molecule is. 
The major advantage is represented by the low amount of protein one needs, which can be 
down to 20 µM. The large excess of ligand, commonly 100-fold in primary screening gives 
spectra with good quality. Moreover mixtures of compounds with different spectra can be 
screened. 
 
 
 
 
Figure 1.16: Schematic representation of the STD experiment. The binding and non-binding compounds 
are represented by circles and stars, respectively. (A) During the off-resonance experiment neither receptor 
nor ligand are saturated and the spectrum gives the intensity I0. (B) Selective irradiation of the receptor leads 
to saturation of the resonance from bound ligands. From the on-resonance spectrum Isat is derived. (C) 
Subtraction of the on- from the off-resonance spectrum gives the difference spectrum. Only binding 
components appear with the intensity ISTD = Ioff – Ion (taken from Peng et al. 2004). 
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1.2.2.3 Quantification and Characterization of Ligand Binding 
Saturation of the protein spin system is very fast and happens within about 100 ms, the 
saturation time of the ligand is usually performed in a time period of around 2-5 s. If a 
large excess of a ligand with a high off-rate is present one protein molecule can saturate 
more than one ligand molecule, meaning the effect becomes amplified. This effect explains 
the range of binding affinity, which can be detected by STD NMR spectroscopy. If the 
affinity is very high (KD ≤ 100 nM), the ligand rests for a longer period of time in the 
binding pocket and the equilibrium is strongly shifted towards the bound state of the 
ligand. Consequently the information of binding is neither sufficiently carried into solution 
nor amplified. On the other side for very weak binders (KD > 10 mM) it is less probable 
that enough binding events happen during the experiment. Titration studies can be used to 
value the binding constant of a ligand by STD by using the so-called STD amplification 
factor (Mayer and Meyer 1999).  
Like most ligand-based methods direct identification of binding compounds is limited to 
low and medium affinity binders. This is generally desired in primary NMR screening, 
since the first hits will be further optimized anyway. However, it is also possible to detect 
and quantify high affinity ligands. The only requirement is a known weak binding ligand at 
the binding site of interest, the so-called reporter ligand (Jahnke et al. 2002). In 
competitions experiments the STD signals of a known weak binder are followed during the 
titration with a ligand with higher affinity and allow for the determination of the KD-value. 
Additionally to its binding strength also information about the orientation of the bound 
ligand in complex with the macromolecule is obtained (Mayer and Meyer 2001, Peikert et 
al. 2004). Moieties of the ligand closer to the binding interface exhibit a stronger relative 
STD effect compared to those parts of the molecule further away from the binding pocket. 
Consequently parts of the molecule, which are closer to the binding pocket can be 
identified, which is of special interest by the development of lead substances.  
 
1.2.3 Chemical Shift Perturbation Mapping in 2D NMR Spectroscopy 
2D experiments like [1H, 15N]-HSQC spectroscopy can be used in order to obtain site 
specific information about the binding of a ligand to a target molecule. To do so 15N 
enriched protein has to be available. Each backbone (except proline) and side chain NH 
group of the protein is represented by a cross peak. Upon binding of a ligand the chemical 
environment of residues directly affected by binding or by conformational changes induced 
by the binding differs, which is directly reflected by changes of the NMR signals of those 
residues depending on the exchange processes. One has to discriminate between slow, 
intermediate and fast exchange processes on the NMR time scale, which result in different 
observations for the chemical shifts of the residues affected by binding. Slow exchange 
processes include a reduction of the cross peak intensity at the initial position and the 
observation of a new cross peak at a different position. Intermediate exchange leads to line 
broadening and therefore to a decrease in signal intensity, which is not accompanied by the 
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appearance of a new cross peak for a given residue. If fast exchange processes on the NMR 
time scale prevail only a single cross peak is observed for the free and complexed form of 
a given residue with a chemical shift at the population averaged position. All these effects 
have to be monitored very accurately in order to prevent errors during data evaluation (see 
next paragraph). If fast exchange is present the combined chemical shift changes 
(Schumann et al. 2007) can directly be monitored as a function of the ligand concentration. 
In the case of slow and intermediate exchange signal intensities or the line widths, 
respectively have to be evaluated. In the first case the relative signal intensity of the new 
cross peak representing the bound conformation is normalized for the overall signal 
intensity of both cross peaks belonging to the same residue. In the case of intermediate 
exchange the change of the line width depending on the ligand concentration is consulted 
for evaluation. Each NMR parameter can be used in order to determine the binding affinity 
by plotting the change against the ligand concentration. 
 
1.2.4 Paramagnetic Relaxation Enhancement 
Paramagnetic systems, such as transition metal complexes or free radicals contain at least 
one unpaired electron. Both the chemical shift and the line width of NMR active nuclei can 
be affected through the interaction with the unpaired electron spins. Consequently 
paramagnetic substances are subdivided into shift and relaxation reagents, respectively. 
The latter ones accelerate the relaxation rates of the NMR active nuclei, a phenomenon 
known as paramagnetic relaxation enhancement (PRE), originally described by Solomon 
(1955). As a consequence the corresponding signals in the NMR spectrum are strongly 
broadened depending on the distance to the paramagnetic centre. This effect can be so 
strong that the signals disappear in the noise level and they are so-called ‘bleached”. The 
transition metal ion Cu2+ exhibits a very fast relaxation rate. Proton signals in a distance 
less than 11 Å are affected (Arnesano et al. 2003). For that reason the binding sites of the 
small organic molecule metal(II)-cyclen, which is known to selectively stabilize the weak 
binding state in active Ras (see section 1.1.6.4) has been investigated in titration studies 
using the paramagnetic derivative Cu2+-cyclen (T. Graf 2006).                                                                                                            
As described in paragraph 1.2.3.1 line broadening is not only caused by the presence of a 
paramagnetic centre, but can also be observed, when exchange processes, which are slow 
or intermediate compared to the NMR time scale occur. For that reason data from binding 
studies using a paramagnetic derivative of the ligand have to be evaluated taking these 
possible effects into account in order to give reliable results. The best approach herein is to 
directly compare the data with the ones obtained in titration studies with a diamagnetic 
derivative of the ligand. Line broadening observable in the presence of both derivatives 
cannot clearly be assigned to the distance-dependent paramagnetic effect, but may also 
represent structural changes induced by the binding of the ligand elsewhere in the protein.   
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2 MATERIALS 
2.1 Chemicals 
The basic equipment in the laboratory is purchased from the companies Fluka (Neu-Ulm, 
Germany), Merck (Darmstadt), Roche (Mannheim), Novabiochem (Läufelingen, 
Switzerland), Acros Organics (Geel, Belgium), Roth (Karlsruhe), Pharma-Waldorf 
(Düsseldorf) and Sigma (Deisenhofen) with analytical grade. 
 
The metal(II)-cyclen and metal(II)-derivatives and the peptide LIGGR have been 
synthesized at the chair of Organic Chemistry (Prof. B. König) at the University of 
Regensburg. 
 
The peptides with consensus Ras binding sequences (CCAVFRL, CCFFRRRL) have been 
synthesized by the company GenScript Corporation (Piscataway, USA) with purity 
between 95% and 98%. 
 
2.2 Enzymes 
Alkaline Phosphatase  Boehringer/Roche (Mannheim, Germany) 
DNase I   Boehringer/Roche (Mannheim, Germany) 
Lysozyme   Sigma (Deisenhofen, Germany) 
Thrombin   Sigma (Deisenhofen, Germany) 
 
2.3 Frequently Used Buffer Solutions 
Buffer A    32 mM Tris/HCl pH 7.4, 10 mM MgCl2, 1 mM DTE 
Buffer B 64 mM Tris/HCl pH 7.4, 10 mM MgCl2, 400 mM NaCl, 
2 mM DTE, 0.1 mM GDP 
Buffer C 50 mM Tris/HCl pH 7.4, 150 mM NaCl, 5 mM EDTA,  
5 mM DTE, 1 mM PMSF 
Buffer D 50 mM Tris/HCl pH 7.4, 150 mM NaCl, 5 mM DTE 
Buffer E 40 mM HEPES/NaOH pH 7.4, 10 mM MgCl2,  
150 mM NaCl, 2 mM DTE 
Buffer F 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE 
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2.4 Plasmids 
For the expression of the different truncated (aa 1 - 166) and full length (aa 1 - 189) human 
H-Ras proteins ptac-vectors have been used. The expression of the Ras binding domain of 
Raf-kinase (aa 51-131) was carried out using pGEX-4T-vectors. 
 
2.5 Bacteria Strains  
Escherichia coli CK600K  supE, hsdM+, hsdR-, kanR (Hoffmann-Berling,  
        Heidelberg, Germany) 
 
Escherichia coli BL21(DE3)  F-, opmT, hsds (rB-, mB-), gal (38,39) (Stratagene,  
     Heidelberg, Germany 
 
2.6 Media and Antibiotics 
Luria-Bertani (LB)-medium 10 g    bacto-tryptone 
5 g    yeast extract  
10    NaCl  
were filled up to 1 L with millipore H2O. After 
adjusting the pH to 7.0 by 5 mmol L-1 NaOH the 
medium was autoclaved. 
 
SL-6 stock solution 100 mg ZnSO4 x 7 H2O 
 30 mg   MnCl2 
 300 mg HBO3 
 200 mg CoCl2 x 6 H2O 
 10 mg  CuCl2 x 2 H2O 
 20 mg  NiCl x 6 H2O 
 30 mg  Na2MoO4 
 were filled up to 1 L with millipore water and 
autoclaved. The stock solution can be stored for long-
term at 4 °C. 
 
SL-4 stock solution 500 mg EDTA 
 200 mg FeSO4 x 7 H2O 
 were filled up to 90 mL with millipore water. This 
solution has to be prepared freshly. 
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SL-mix 1 mL  SL-6 stock solution  
 0.9 mL SL-4 stock solution 
 were filled up to 10 mL with millipore water and 
sterile filtered. 
 
Minimal medium 7.5 g   NaHPO4 
 
3 g  KH2PO4 
 0.5 g  NaCl 
 0.25 g  MgSO4 x 7 H2O 
 0.014 g CaCl2 x 2 H2O 
 were filled up to 900 mL with millipore water and 
autoclaved. 
 
New minimal medium (NMM) 900 mL  minimal medium 
10 mL  SL-mix 
4 g   glucose  
1 g  NH4Cl  
were filled up to 1 L with sterile millipore water.  
 
 
Each antibiotic was purchased from GERBU Biotechnik GmbH (Gaiberg, Germany). 
 
2.7 Protein Standard 
SDS7 
(66/45/36/29/24/20.1/14.2 kDa) Sigma (Deisenhofen, Germany) 
 
2.8 Expendable Materials 
Bradford reagent   Biorad (München, Germany) 
NMR sample tubes  
 5 mm    Norell Inc. (Landsville, NJ, USA) 
 8 mm    Shigemi Co. LTD (Tokyo, Japan) 
Quart glass cells   Perkin Elmer (Waltham, MA, USA) 
Vivaspin ultrafiltration units  Vivascience (Hannover, Germany) 
 
 
 
 
Chapter 2                                                                                                                Materials 
 
 
- 29 - 
2.9 Columns 
Nucleosil 100 C18 precolumn Bischoff Cromatography (Leonberg, Germany) 
ODS hypersil C18 column  Beckman Coulter (Fullerton, CA, USA) 
Q-sepharose     Amersham Pharmacia (Freiburg, Germany) 
Q-sepharose fast flow  Amersham Pharmacia (Freiburg, Germany) 
Superdex G-75 prep grade  Amersham Pharmacia (Freiburg, Germany) 
 
2.10 Instruments 
Beckman HPLC-system Gold  Beckman (München, Germany) 
FPLC-System     Amersham Pharmacia (Freiburg, Germany) 
Luminescence spectrometer LC-50  Perkin Elmer (Waltham, MA, USA) 
NMR spectrometer 
 Avance 500    Bruker (Karlsruhe, Germany) 
 Avance 600    Bruker (Karlsruhe, Germany) 
 Avance 800    Bruker (Karlsruhe, Germany) 
Ultrasonic device Sonifier 250/450  Branson (Schwäbisch Gmünd, Germany) 
UV/Vis-Spectrometer Uvikon 933  Kontron (Neufahrn, Germany) 
  
2.11 Data Analysis and Graphical Software 
Auremol 2.4.0   www.auremol.de 
CorelDraw 12   Corel Corporation (Ottawa, Canada) 
Origin 6.0   Microcal Software Inc. (Northampton, MA, USA) 
PyMOL   DeLano Scientific (San Francisco, CA, USA) 
Topspin 2.0   Bruker (Karlsruhe, Germany) 
ViewerLite 4.2  Accelrys Inc. (San Diego, CA, USA) 
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3 METHODS 
3.1 Molecular Biology 
3.1.1 Expression and Purification of Unlabeled Ras Proteins 
Overexpression of human H-Ras was performed according to Tucker et al. (1986) by using 
ptac-vectors in the E. coli strain CK600K. 10 L of the standard LB medium containing  
100 mg L-1 carbenicilline and 25 mg L-1 kanamycin was inoculated with 100 mL of an 
overnight culture. Incubation was carried out at 37 °C and a shaker speed of 180 rpm. 
Expression was induced at an OD600-value between 0.8 and 1 with 1 mM IPTG. 
Centrifugation of the culture was performed after overnight incubation (about 14 to 
18 hours). The precipitate was frozen and stored at -20 °C. 
The unfreezed cell pellet was resuspended in cell disruption buffer (32 mM Tris/HCl 
pH 7.4, 5 mM EDTA, 2 mM DTE and 1 mM PMSF) and cell disruption was initiated by 
addition of lysozyme (1 mg per mL cell suspension). After 30 minutes of incubation 
10 mM MgCl2 and 20 mg DNase I per 100 mL cell suspension were added and the mixture 
was allowed to incubate another 30 minutes at 4 °C. Sedimentation of the cell fragments 
was achieved by 60 minutes of centrifugation with 18.000 g. The clear supernatant was 
brought on a Q-sepharose column (500 mL volume), which has been equilibrated with 
buffer A (32 mM Tris/HCl pH 7.4, 10 mM MgCl2, 1 mM DTE) before. Upon washing with 
1.5 column volumes of buffer A a linear salt gradient (0 - 800 mM NaCl in buffer A) was 
run over an overall volume of 4 L with 4 mL min-1. All steps have been carried out at 4 °C. 
Fractions containing the Ras protein were identified by SDS-PAGE following the Lämmli 
protocol (see section 3.2.1), pooled, concentrated and purified further using a  
Sephadex G-75 prep grade column equilibrated with buffer B (64 mM Tris/HCl pH 7.4, 
10 mM MgCl2, 400 mM NaCl, 2 mM DTE, 0.1 mM DTE). Again SDS-PAGE according 
to Lämmli (section 3.2.1) allowed for the identification of the fractions containing pure 
Ras. The corresponding fractions were pooled and concentrated up to about  
20 - 50 mg mL-1. Quantification of the protein solution was done by HPLC as described in 
section 3.2.2. Aliquots of the solution have been frozen in liquid nitrogen and stored at  
-80 °C. 
  
3.1.2 Expression and Purification of Uniformly 15N-Labeled Ras 
Overexpression of uniformly 15N-labeled protein was performed by using T7-vectors in the 
E. coli strain BL21(DE3). A cell pellet derived from the sedimentation of an overnight 
culture prepared in LB medium containing carbenicilline with a final concentration of  
25 mg L-1 was washed with new minimal medium (NMM, see section 2.6) twice and 
dissolved in NMM. The cell suspension was transferred into NMM containing  
1 g L-1 15NH4Cl as the sole nitrogen source (Neidhardt et al. 1974). Per 1 L main culture 
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100 mL overnight starter culture was used. The bacteria were allowed to grow in  
15N-enriched NMM at 37 °C and a shaker speed of 200 rpm. Expression of Ras was 
induced by addition of IPTG (final concentration 0.4 mM). The culture was incubated 
further at 30 °C and a shaker speed of 180 rpm over night. The following steps were 
carried out as described for unlabeled Ras in section 3.1.1. 
 
3.1.3 Expression and Purification of Raf-RBD 
Raf-RBD (amino acids 51 - 131) was expressed as GST-fusion protein using a  
pGex-4T-vector in the E. coli strain BL21(DE3). 10 L LB medium containing 100 mg 
carbenicilline per liter were inoculated with 100 mL of an overnight culture and incubated 
at 37 °C using a shaker speed of 180 rpm. Protein expression was induced at an  
OD600-value of 0.6 with IPTG (final concentration 0.3 mM). Overnight incubation at 30 °C 
was followed by centrifugation of the culture media. The precipitate was frozen and stored 
at -20 °C.  
The unfreezed cell pellet was resuspended in buffer C (50 mM Tris/HCl pH 7.4,  
150 mM NaCl, 5 mM EDTA, 5 mM DTE, 1 mM PMSF) and disrupted as described above 
for the Ras protein (section 3.1.1). Additionally ultrasound was applied at the end of the 
disruption process. The cell fragments have been sedimented by 30 minutes of 
centrifugation with 25.000 g.  
The clear supernatant was brought on a GSH column, which has been equilibrated with 
buffer D (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 5 mM DTE) before with a flow rate of  
1 mL min-1. The column material carries immobilized glutathione on the surface, which 
binds the GST-domain of the fusion protein. Upon washing with 3 to 5 column volumes of 
buffer D unspecifically proteins binding have been eluted. For the cleavage of Raf-RBD 
from the GST-tag 1 U thrombin per 2 mg protein was brought on the column and the 
cleaving reaction was allowed to proceed slowly (0.3 mL min-1) at 4 °C over night. The 
fractions of the eluate containing Raf-RBD have been identified by SDS-PAGE according 
to Schägger and v. Jagow (see section 3.2.1), pooled and concentrated. Further purification 
was done by gel filtration using a Sepahdex G-75 column, which has been equilibrated 
with buffer E (40 mM HEPES/NaOH pH 7.4, 10 mM MgCl2, 150 mM NaCl, 2 mM DTE). 
The fractions containing pure Raf-RBD were identified by SDS-PAGE according to 
Schägger and v. Jagow (1987), pooled and concentrated again with a final concentration of 
40 - 80 mg mL-1. Determination of the protein concentration was done using the Bradford 
reagent (see section 3.2.2). Aliquots of Raf-RBD have been frozen in liquid nitrogen and 
stored at -80 °C. 
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3.1.4 Nucleotide Exchange 
3.1.4.1  Nucleotide Exchange against GTP 
The Ras protein is loaded with GDP after the above described purification steps. By 
ultrafiltration Ras·GDP was transferred into exchange buffer (50 mM Tris/HCl pH 7.4, 
2 mM DTE), which does not contain Mg2+-ions in order to weaken the binding of GDP. 
Addition of 200 mM (NH4)2SO4 and 20 mM EDTA to the sample further destabilized 
nucleotide binding via coordination of Mg2+. A 50- to 60-fold excess of GTP was added to 
the Ras·GDP sample. Upon 3 to 4 hours of incubation on ice the protein was loaded with 
about 90% GTP as determined by HPLC (see section 3.2.2). Free nucleotides were 
separated by size exclusion chromatography using a Sephadex G-25 PD 10 column, which 
has been preincubated with buffer F (40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE) 
and loaded with the concentrated sample. Fractions of 750 µM volume have been 
collected. The fractions containing the protein have been identified by using the Bradford 
reagent (see section 3.2.2), pooled and concentrated. The purification step was repeated for 
a second time. The final concentration of the protein and its relative loading with GTP and 
GDP was determined by HPLC (see section 3.2.2). Appropriate aliquots of the final sample 
were frozen in liquid nitrogen and stored at -80 °C or directly transferred into the NMR 
sample tube.  
 
3.1.4.2 Nucleotide Exchange against GppNHp and GTPγS 
The exchange of GDP against the stable GTP-analogues GppNHp or GTPγS was done 
using alkaline phosphatase treatment (John et al. 1990). Upon transferring the Ras·GDP 
sample into exchange buffer (50 mM Tris/HCl pH 7.4, 2 mM DTE) 200 mM (NH4)2SO4 
and a 2-fold excess of GppNHp or GTPγS over GDP were added. In addition 2 U alkaline 
phosphatase per mg Ras·GDP were present in the sample facilitating the dephosphorylation 
of GDP, but not GppHNp or GTPγS. The sample was allowed to incubate at 4 °C over 
night. Separation of the desired protein sample from the free nucleotides was done as 
described for Ras·GTP in section 3.1.4.1. 
 
3.2 Biochemical Methods 
3.2.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was used for the identification of the fractions containing Ras or Raf-RBD, 
respectively during the different purification steps. The different components of the protein 
mixture are separated according to their molecular weight. A 6 µL sample of each fraction 
was added to 18 µL of 4 x SDS-sample buffer (150 mM Tris/HCl pH 6.8, 2% (w/v) SDS, 
20% glycerol, 0.1% (w/v) bromine-phenol-blue, 10 mM DTE) and subsequently denatured 
by heat for about 5 minutes at 95 °C. 18 µL of the denatured protein sample were put into 
the pockets of the stacking gel. A standard protein mixture (L7, see section 2.7) was run in 
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parallel. For the identification of Ras fraction further steps have been carried out according 
to Lämmli et al. (1970). The content of acryl amide was 15% in the running gel and 5% in 
the stacking gel, respectively. The running buffer was composed of 25 mM Tris-base/  
200 mM glycine/ 0.1% (w/v) SDS. The gels were run with a constant current of 36 mA per 
gel for about 50 - 60 minutes. The proteins on the gel were visualized using Coomassie 
Brilliant Blue. 
During the purification of Raf-RBD gel electrophoresis was done following the Schägger 
and v. Jagow system (1987) due to its molecular weight of less than 10 kDa. The acryl 
amide content was 16.5% in the running gel and 5% in the stacking gel. The anode buffer 
consisted of 200 mM Tris/HCl pH 8.9. The cathode buffer was composed of 100 mM Tris, 
100 mM tricine and 0.1% (w/v) SDS. The gels were allowed to run at a constant voltage of 
100 mV for about 70 - 90 minutes. Visualization of the protein was achieved as described 
before.  
 
3.2.2 Determination of Protein Concentrations 
After removal of free nucleotides reversed phase HPLC was utilized for the quantification 
of the Ras concentration via the bound guanine nucleotides, which can be detected at a 
wavelength of 254 nm. Additionally the distinct retention times of the different nucleotides 
(GMP, GDP, GTP and the corresponding analogues) on the column allow for the 
determination of their relative loading on Ras. The running buffer consisted of 100 mM 
K2HPO4/KH2PO4 pH 6.4, 10 mM TBA, 8% aceto nitrile. Calibration was done with  
GDP-stock solutions with known concentration derived via UV-measurements  
(λ = 254 nm, ε254(GDP) = 13700 cm-1 M-1).  
For the determination of the concentration of Raf-RBD the Bradford reagent 
(Bradford 1976) was used. The binding of basic or aromatic amino acid residues in the 
protein to Coomassie Blue G 250 is detected and quantified at a wavelength of 595 nm. 
Calibration was carried out with samples containing BSA in defined concentrations.  
 
3.3 NMR Spectroscopy 
3.3.1 Saturation Transfer Difference Spectroscopy 
3.3.1.1 Sample Preparation, Data Collection and Processing 
For STD spectroscopy the samples originally contained 50 µM c´Ras(T35A)·GppNHp in 
40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 5% D2O and 0.2 mM DSS as a reference 
standard, if not otherwise stated. In binding studies the ligands were dissolved in the 
sample buffer and titrated to the protein sample. 
The on-resonance irradiation frequency was set to a chemical shift value between -2 ppm 
and 0.3 ppm. Off-resonance irradiation was applied at +30 ppm. The protein was 
selectively saturated by a train of 40 Gauss-shaped 90° pulses of 50 ms length giving a 
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total saturation time of 2 s. On- and off-resonance experiments have been performed in an 
interlaced fashion. Water suppression was achieved using a delay d19 of 100 µs for 
binomial water suppression. Prior to acquisition a so-called T1ρ-filter consisting of a 
spinlock pulse with 50 ms length and an attenuation of 15 dB was implemented in order to 
suppress protein proton resonances, which eases data evaluation (Scherf and 
Anglister 1993). The experiments were performed on a Bruker Avance 600 MHz 
spectrometer equipped with a 5 mm triple resonance cryo probe at 278 K. 32k data points 
have been collected, zero-filled to 64k and multiplied by an exponential line broadening 
function of 0.3 Hz. After splitting the data into on- and off-resonance both spectra were 
processed and phased identically. Baseline correction was done automatically using a 
polynomial of degree 5. Processing was performed using topspin 2.0 software.  
 
3.3.1.2 Quantification of Ligand Binding 
Quantification of ligand binding by STD NMR spectroscopy was done by using the  
so-called STD amplification factor ASTD introduced by Mayer and Meyer (1999). ASTD is 
defined as the relative STD effect multiplied by the ligand excess (Equation 3.1). 
 
excessligand
I
IIASTD ⋅
−
=
0
0
 
 
Equation 3.1 
 
ASTD was plotted against the total ligand concentration, which gives a normal binding 
isotherm, which can be used to derive the KD value following Equation 3.2 with αSTD being 
the maximum ASTD and [L] the total ligand concentration. 
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Equation 3.2  
 
Determination of the STD effect was achieved via the relative intensities determined using 
the Topspin 2.0 software. Fitting of the data was done using Microcal Origin.  
 
3.3.2 31P NMR Spectroscopy 
For 31P NMR spectroscopy the protein or nucleotide, respectively was dissolved in 40 mM 
Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE and 0.1 mM DSS and 5% D2O, if not 
otherwise stated. In the titration studies with Raf-RBD the sample additionally contained 
150 mM NaCl to avoid aggregation of Raf-RBD. An 8 mm Shigemi sample tube 
containing 0.7 - 1.2 mL protein solution with a concentration betwewn 0.5 and 2 mM Ras 
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or nucleotide was used for the measurements. The NMR spectra were recorded with a 
Bruker Avance-500 NMR spectrometer operating at a 31P frequency of 202 MHz using a 
70° pulse and a repetition time of 6 s. Measurements were performed in a 10 mm selective 
31P probe using 8 mm Shigemi sample tubes at various temperatures. Protons were 
decoupled during data acquisition by a GARP sequence (Shaka et al. 1985) with strength 
of the B1-field of 830 Hz. A Ξ-value of 0.4048073561 reported by Maurer and Kalbitzer 
(1996) was used which corresponds to 85% external phosphoric acid contained in a 
spherical bulb. Temperature was controlled using the line separation (methylene-hydroxyl) 
of external ethylene glycol for calibration (Raiford et al. 1979). The absolute accuracy of 
the temperatures given in this work is better than ± 0.5 K. All 31P NMR measurements 
have been carried out at 278 K. 
 
3.3.3  [1H, 15N](-TROSY)-HSQC Spectroscopy 
3.3.3.1 Sample Preparation and Data Collection 
2D NMR measurements used for the titrations with the different metal(II)-chelate 
complexes and the peptide LGGIR were performed on approximately 1 mM 15N labeled 
Ras·Mg2+·GppNHp samples in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE,  
0.1 mM DSS and 5% D2O. In the binding studies with the peptides CCAVFRL and 
CCFFFRRL the protein samples were dissolved in 20 mM Na2HPO4-NaH2PO4 pH 5.5,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O. In each titration the ligand was 
dissolved in the same buffer as the protein sample and added stepwise. The data with 
metal(II)–BPA were collected with a Bruker AVANCE-600 spectrometer equipped with a 
TXI cryoprobe at operating frequencies of 600.13 MHz for 1H and 60.81 MHz for 15N. 
Measurements with the peptides were performed on a Bruker AVANCE-800 spectrometer 
equipped with a TXI cryoprobe operating at a proton frequency of 800.12 MHz and  
81.08 MHz for 15N. All NMR spectra within the titration studies were acquired at 293 K. 
At every titration step a standard [1H, 15N]-HSQC experiment with sensitivity improvement 
(Palmer et al. 1969) was performed. Each 2D spectrum was recorded as a complex data 
matrix comprised of 128, 256 or 516 x 2048 points using a sweep width of 8400 Hz or 
9600 Hz in the 1H dimension and 2400 Hz or 2800 Hz in the 15N dimension. A recycle 
delay of 3.4 s was used with 16 scans/FID. Before each 2D experiment a standard 1H NMR 
spectrum was recorded. 1H chemical shifts were directly and 15N chemical shifts indirectly 
referenced to DSS as described by Wishart et al. (1995).  
 
3.3.3.2 Data Processing and Evaluation 
All NMR spectra were processed using the TOPSPIN 2.0 software (Bruker Biospin). The 
assignment of the amide resonances for Ras(wt)·Mg2+·GppNHp was performed with regard 
to the assignment published by Ito et al. (1997). The cross peaks of Ras(T35S) and 
Ras(T35A) bound to Mg2+·GppNHp were assigned by F. Schumann (University of 
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Regenburg, to be published elsewhere). Within the single titrations steps the assignment 
was transferred using AUREMOL-SHIFTOPT (Baskaran et al. 2009). Combined amino 
acid specific chemical shift differences ∆δcomb of the amino acids j were calculated using 
the program AUREMOL. ∆δcomb is defined by Equation 3.3, where ∆δH,j and ∆δN,j are the 
chemical shift differences of the amide proton and nitrogen of amino acid j in the partly 
complexed and free protein, respectively. The weighting factors wH,j and wN,j are specific 
for the kind of atom and the type of amino acid in position j.  
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Equation 3.3 
 
Chemical shift changes ∆δcomb,j were considered as significant when they were larger than 
the corrected standard deviation σ0corr to zero (Schumann et al. 2007).  
 
3.3.3.3 Determination of Binding Constants 
For the determination of the dissociation constant of the peptide LGGIR the combined 
chemical shift changes ∆δcomb for an amino acid j was plotted against the total ligand 
concentration [L]. The data were fitted using a simple one-site binding isotherm following 
Equation 3.4. ∆δcomb of amino acid j was calculated as described above. max, jcombδ∆ is the 
maximum combined chemical shift change.  
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Equation 3.4 
 
3.3.4 High Pressure NMR Spectroscopy 
3.3.4.1 Sample Preparation and Data Collection 
The pressure series with Ras(wt)·Mg2+·GppNHp were carried out at 278 K between 3 MPa 
and 200 MPa and at 303 K between 3 MPa and 180 MPa. The samples contained 1.05 mM 
(278 K) and 1.84 mM (303 K) 15N-labeled Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl  
pH 7.4, 10 mM MgCl2, 2 mM DTE and 12% D2O. In the sample for the pressure series 
recorded at 278 K additionally 0.1 mM DSS was present as internal reference standard. For 
the pressure series carried out at 278 K the sample was transferred into a class capillary 
with an outer diameter of 5 mm and an inner diameter of 1.2 mm. The measurements at 
303 K were performed on a ceramic cell with an outer diameter of 4 mm and an inner 
diameter of 1.1 mm as described by Beck-Erlach et al. (manuscript submitted). The 
samples were pressurized using the Yamada glass cell method (Yamada 1974). To protect 
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the spectrometer probe from damage, the glass capillary or ceramic cell was placed into a 
short polished Teflon tube (50 mm length, 5 mm inner diameter, 0.5 mm walls).  
Measurements were performed on a Bruker AVANCE-800 spectrometer equipped with a 
TXI cryo probe operating at a frequency of 800.12 MHz for protons and 81.08 MHz for 
15N. At every pressure step a phase-sensitive [1H, 15N]-HSQC experiment was performed. 
Each 2D spectrum was recorded as a complex data matrix comprised of 2048 x 512 points 
using a sweep width of 8400 Hz in the 1H-dimension and 2400 Hz in the 15N-dimension. A 
recycle delay of 3.4 s was used with 8 scans/FID and 16 scans/FID at the series performed 
at 278 K and 303 K, respectively. At 278 K additionally experiments with 32 scans/FID 
have been recorded at 3 MPa and 200 MPa. Before and after each 2D experiment a 
standard 1H NMR spectrum was recorded. 1H chemical shifts were directly and  
15N chemical shifts indirectly referenced to DSS at the pressure series at 278 K and to the 
signal of Tris at the pressure series at 303 K. 
 
3.3.4.2 Data Processing and Evaluation 
The assignment of the amide resonances for Ras(wt)·Mg2+·GppNHp was performed with 
regard to the assignment published by Ito et al. (1997). Additionally pH and temperature 
series recorded by M. Spörner (University of Regensburg) have been included in the 
assignment of the spectra, since the temperature or the pH value differed from the 
conditions within the assignment performed by Ito et al. (1997). All NMR spectra were 
processed using the TOPSPIN 2.0 software. Data analysis was performed using the 
Auremol software. The data have been evaluated as described in the following paragraphs. 
 
3.3.4.3 Analysis of the Chemical Shifts  
The pressure dependence of the chemical shift values of the amide protons and nitrogen 
atoms in the [1H, 15N]-HSQC spectra of the protein was fitted in two different ways. 
Using a second order Taylor expansion (Equation 3.4) the first and second order pressure 
coefficients B1 and B2, respectively can be derived. 
 
2
000200010000 ))(,())(,(),(),( ppTpBppTpBTpTp −+−+= δδ           
   
Equation 3.4 
 
δ0 is the chemical shift at ambient pressure p0 at temperature T0. The chemical shifts of the 
amide protons were corrected by the known pressure response of random-coil peptides 
(Gly-Gly-X-Ala) of the corresponding amino acid (Arnold et al. 2002, Kremer et al. 2004) 
giving the corrected coefficients B1* and B2*.  
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If there is an equilibrium between two conformations of the protein, which are in fast 
exchange on the time scale of the NMR experiment, the observed chemical shifts are the 
weighted average of the chemical shifts of the two states 1 and 2. With an equilibrium 
constant for the conformational exchange K12 defined by the probabilities N1 and N2 to be 
in state 1 and 2 
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Equation 3.5 
 
the chemical shift δ is given by  
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Equation 3.6 
 
Since in addition to the main process always classical continuous chemical shifts by 
compression of the molecule occur, these (small) effects can be accounted for by assuming 
an additional pressure dependence of the chemical shift values δ1(p) and δ2(p) or by 
correcting the experimental values before fitting by suitable data such as random-coil 
pressure induced shifts (see above). The free energy at ambient pressure ∆G120 =∆G12(p0) 
can be determined by fitting the data to Equation 3.7.  
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Equation 3.7 
 
Here, ∆V120 = ∆V12(p0)  = V2(p0) –V1(p0)  is the difference of the partial molar volumes and 
∆β12 the difference of the partial molar compressibilities. For the calculations of the 
∆G12(p0)  values the quadratic term in Equation 3.7 was neglected giving Equation 3.8. 
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Equations 3.6 and 3.8 can be generalized for a n-state process with the chemical shifts δ1, 
δ2, ..,δn by 
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          Equation 3.9 
 
 
3.3.4.4 Analysis of the Signal Volumes 
As described in section 4.8.3.1 the observed intensity in the [1H, 15N]-HSQC spectra 
recorded at different pressure are higher than the actual ones caused by the compression of 
the sample. Thus the area of the signal of the Tris buffer in the sample was used as an 
internal correction factor. The plot of the relative signal area Ap / A3 MPa against the applied 
pressure p was regressed linearly according to Equation 3.10.  
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                           Equation 3.10 
 
The slope a and the intercept b obtained by the fit according to Equation 3.10 were used 
for the correction of the observed intensity I in the single [1H, 15N]-HSQC spectra giving 
the corrected intensity Icorr following Equation 3.11, which was used in the further 
evaluation. 
 
bpa
IIcorr +⋅
=  
Equation 3.11 
                      
Is there a conformational exchange between two states 1 and 2 which is slow relative to the 
time scale of the NMR experiment (|ω2 –ω1| >> 1/τex, τex exchange correlation time) the 
signal volume Ii of state i (i = 1,2) is proportional to its population Ni. Assuming a  
two-state transition for the change of the conformational equilibrium with increased 
pressure, the equilibrium constant K12 can be calculated from the relative cross-peak 
intensities of the HSQC spectra by Equation 3.12 (Akasaka 2006). Ii(p) is the cross-peak 
intensity at pressure p and I0 is defined by I0 = I1 + I2.  
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With Equation 3.5 the observed intensity I is given by  
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The free energy at ambient pressure iG1∆ is defined by Equation 3.8, when neglecting the 
quadratic term in Equation 3.7. When only one of the two cross peaks is observable, I0 can 
be used as additional fit parameter.        
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4 RESULTS 
4.1 Saturation Transfer Difference Spectroscopy 
4.1.1 General Considerations 
Since oncogenic Ras proteins are key players in aberrant signalling contributing to cancer 
development its inhibition is of high medicinal interest (Wittinghofer and Waldmann 
2000). One promising strategy herein is the stabilization of conformational state (1) of 
activated oncogenic Ras (see section 1.1.6.4). A calculated structure of the binding site of 
metal(II)-cyclen in the partial loss-of-function mutant Ras(T35A) complexed to 
Mg2+·GppNHp is available (T. Graf 2006). Using the computer program LUDI S. Kreitner 
(University of Regensburg) is working on the structure-based virtual screening for de novo 
ligands binding at the same position as does the metal(II)-cyclen and additionally for small 
fragments binding in a defined distance to the metal(II)-cyclen, which can be linked to the 
compounds. Potential hits identified in this approach will be further investigated 
concerning their actual binding activity by STD NMR spectroscopy and therefore the 
method was optimized for the Ras protein.  
The experiments have been carried out with Ras(T35A)·Mg2+·GppNHp for several reasons. 
First, this mutant was also used in the virtual screening, secondly each compound being 
capable of stabilizing conformational state (1) should also preferentially bind to a mutant 
existing in this state. Third, the [1H, 15N]-HSQC assignment for this mutant is available 
allowing for further investigations of identified Ras ligands in terms of their binding 
site(s). 
 
4.1.2 Determination of Measurement Parameters  
Saturation transfer difference spectroscopy consists of two experiments, which are 
acquired in an interleaved fashion. The off-resonance spectrum represents a common 
spectrum with on-resonance irradiation far away from the resonances of any compound in 
the screening mixture containing the protein and different potential ligands. It was set to  
30 ppm in each experiment, which is commonly applied (Mayer and Meyer 1999). The on-
resonance spectrum ensures selective irradiation of some protein proton resonances leading 
to the saturation of the entire protein via spin diffusion and additionally of bound ligands 
via intermolecular cross relaxation. In order to obtain reliable results one has to ensure the 
selective and sufficient saturation of the protein. Important parameters herein are the  
on-resonance irradiation frequency for the saturation of the protein and the attenuation of 
the saturation pulse. Different on-resonance irradiation frequencies have been tested as 
well as different attenuations. As soon as the saturation is efficient one expects the same or 
at least similar protein signal intensity in the difference spectrum as in the reference 
spectrum. Additionally signals from nonbinding compounds should not appear in the 
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difference spectrum avoiding false positive results. Figure 4.1 shows the difference spectra 
obtained with different on-resonance irradiation frequencies. 
 
 
 
Figure 4.1: Variation of the on-resonance irradiation frequency for saturation. Shown are the difference 
spectra obtained from STD experiments with an on-resonance irradiation frequency of 1.4 ppm (A), 
0.3 ppm (B), -0.4 ppm (C) and -1 ppm (D) with an attenuation of 40 dB, respectively. In spectrum (E) the 
reference spectrum is shown fro comparison. 20 mM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 
10 mM MgCl2, 0.2 mM DSS and 5% D2O. All spectra have been recorded at 278 K. 
 
 
Within the different frequencies applied no significant differences are observed in terms of 
the degree of saturation, but concerning the selectivity for the protein over other sample 
additives. As one can see very clearly the different resonance signals belonging to DSS 
appear in the difference spectrum depending on the on-resonance frequency. Irradiation at 
850 Hz (1.4 ppm at a spectrometer operating at 600 MHz) leads to the direct saturation of 
the pentet signal of DSS at 1.75 ppm (Figure 4.1 (A)). Setting the on-resonance irradiation 
frequency to 200 Hz (0.33 ppm) leads to the appearance of a triplet signal at 0.63 ppm 
assigned to DSS in the difference spectrum (Figure 4.1 (B)). Irradiating at 600 Hz (1 ppm) 
gives a difference spectrum showing only signals from the protein, except the signal of the 
nine methyl protons of DSS (0 ppm), which is also present when irradiating at  
-600 Hz (-1 ppm). As described in section 1.2.2.2 the on-resonance irradiation frequency 
should be set to a value, which is at least 1.2 ppm away from the closest ligand signal. If 
one wants to study peptide ligands for example an on-resonance irradiation frequency of  
-1 ppm might not be far enough from the peptide resonances and on-resonance irradiation 
has to be performed at an even lower frequency range. For that reason the attenuation for 
the shaped pulse for saturation was adjusted such that both selective and sufficient 
saturation is achieved even with on-resonance frequencies at higher fields. The 
corresponding difference spectra obtained with an on-irradiation frequency of -2 ppm with 
different power levels are shown in Figure 4.2. As one can see an attenuation of 30 dB is 
sufficient for the saturation of the protein resonances. The protein appears with a similar 
signal intensity compared to the reference spectrum, whereas signals from DSS except the 
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one at 0 ppm do not appear in the reference spectrum. The saturation spreads over the 
entire protein, signals of the aromatic region and the backbone and side chain HN are also 
showing up with a signal intensity comparable to the reference spectrum. Consequently 
sufficient and selective saturation of the protein signals is achieved. Additionally the 
saturation obtained with an attenuation of 40 dB is sufficient for the experiments.  
 
 
 
Figure 4.2: Comparison of different power levels (sp13) for the saturation of the protein resonances at 
an on-resonance frequency of -2 ppm. Difference spectra of a sample containing 50 µM 
Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O obtained 
with a power level of 60 dB (A), 50 dB (B), 40 dB (C) and 30 dB (D) for protein saturation in the  
on-resonance spectrum, respectively. The reference spectrum (E) is shown for comparison. All spectra have 
been recorded at 278 K. 
 
Irradiation closer to the methylen signals of the protein at 30 dB does neither alter the 
degree of saturation nor the relative signal intensity of the DSS signal at 0 ppm 
significantly as shown in Figure 4.3. DSS obviously binds to the Ras protein with its signal 
around 0 ppm showing the biggest response.  
STD NMR is a so-called ligand-based method, i.e. changes of the NMR parameters of the 
ligand are observed. In order to ease the evaluation of the spectra a spinlock filter can be 
implemented to the STD pulse sequence prior to acquisition eliminating protein resonances 
in the spectra eventually overlapping with ligand signals (Mayer and Meyer 2001). 
Figure 4.4 shows the difference spectrum of the same sample recorded with and without a 
spinlock filter. As one can see very clearly, no protein resonances are visible in the 
difference spectrum, when a spin lock filter T1ρ is applied. Again, the DSS signal at 0 ppm 
appears in the difference spectrum and additional the pentet signal around 1.75 ppm. The 
sample additionally contained DTE, commonly used as reducing agent for disulfide bonds 
in protein samples. In the difference spectrum the signals representing DTE and its 
oxidized disulfide from around 2 ppm and 2.8 ppm do not give signals. This again shows 
that saturation is achieved selectively.  
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Figure 4.3: Different on-resonance irradiation frequencies used at 30 dB.  Shown are the difference 
spectra obtained from STD experiments with a sample containing 50 µM Ras(T35A)·Mg2+·GppNHp in 
40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O with on-resonance irradiation frequency  
set to -2 ppm (A), -1.3 ppm (C) and -1 ppm (C), respectively. All spectra have been recorded at 278 K. 
 
 
 
 
 
Figure 4.4: Integration of the spinlock filter into the STD experiment. The difference spectrum of sample 
containing 50 µM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and  
5% D2O is shown in with (A) and without (B) a spinlock filter T1ρ of 50 ms at 25 dB. The reference spectrum 
of the sample (C) is shown for comparison.   
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4.1.3 STD NMR Spectroscopy with the Known Ras Ligand Zn2+-Cyclen  
As described in section 1.1.6.4 the small organic compound Zn2+-cyclen has been 
identified as Ras ligand. In order to know whether the above determined parameters are 
appropriate for the detection of binding activity for Ras the experiment was carried out 
with Zn2+-cyclen. The latter compound was present in a 100-fold excess over 
Ras(T35A)·Mg2+·GppNHp in the sample. This ratio of protein to ligand is commonly used 
in screening experiments (Meyer and Peters 2003) using STD. Figure 4.5 shows the 
spectra obtained with Ras(T35A)·Mg2+·GppNHp with Zn2+-cyclen.  
 
 
 
 
 
Figure 4.5: STD experiment with Ras(T35A)·Mg2+·GppNHp and Zn2+-cyclen. The sample contained  
50 µM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O and 
5 mM Zn2+-cyclen * 2 Cl-. On-resonance irradiation was performed at -2 ppm at 30 dB. A spinlock filter was 
implemented (50 ms at 15 dB). All spectra were recorded at 278 K.  
 
 
As one can see the resonance signals of the compound are visible in the difference 
spectrum. For the determination of the dissociation constant Zn2+-cyclen was titrated to 
Ras(T35A) bound to Mg2+·GppNHp and the STD amplification factor ASTD was calculated 
after each step according to Equation 3.1. The obtained binding curve is shown in Figure 
4.6. The results have been fitted according to Equation 3.2 yielding an overall KD-value of 
9.65 ± 1 mM.   
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Figure 4.6: Plot of ASTD against the concentration of Zn2+-cyclen. The amplification factor was calculated 
from data obtained in STD titrations experiments with a sample originally containing 50 µM 
Ras(T35A)·Mg2+·GppNHp in 40 mM Tris-D11/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O.  
On-resonance irradiation was performed at -2 ppm at 40 dB. A spinlock filter was implemented (50 ms at 
15 dB). All spectra were recorded at 278 K. The data were fitted according to Equation 3.2 giving a KD-value 
of 9.65 ± 1 mM. The fit is given by the red line. 
 
 
4.1.4 Identification of Zn2+-BPA as Ras Ligand 
Zn2+-cyclen has been found to bind close to the bound nucleotide in conformational state 
(1) of active Ras. Receptors based on metal(II)-bis(2-picolyl)amine (subsequently referred 
to as metal(II)-BPA) are known in molecular recognition for phosphate sensing (Sakamoto 
et al. 2009). Consequently the compound class was initially tested in terms of its binding 
activity for Ras(T35A)·Mg2+·GppNHp using STD NMR spectroscopy. The on-resonance 
irradiation frequency was set to 0.3 ppm at 40 dB in the experiment with Zn2+-BPA since 
this frequency should be far away enough from the closest Zn2+-BPA signal around 4 ppm. 
However, the experiment was carried out both with a sample containing the ligand in the 
absence and the presence of the protein. Figure 4.7 shows the obtained spectra. The only 
resonance visible in the difference spectrum of the experiment in the absence of Ras 
(Figure 4.7 (B)) is the one belonging to DSS, which is very close to the on-resonance 
irradiation frequency and became saturated directly. No resonances belonging to Zn2+-BPA 
appear and consequently false positive results should not be obtained in the presence of the 
protein. The same experiment was carried out with a sample containing additionally 50 µM 
Ras(T35A)·Mg2+·GppNHp. Now the signals from Zn2+-BPA show up in the difference 
spectrum (Figure 4.7 (C)) and the compound can clearly be identified as a binding ligand. 
Note that in the difference spectrum the DSS signal at 0 ppm is also appearing again in 
contrast to the difference spectrum obtained in the sample without Ras. 
Zn2+-BPA was titrated to Ras(T35A)·Mg2+·GppNHp up to a 320-fold molar excess over 
Ras and the STD amplification factor ASTD has been determined at each step according to 
Equation 3.1. Figure 4.8 shows the plot of ASTD for the single proton resonances against 
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the ligand concentration. Fitting the data according to Equation 3.2 gives a dissociation 
constant of 2.07 ± 0.25 mM. 
 
 
 
Figure 4.7: Identification of Zn2+-BPA as Ras ligand. (A) Reference spectrum of a sample containing  
5 mM Zn2+-BPA in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O recorded with an  
off-resonance irradiation frequency of 30 ppm. (B) and (C) show the difference spectra obtained in the 
absence and presence of 50 µM Ras(T35A)·Mg2+·GppNHp, respectively. On-resonance irradiation was 
performed at 0.3 ppm. A spinlock filter of 50 ms at 15 dB was implemented in order to avoid overlapping 
between protein and ligand resonances. All spectra were recorded at 278 K. 
 
 
 
 
 
Figure 4.8: Plot of the STD amplification factor obtained for each ligand proton against the ligand 
concentration.  The amplification factors were calculated from data obtained in STD titrations experiments 
with a sample originally containing 50 µM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 0.2 mM DSS and 5% D2O . On-resonance irradiation was set to 0.3 ppm in this case. All 
spectra have been recorded at 278 K. The data were fitted according to Equation 3.2 giving a  
KD-value of 2.07 ± 0.25 mM. 
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4.2 31P NMR Spectroscopic Investigations on the Influence of 
Metal(II)-Cyclen and -BPA on Ras 
4.2.1 Binding of Metal(II)-Cyclen and -BPA to Mg2+·GppNHp 
Zn2+-cyclen binds in close proximity to the bound nucleotide, when Ras is complexed to 
Mg2+·GppNHp (Rosnizeck et al., accepted). In this section the influence of the compound 
to GppNHp in free form is studied by 31P NMR spectroscopy under identical conditions 
compared to the experiments of the Ras-nucleotide complex, i.e. at 278 K and pH 7.4 with 
10 mM MgCl2 being present in the sample. The spectra of Mg2+·GppNHp in the presence 
of increasing concentrations of Zn2+-cyclen are shown in Figure 4.9. An upfield shift is 
observed for the β-phosphate resonance, while the shift direction of the γ-phosphate signal 
is downfield. For the α-phosphate resonance no significant shift differences are observed. 
Additionally significant line broadening is observed for each signal with the strongest 
effects for the β- and the γ-phosphate, respectively. The shift behaviour of the resonances 
is in good agreement with that observed, when Mg2+·GppNHp is complexed to the Ras 
protein (Spoerner et al. 2005c). GppNH2 and inorganic phosphate Pi, which are the 
hydrolysis products of GppNHp were also present in the sample. As one can see, also 
significant shift differences are observed for both the phosphate peak and the resonance 
representing the β-phosphate group of GppNH2 around -0.9 ppm. 
 
 
 
 
Figure 4.9: Complex formation between Mg2+·GppNHp and Zn2+-cyclen.  31P NMR spectra of a sample 
containing 2 mM GppNHp in 40 mM Hepes/NaOH pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O in the 
absence and presence of increasing concentrations of Zn2+-cyclen. All spectra have been recorded at 278 K. 
Data processing using an exponential filter led to an additional line broadening of 8 Hz.  
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The same experiment was also carried out with Zn2+-BPA. The obtained spectra are given 
in Figure 4.10. Again, an upfield and a downfield shift are observed for the signals 
representing the β- and the γ-phosphate group, respectively. In contrast to the results 
obtained in the presence of Zn2+-cyclen significant shift differences are also observed for 
the α-phosphate group, actually being stronger than the effects observed for the  
β-phosphate group. The observed results are summarized in Table 4.1.  
 
 
 
Figure 4.10: Complex formation between Mg2+·GppNHp and Zn2+-BPA. 31P NMR spectra of a sample 
containing 0.5 mM GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 0.2 mM DSS and 5% D2O in the 
absence and presence of increasing concentrations of Zn2+-BPA. All spectra have been recorded at 278 K. 
Data processing using an exponential filter led to an additional line broadening of 8 Hz.  
 
 
Table 4.1: Chemical shift changes and line width obtained in the 31P NMR spectra of Mg2+·GppNHp in 
the presence of Zn2+-cyclen and -BPA, respectively. 
  α-phosphate β-phosphate γ-phosphate 
Zn2+- n:l δ [ppm] ∆ν1/2 [Hz]a δ [ppm] ∆ν1/2 [Hz]a δ [ppm] ∆ν1/2 [Hz]a 
1:0 -10.12 22 -5.78 24.0 -1.16 11 
cyclen 
1:10 -10.12 39 -6.71 142   0.31 51 
1:0 -10.12 24 -5.66 43 -1.10 19 
1:8 -10.93 74 -6.61 36 -0.64 56 BPA 
1:16 -11.17 57 -6.86 28 -0.26 41 
a
 the line width was corrected with respect to the exponential filter applied during data processing 
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4.2.2 Binding of Zn2+-BPA to Ras(wt)·Mg2+· GppNHp 
STD NMR spectroscopy clearly revealed the binding activity of Zn2+-BPA for 
Ras(T35A)·Mg2+·GppNHp. It was also shown that the compound binds to Mg2+·GppNHp. 
For these reasons it was of interest whether the compound binds close to the active centre 
and might influence the dynamic equilibrium in active Ras in any way. Zn2+-BPA was 
titrated to wild type Ras complexed to Mg2+·GppNHp up to a molar ratio of 1:28. During 
the titration precipitation was observed and resonances representing Mg2+·GppNHp 
showed up and shifted upfield in the corresponding 31P NMR spectra. SDS-Page analysis 
of the precipitant after the last titration step clearly revealed that Ras precipitated. 
Figure 4.11 shows the obtained spectra.  
 
 
 
Figure 4.11: Influence of Zn2+-BPA on the dynamic equilibrium of Ras(wt)·Mg2+·GppNHp. 31P NMR 
spectra of 0.4 mM Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 
0.2 mM DSS and 5% D2O in the absence and presence of Zn2+-BPA. The molar ratios Ras:BPA are 
indicated. All spectra have been recorded at 278 K. Experimental data were filtered exponentially resulting in 
an additional line broadening of 15 Hz.  
 
Qualitatively is clear from these spectra that Zn2+-BPA selectively binds to conformational 
state (1) when looking at the γ- and α-phosphate signals. The resonances representing 
conformational state (1) gain in population. At the same time a loss in the peak area is 
observed for resonances assigned to conformational state (2). In contrast to Zn2+-cyclen a 
significant shift change is not observed for any of the signals. Quantification of the 
observed effect is quite cumbersome due to the poor quality and the lack of knowledge 
about the exact concentrations. However the data have been evaluated ignoring the 
precipitated fraction and the results are given in Table 4.2. 
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Table 4.2 Chemical shifts observed for Ras(wt)·Mg2+·GppNHp in the presence of Zn2+-BPA. 
 α-phosphate β-phosphatea γ-phosphate  
p:l δ1 [ppm] δ2 [ppm] δ1 [ppm] δ2 [ppm] δ1 [ppm] δ2 [ppm] Κ12b 
1:0 -11.18 -11.67 -0.27a -2.59 -3.37 1.74 
1:4c -11.15 -11.69 -0.30a -2.60 -3.35 1.27 
1:28d -11.20 -11.50e -0.33e -2.43 -3.33 0.58 
   a
 signals for conformational state (1) and (2) overlap at the magnetic field used. 
   b
 K12 was calculated from the relative peak areas observed for the γ-phosphate resonance: K12 = A(γ2)/A(γ1) 
  
c
 precipitation was not observed at this ligand excess 
   d
 Ras started to precipitate at this ligand excess 
   e could not be determined accurately due to the overlap with the α-phosphate signal from free  
    Mg2+·GppNHp 
 
 
4.2.3 Binding of Cu2+-BPA to Wild Type Ras and Ras(T35A) Complexed 
to Mg2+·GppNHp 
Whereas in the presence of Zn2+-cyclen the change of the relative population of 
conformational state (1) over state (2) is accompanied by large chemical shift changes for 
the resonances representing state (1) this is not the case for Zn2+-BPA. The question 
remaining was, whether stabilization of conformational state is achieved with  
metal(II)-BPA by binding in the active centre or whether long range conformational 
changes induced by a binding elsewhere in the protein influences the dynamic equilibrium, 
which is then detected in the 31P NMR spectra. The presence of a paramagnetic centre 
leads to the enhancement of the relaxation rates of NMR active nuclei. The latter effect can 
be observed by strong line broadening of the affected resonances in a distance-dependent 
manner. Consequently the effect of the paramagnetic derivative Cu2+-BPA on the  
31P resonance signals of active Ras has been investigated like we have done with the 
metal(II)-cyclens (Rosnizeck et al., accepted). Metal(II)-BPA might bind to active Ras in a 
comparable manner, i.e. close to the bound nucleotide in conformational state (1). 
Consequently the resonances belonging to the latter state should be influenced to a larger 
extend in wild type Ras·Mg2+·GppNHp than the one representing the effector-binding state 
(2). Additionally the expected effects should be stronger in the Ras mutant T35A, which 
predominantly exists in conformational state (1). Cu2+-BPA was titrated to wild type Ras 
and Ras(T35A) complexed to Mg2+·GppNHp up to a molar ratio of 1:8. The obtained 
spectra are shown in Figure 4.12 and 4.13, the results are summarized in Table 4.3. No 
significant shift changes are observed in both titrations. The lines of the β- and γ-phosphate 
peaks are broadened to a much greater extend than the one of the α-phosphorus in each 
case. The strongest effects are observed for the resonances belonging to conformational 
state (1). This becomes apparent when comparing the results obtained for wild type Ras 
and Ras(T35A).  
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Figure 4.12: Influence of Cu2+-BPA on Ras(wt)·Mg2+·GppNHp. 31P NMR spectra of 0.4 mM 
Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in 
the absence and presence of Cu2+-BPA. The molar ratios Ras:BPA are indicated. All spectra have been 
recorded at 278 K. Experimental data were filtered exponentially leading to an additional line broadening of 
15 Hz. 
 
 
 
 
Figure 4.13: Influence of Cu2+-BPA on Ras(T35A)·Mg2+·GppNHp. 31P NMR spectra of 
0.7 mM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS 
and 5% D2O in the absence and presence of Cu2+-BPA. The molar ratios Ras:BPA are indicated. All spectra 
have been recorded at 278 K. Exponential filtering of experimental data led to additional line broadening of 
15 Hz. 
 
At a molar ratio of 1:8 the β- and γ-phosphate peaks are almost broadened beyond 
detection in the latter mutant. In wild type Ras the selectivity for conformational state (1) 
over (2) can be seen very clearly. The γ-phosphate signal of state (1) becomes significantly 
broadened and is no longer detectable at molar ratio of Ras:BPA of 1:8. At a 4-fold excess 
the line width is 563 Hz compared to 71 Hz in the absence of the compound. Additionally 
the α-phosphate resonance, which is not significantly influenced by the  
Cu2+-centre in terms of line broadening clearly reveals a shift of the dynamic equilibrium 
towards the weak effector-binding state in the wild type protein. 
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Table 4.3: Chemical shift differences and relative peak areas observed for Ras complexed to 
Mg2+·GppNHp in the absence and presence of Cu2+-BPA. 
   α-phosphate β-phosphate γ-phosphate 
 p:l K12 α1  α2  β1  β2  γ1  γ2  
   Ras(wt)·Mg2+·GppNHp 
δ [ppm] 1:0 2.00a -11.14 -11.67 -0.28b -2.58 -3.34 
 
1:8 0.45c -11.07 -11.66 -0.12b n.d.d -3.43 
∆ν1/2 [Hz] 1:0  65 85 47b 71 58 
 
1:8 
 
92 77 118b n.d.d 86 
   Ras(T35A)·Mg2+·GppNHp 
δ [ppm] 1:0 -10.93  -0.36  -2.51  
 
1:8 -10.94 
 
-0.18 
 
-3.09 
 
∆ν1/2 [Hz] 1:0 60  47  29  
 
1:8 
>0.05 e 
84 
 
474 
 
603 
 
a
  K12 was calculated from the relative peak areas observed for the γ-phosphate resonance: K12 = A(γ 2)/A(γ 1) 
b
 resonances representing conformational state (1) and (2) are not separated for the β-phosphate group at the 
   magnetic field used 
c
  K12 was calculated from the relative peak areas observed for the γ-phosphate resonance: K12 = A(α2)/A(α1) 
d
  resonances already broadened beyond detection. At molar ratio of 1:4 following values have been obtained:  
   δ (γ1) = -2.42, ∆ν1/2 = 563 Hz. 
e 
 taking into account the signal to noise ratio the limit for K12 can be estimated  
 
 
4.2.4 Binding of Zn2+-Cyclen and -BPA to Ras(G12V) Complexed to 
Mg2+·GTP and Mg2+·GppNHp 
The small organic compound Zn2+-cyclen selectively binds the weak binding state of 
Ras(wt)·Mg2+·GppNHp and is able to shift the dynamic equilibrium completely towards 
this state (Spoerner et al. 2005c). The same was shown for Zn2+-BPA. The effect of both 
metal(II)-chelates on the oncogenic mutant Ras(G12V) in its active conformation was also 
investigated. Bound to Mg2+·GppNHp the dynamic equilibrium is slightly shifted towards 
state (1) with K12 = 0.9 (Spoerner et al. 2004 2005) in the oncogenic mutant compared to 
wild type with K12 = 1.9. Ras(G12V)·Mg2+·GppNHp shows a similar free activation energy 
for exchange compared to wild type Ras·Mg2+·GppNHp. Zn2+-cyclen and -BPA were 
titrated to Ras(G12V)·Mg2+·GppNHp followed by 31P NMR spectroscopy. The reference 
and final spectra are shown in Figures 4.14 and 4.15, respectively. Regarding the relative 
population of conformational state (1) over state (2) the effect of Zn2+-BPA is stronger than 
the one observed for Zn2+-cyclen. At a molar ratio of 1:10 the shift towards state (1) is 
almost complete, whereas a 32-fold excess in the case of Zn2+-cyclen is still not sufficient. 
Zn2+-cyclen influences the resonances of the all three phosphate groups in terms of their 
chemical shift. The shift direction is comparable with the ones observed in wild type Ras, 
i.e. the α- and γ-phosphate resonances shift downfield and the β-phosphate peak shifts 
upfield. However, quantitatively the shift effect is stronger in Ras(wt)·Mg2+·GppNHp. For 
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Zn2+-BPA no significant shift differences can be observed. At a molar ratio of about 1:10 
the protein starts to precipitate as already observed in the titration with 
Ras(wt)·Mg2+·GppNHp and for that reason the experiment was not carried out at higher 
concentrations for Zn2+-BPA.  
 
 
 
Figure 4.14: Influence of Zn2+-cyclen on the dynamic equilibrium of Ras(G12V)·Mg2+·GppNHp.  
31P NMR spectra 1 mM Ras(G12V)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 
0.2 mM DSS and 5% D2O in the absence and presence of Zn2+-cyclen. The molar ratios are indicated. All 
spectra have been recorded at 278 K. Experimental data were fitted exponentially leading to an additional 
line broadening of 15 Hz. 
 
 
 
Figure 4.15: Influence of Zn2+-BPA on the dynamic equilibrium of Ras(G12V)·Mg2+·GppNHp.  
31P NMR spectra of 0.6 mM Ras(G12V)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 
2 mM DTE, 0.2 mM DSS and 5% D2O in the absence and presence of Zn2+-BPA. The molar ratios are 
indicated. All spectra have been recorded at 278 K. Experimental data were fitted exponentially leading to an 
additional line broadening of 15 Hz. 
 
Ras(G12V) is an oncogenic mutant of Ras and consequently exhibits a very slow 
hydrolysis rate of 0.0017 min-1 (Ahmadian et al. 1999) allowing to study the active 
conformation of Ras complexed to its physiological nucleotide GTP. Ras(wt)·Mg2+·GTP 
predominantly exists in a conformation corresponding to state (2). Saturation transfer 31P 
NMR experiments reveal the existence of a conformational equilibrium with a second 
conformational state, which is found in the partial loss-of-function mutants T35A and 
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T35S complexed to Mg2+·GTP (Spoerner et al., unpublished results). The same is true for 
Ras(G12V)·Mg2+·GTP. It was investigated whether the two chelate complexes are able to 
shift the dynamic equilibrium towards the weak effector-binding state of (G12V) 
complexed to Mg2+·GTP. Figure 4.16 and 4.17 show the influence of Zn2+-cyclen and  
-BPA on Ras(G12V)·Mg2+·GTP.  
 
 
 
Figure 4.16: Influence of Zn2+-cyclen on the conformational equilibrium of Ras(G12V) complexed to 
Mg2+·GTP. 31P NMR spectra of 0.8 mM Ras(G12V)fl·Mg2+·GTP in 40 mM Hepes/NaOH pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in the absence and presence of Zn2+-cylen recorded at 
278 K. The molar ratios are indicated. Experimental data were filtered exponentially leading to an additional 
line broadening of 15 Hz. 
 
 
 
 
Figure 4.17: Influence of Zn2+-BPA on the conformational equilibrium of Ras(G12V) complexed to 
Mg2+·GTP. 31P NMR spectra of 0.6 mM c'Ras(G12V)·Mg2+·GTP in 10 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in the absence and presence of Zn2+-BPA recorded at 
278 K. The molar ratios are indicated. Experimental data were filtered exponentially leading to an additional 
line broadening of 15 Hz. 
 
The results clearly reveal the selective stabilization of conformational state (1) in the 
protein. However the affinity is much lower than to the protein in complex with 
Mg2+·GppNHp. Again, qualitatively one can say that the effect is stronger in the case of 
Zn2+-BPA. The same was also observed for Ras(G12V) complexed to Mg2+·GppNHp. It is 
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noteworthy that in the presence of Zn2+-cyclen, but not -BPA a resonance line representing 
free inorganic phosphate is observed at higher concentrations. The obtained results from 
the titration of Ras(G12V) complexed to Mg2+·GppNHp and Mg2+·GTP, respectively with 
the two Zn2+-chelates are summarized in Table 4.4. 
 
Table 4.4: Chemical shift differences and relative peak areas observed for Ras(G12V)·Mg2+·GppNHp 
and Ras(G12V)·Mg2+·GTP in the absence and presence of Zn2+ cyclen and Zn2+-BPA, respectively. 
   α-phosphate β-phosphate γ-phosphate 
Zn2+- p:l K12b δ1 [ppm] δ2 [ppm] δ1 [ppm] δ2 [ppm] δ1 [ppm] δ2 [ppm] 
Ras(G12V)·Mg2+·GppNHp 
1:0 0.95 -11.23 -11.63 0.00a -2.36 -4.12 
cyclen 
1:32 0.40 -10.93  0.25a -2.05  
1:0 0.86 -11.19 -11.50 0.04a -2.40 -4.06 
BPA 
1:10 0.29 -11.31 -11.66 0.05a -2.37  
Ras(G12V)·Mg2+·GTP 
1:0 15.3c -11.57 -15.07 -14.72 -6.18 -7.59 
cyclen 
1:48 3.96 -11.48 -15.33  -6.23  
1:0 6.97c -11.53 -14.92 -14.68 -6.12 -7.59 
BPA 1:24 2.86 -11.53 -15.09  -6.02  
  a the signals representing the two conformational states in active Ras are not separated at the magnetic field  
   used  
  b
 K12 was calculated from the relative peak areas observed for the γ-phosphate resonance: K12 = A(α2)/A(α1) 
  c
 the value for K12 is afflicted with large errors since conformational state (1) is only sparely populated  
 
 
4.2.5 Binding of Metal(II)-Cyclens to Mg2+·GTPγS in Free Form and 
Complexed to Ras 
The 31P NMR spectrum of Ras(T35A)·Mg2+·GTPγS reveals two substates of the weak 
effector-binding state, which are in a slow conformational equilibrium (Spoerner et al. 
2007). Since Zn2+-cyclen is capable of stabilizing state (1) its influence on both substates 
was studied by 31P NMR spectroscopy.  
Initially Mg2+·GTPγS was titrated with Zn2+- and Cu2+-cyclen up to a molar ratio of 
Mg2+·GTPγS:metal(II)-cyclen of 1:20 and 1:6.4, respectively and the effect was followed 
by 31P NMR spectroscopy. The obtained spectra and the derived chemical shifts are 
depicted and summarized in Figure 4.18 and Table 4.5, respectively. In the presence of 
Cu2+-cyclen the signals of all three phosphate groups are significantly broadened with the 
strongest effects observed for the γ-phosphate, which is already broadened beyond 
detection at a molar excess of 1:0.2 and the β-phosphate showing a line width of 330 Hz at 
a molar ratio of GTPγS:Cu2+-cyclen of 1:6.4 compared to 82 Hz in the reference spectrum. 
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Figure 4.18: Binding of metal(II)-cyclens to Mg2+·GTPγS. 31P NMR spectra of 1 mM GTPγS in  
40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in the absence (A) and 
presence of Zn2+-cyclen with a molar excess of 5 (B) and 20 (C) and Cu2+-cyclen with a molar excess 
6.4 (D), respectively. All spectra have been recorded at 278 K. The experimental have been filtered 
exponentially leading to an additional line broadening of 20 Hz.  
 
 
Table 4.5: Chemical shift differences and line broadening observed for Mg2+·GTPγS upon addition of 
metal(II)-cyclens. 
  α-phosphate β-phosphate γ-phosphate 
-cyclen n:l δ [ppm] ∆ν1/2 [Hz]a δ [ppm] 
∆ν1/2 
[Hz]a δ [ppm] 
∆ν1/2 
[Hz]a 
1:0 -10.77 21 -20.96 82 36.70 36 Cu2+- 
1:6.4 -10.59 140 -21.45 329 n.d.b 
1:0 -10.67 16 -20.68 93 36.77 41 
1:5 -11.05 18 -23.55 136 24.32 293 Zn2+- 
1:20 -11.16 21 -23.72 43 24.51 36 
a
 the line width was corrected with respect to the exponential filter applied during data processing 
b lines for the γ-phosphate group were already broadened beyond detection at a molar ratio of n:l = 1:0.2. At a  
  molar excess of 0.1 the following values are obtained: δ(γ) = 36.52 ppm, ∆ν1/2 = 1018 Hz. 
 
In the presence of the diamagnetic derivative each signals shifts upfield to a different 
extend. The strongest effects are again observed for the γ- and the β-phosphate resonance, 
whereas the influence on the α-phosphate is very small with 0.6 ppm compared to 2.9 ppm 
and 12.3 ppm for the β- and γ-phosphate signal, respectively. During the titration with 
Zn2+-cyclen also intermediate exchange processes can be observed for the γ- and the  
β-phosphate signals at a molar ratio of Mg2+·GTPγS:Zn2+-cyclen between 1:1 and 1:5. The 
signals are almost broadened beyond detection for the γ-phosphate signal and show up 
again at a molar excess of 1:10 without being significantly broadened compared to the 
reference spectrum. An example is shown in Figure 4.18 and the corresponding data are 
given in Table 4.5. 
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In the next step Ras(T35A)·Mg2+·GTPγS was titrated with Cu2+-cyclen up to a molar ratio 
of 1:4. The strongest line broadening effects are again observed for the γ- and β-phosphate 
group. The dynamic equilibrium is shifted towards state (1a). Ras(T35A)·Mg2+·GTPγS was 
further titrated with the diamagnetic derivative Zn2+-cyclen up to a molar excess of  
Zn2+-cyclen of 20 (see Figure 4.20). It is striking that in this titration the resonances 
assigned to state (1a) are mainly affected. Additional one can see that between an ratio of  
metal(II)-cyclen to Ras of 1:2 and 1:4 also a strong line broadening is observed for the 
resonance of the γ-phosphate belonging to substate (1a). The latter resonance is broadened 
beyond detection at the same molar ratio as in the case of the titration with the 
paramagnetic derivative. In order to ensure that the bleaching effect observed in the 
titration with Cu2+-cyclen can clearly be related to its paramagnetism the titration was 
repeated with molar ratios of 1:0, 1:4, 1:10 and 1:20. The obtained spectra are shown in 
Figure 4.19 together with the spectra from the previous titration.  
 
 
 
 
Figure 4.19: Binding of Cu2+-cyclen to Ras(T35A) complexed to Mg2+·GTPγS. 31P NMR spectra of  
0.76 mM Ras(T35A)·Mg2+·GTPγS in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 
5% D2O in the absence and presence of increasing concentrations of Cu2+-cyclen. The molar ratios between 
Ras and metal(II)-cyclen are indicated. All spectra have been recorded at 278 K. The experimental have been 
filtered exponentially leading to an additional line broadening of 20 Hz.  
 
The γ-resonance representing substate (1a) does not appear again indicating strong line 
broadening effects caused by the paramagnetic Cu2+-ion of the ligand than rather by 
exchange phenomena. For the β-phosphate peak further line broadening and an extended 
upfield shift is observed. The resonances belonging to substate (1b) are disappearing in the 
case of the β- and γ-phosphate due to the shift of the dynamic equilibrium towards state 
(1a). The obtained results are summarized in Table 4.6. 
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Figure 4.20: Influence of Zn2+-cyclen on the dynamic equilibrium in Ras(T35A) complexed to 
Mg2+·GTPγS. 31P NMR spectra of 0.88 mM Ras(T35A)·Mg2+·GTPγS in 40 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in the absence and presence of increasing 
concentrations of Zn2+-cyclen. The molar ratios of Ras:metal(II)-cyclen are indicated. All spectra have been 
recorded at 278 K. Experimental have been filtered exponentially leading to an additional line broadening of 
20 Hz.  
 
 
Table 4.6: Chemical shift values and line widths observed for Ras(T35A)·Mg2+·GTPγS upon addition 
of metal(II)-cyclens. 
  α-phosphatea β-phosphate γ-phosphate 
 p:l α1a α1b β1a β1b γ1a γ1b 
  Cu2+-cyclen 
δ [ppm] 1:0 -10.88 -17.20 -17.85 37.96 32.74 
 1:20 -10.35 -26.07 n.d.b n.d.c n.d.b 
∆ν1/2 [Hz]d 1:0 75 65 111 64 84 
 1:20 149 551 n.d.b n.d.c n.d.b 
  Zn2+-cyclen 
δ [ppm] 1:0 -10.92 -17.25 -17.98 37.92 32.78 
 1:20 -10.71 -18.06 n.d.e 28.78 32.88 
∆ν1/2 [Hz]d 1:0 108 85 108 74 89 
 1:20 147 83 n.d.e 259 72 
a
 the signals representing the two conformational states are not separated at the magnetic field used 
b could not be determined. The equilibrium is completely shifted towards state (1a) at a molar ratio of 1:4 
c could not be determined. The signal is already broadened beyond detection after the first titration step 
d
 the line width was corrected with respect to the exponential filter used during data processing. 
e
 could not be determined due to the overlap with the signal of γ(1a) 
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From this titrations it is clear that the small compound binds in close proximity of the  
γ- and β-phosphate group and herein selectively to conformational state (1a). Interestingly 
the line broadening effects strongly indicating slow exchange between the free and the 
bound form are also observed for the free nucleotide. The resonances belonging to state 
(1b) are not affected in terms of their chemical shift in both titrations. The only effect 
observed is a loss in peak intensity or area, respectively, which is caused by the 
stabilization of the conformational substate (1a). 
GTPγS is probably most similar to the physiological nucleotide GTP compared to 
GppNHp or GppCH2p, especially in terms of the conformational equilibrium in active  
Ras (Spoerner et al. 2007). Mainly conformational state (2) is found in wild type Ras 
complexed to Mg2+·GTPγS (Spoerner et al. 2007) and Mg2+·GTP (M. Spoerner, 
unpublished results). In section 4.2.4 it was shown that in the oncogenic mutant 
Ras(G12V) complexed to Mg2+·GTP the same conformational state is found as in the wild 
type protein. Upon addition of a large excess of Zn2+-cyclen resonances representing 
conformational state (1) appeared in the 31P NMR spectrum. Consequently the oncogenic 
mutant was complexed to Mg2+·GTPγS in order to see, whether also mainly 
conformational state (2) is found. The corresponding spectrum is shown in Figure 4.21 and 
compared to Ras(T35A)·Mg2+·GTPγS.  
 
 
 
Figure 4.21: Influence of Zn2+-cyclen on the dynamic equilibrium in Ras(G12V) complexed to 
Mg2+·GTPγS. 31P NMR spectra of 0.58 mM Ras(G12V)·Mg2+·GTPγS in 40 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in the absence (B) and presence (C) of Zn2+-cyclen 
with a molar ratio of Ras:metal(II)-cyclen of 1:20. The 31P NMR spectrum of Ras(T35A)·Mg2+·GTPγS is 
shown for comparison (A). All spectra have been recorded at 278 K. Experimental have been filtered 
exponentially leading to an additional line broadening of 15 Hz ((B), (C)) and 20 Hz (A), respectively.  
 
 
Indeed as expected one resonance signal for each phosphate group representing 
conformational state (2) is found. In the next step Zn2+-cyclen was titrated to the sample. 
As one can see additional resonances appear with chemical shift values of 36.3 ppm and  
-17.80 ppm, when a molar excess for Zn2+-cyclen of 20 is present. In the case of the  
β-phosphate group this chemical shift value is in good agreement with the one found for 
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substate (1a) in Ras(T35A)·Mg2+·GTPγS. The latter state has already been shown to be 
selectively bound by the small compound compared to state (1b). The signal representing 
conformational state (1a) is strongly shifts upfield in the presence of Zn2+-cyclen. Thus, the 
signal appearing at 36.3 ppm at a molar excess of Zn2+-cyclen over Ras of 20 is most 
probably representing conformational substate (1a) in complex with Zn2+-cyclen. 
However, data quality is not sufficient for quantification.  
 
4.2.6 Binding of Cyclens and Metal(II)-BPA to Ras·Mg2+·GDP 
High field EPR and 31P NMR studies could show that also the GDP bound “off” state of 
Ras exists in two different conformational states (Rohrer et al. 2001). For that reason and 
due to suggestion that conformational state (1) of active Ras is structurally similar to the 
inactive conformation of Ras, the effect of Cu2+-cyclen on Ras(wt)·Mg2+·GDP has already 
been investigated. Neither significant line broadening nor chemical shift differences have 
been observed at molar ratios between Ras(wt)·Mg2+·GDP and Cu2+-cyclen, where already 
strong effects are observed in the active conformation (Spoerner at al. 2005c). To complete 
the picture the effect of different cyclens on the partial loss-of-function mutant Ras(T35A) 
complexed to Mg2+·GDP was investigated. Figure 4.22 shows the spectra obtained in the 
presence of molar excess of 16 of cyclen, Zn2+-cyclen and Cu2+-cyclen. Chemical shift 
differences and line broadening have been evaluated, the results are summarized in Table 
4.7. Slight line broadening effects and chemical shift changes can be observed for the  
α-phosphate resonances in the presence of Zn2+- and Cu2+-cyclen. The β-phosphate 
resonances are not affected significantly.  
 
 
 
 
Figure 4.22: Influence of different cyclen derivatives on the 31P NMR spectra of Ras(T35A)·Mg2+·GDP. 
31P NMR spectra of 1 mM Ras(T35A)·Mg2+·GDP in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 
0.2 mM DSS and 5% D2O in the absence (A) and presence of cyclen (B), Zn2+-cyclen (C) and Cu2+-cyclen 
(D) with a molar ratio of Ras:cyclen of 1:16. All spectra were recorded at 278 K. Experimental data were 
filtered exponentially leading to an additional line broadening of 15 Hz. 
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Table 4.7: Chemical shift values and line broadening of the phosphate resonances of 
Ras(T35A)·Mg2+·GDP in the absence and presence of different cyclen derivatives. 
  α-phosphate β-phosphate 
 p:l δ [ppm] ∆ν1/2 [Hz]a δ [ppm] ∆ν1/2 [Hz]a 
1:0 -10.55 61 -2.03 33 Zn2+-cyclen 
1:16 -10.32 70 -2.00 35 
1:0 -10.55 64 -2.04 33 Cu2+-cyclen 1:16 -10.44 69 -2.02 37 
1:0 -10.55 68 -2.06 35 
cyclen 1:16 -10.51 66 -2.02 35 
a
 the line width was corrected with respect to the exponential filter used in data processing 
 
The effect of metal(II)-BPAs on the inactive conformation of wild type and mutant Ras 
complexed to Mg2+·GDP was studied for the same reasons as in the case of the  
metal(II)-cyclens. The experiments have been carried out with wild type and mutant 
Ras·Mg2+·GDP. The obtained spectra are given in Figure 4.23. 
 
 
 
 
Figure 4.23: Influence on metal(II)-BPA on Ras complexed to Mg2+·GDP. 31P NMR spectra of 
Ras·Mg2+·GDP in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2 and 2 mM DTE, 0.2 mM DSS and 5% D2O. (A), 
(B), (C) 0.48 mM Ras(wt) in the absence and presence of Zn2+-BPA and Cu2+-BPA, respectively with a 
molar excess of 16. (E) and (D) 0.57 mM Ras(T35A) in the absence and presence of a 16-fold excess of 
Cu2+-BPA. (F) and (G) 0.71 mM Ras(G12V) in the absence and presence of an 18-fold excess of Cu2+-BPA. 
All spectra have been recorded at 278K. Experimental data have been filtered exponentially leading to an 
additional line broadening of 15 Hz. 
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Ras(wt)·Mg2+·GDP was titrated with Zn2+- and Cu2+-BPA. The resonance of the  
β-phosphate group is not influenced significantly by the presence of the two compounds 
concerning both the line width and the chemical shift. For the α-phosphate peak a 
downfield shift can be observed upon addition of both compounds, with the effect being 
stronger in the presence of Cu2+-BPA. The line width of the α-phosphate signal is also not 
influenced significantly. 
Additionally the Ras mutants T35A and G12V complexed to Mg2+·GDP have been titrated 
with Cu2+-BPA. Again in both cases the β-phosphate resonance is not influenced 
significantly, whereas the signals of the α-phosphate shift downfield. The effects are 
comparable for both Ras mutants with a chemical shift difference of 0.43 and 0.39 ppm for 
T35A and G12V, respectively between Ras·Mg2+·GDP in the absence and presence of a 
16-fold and 18-fold ligand excess, respectively. This is also in good agreement with wild 
type Ras, were a downfield shift of 0.45 ppm is observed upon addition of a 16-fold excess 
Cu2+-BPA. Significant line broadening can not be observed for both signals. Table 4.8 
summarizes the effects of metal(II)-BPA on Ras·Mg2+·GDP. 
 
 
Table 4.8: Chemical shift values and line broadening of the phosphate resonances of 
Ras(T35A)·Mg2+·GDP in the absence and presence of different BPA derivatives. 
  α-phosphate β-phosphate 
Ras·Mg2+·GDP p:l δ [ppm] ∆ν1/2 [Hz]a δ [ppm] ∆ν1/2 [Hz]a 
  Cu2+ -BPA 
1:0 -10.59 47 -1.97 30 
wild type 
1:16 -10.14 72 -1.95 43 
1:0 -10.59 59 -2.04 30 
T35A 
1:16 -10.16 78 -1.98 44 
1:0 -10.42 45 -1.83 29 
G12V 
1:18 -10.03 70 -1.80 45 
  Zn2+ -BPA 
1:0 -10.59 47 -1.97 30 
wild type 
1:16 -10.46 66 -2.01 33 
a
 the line width was corrected with respect to the exponential filter used during data processing 
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4.3 Perturbation of the Ras-Raf-RBD Interaction by Metal(II)-
Chelates 
4.3.1 General Considerations 
As described in section 1.1.5.2 conformational state (1) of active Ras shows drastically 
reduced affinity for effector molecules. The above characterized metal(II)-chelates have 
been shown to selectively recognize and stabilize conformational state (1) of active Ras. 
Consequently it should also be possible to perturb the Ras-effector interaction by both 
mutants via stabilization of conformational state (1). This was already shown by ITC, 
where a drop of the apparent affinity constant of Raf-RBD for Ras(wt)·Mg2+·GppNHp in 
the presence of Zn2+-cyclen and Cu2+-cyclen is observed (Rosnizeck et al., accepted). No 
data are available about the association kinetics between Ras and Raf-RBD in the presence 
of both compounds. Additionally their mode of inhibition is not known. Since Raf-RBD 
can bind both conformational states of active Ras the question remains, whether a 
heterotrimeric complex is formed consisting of Ras·Mg2+·GppNHp in conformational state 
(1), Raf-RBD and Zn2+-cyclen or whether the effector and the metal(II)-chelate bind 
separately to Ras. To address these questions the Ras-Raf-RBD association in the presence 
of the two compounds was studied further by 31P NMR spectroscopy.  
 
 
4.3.2 31P NMR Titration of Ras(T35S)·Mg2+·GppNHp Complexed to Raf-
RBD with Zn2+-Cyclen and Zn2+-BPA 
The partial loss-of-function mutant Ras(T35S)·Mg2+·GppNHp predominately exists in the 
weak effector-binding state. Upon addition of effector the signals corresponding to 
conformational state (2) appear in the corresponding 31P NMR spectrum. The signals 
representing conformational state (1) and (2) for the γ-phosphate group in 
Ras(T35S)·Mg2+·GppNHp are very well separated allowing the determination of the 
proportion of the single states quite easily via the peak areas. Ras(T35S)·Mg2+·GppNHp 
was complexed to Raf-RBD and the displacement of the latter was studied by 31P NMR 
titration with the two Zn2+-chelates. Figure 4.24 shows the results obtained with  
Zn2+-cyclen. The three phosphate groups in Ras(T35S)·Mg2+·GppNHp are represented by 
one signal each. Upon addition of Raf-RBD the equilibrium is almost completely shifted 
towards the effector-binding state. The line widths of the signals representing 
conformational state (2) are broadened by a factor of 1.43, 1.41 and 1.44 for the α-, the  
β- and the γ-phosphate peak in complex with Raf-RBD compared to conformational state 
(1). This relates very well with the increase of the molecular mass by a factor of 1.46, 
when effector is bound. To the present complex between Ras(T35S)·Mg2+·GppNHp and 
Raf-RBD Zn2+-cyclen was added up to a 48-fold molar excess. As one can see very clearly 
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the signals representing conformational state (1) of Ras(T35A)·Mg2+·GppNHp increase 
with increasing concentrations of Zn2+-cyclen accompanied by an upfield shift for the  
β-phosphate peak and an downfield shift for the α- and γ-resonance, respectively. At the 
same time the population of the resonances belonging to the effector-binding state (2) 
decreases. No significant shift changes are observed for the signals of the α- and  
γ-phosphate group representing state (2). The resonances of both conformational states can 
be separated for the β-phosphate peak at a molar ratio of Ras:cyclen of 1:16.  
 
 
 
 
Figure 4.24: Displacement of Raf-RBD from Ras(T35S)·Mg2+·GppNHp by Zn2+-cyclen. 
Ras(T35S)·Mg2+·GppNHp in the absence (A) and presence of a 1.5-fold excess of Raf-RBD (B) and 
subsequent addition of a 4-fold (C), 16-fold (D), 32-fold (E) and 48-fold (F) excess of Zn2+-cyclen, 
respectively. The sample initially contained 2.1 mM Ras(T35S)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O. All spectra have been recorded at 278 K. 
Experimental data have been filtered exponentially leading to an additional line broadening of 15 Hz. 
 
 
The same experiment was carried out with Zn2+-BPA. A precipitation of Ras was observed 
upon addition of increasing amounts of the ligand, which was already observed in the 
titration of Ras(wt)·Mg2+·GppNHp. For that reason the titration was only performed up to a 
molar excess of BPA of 11-fold. The obtained spectra are given in Figure 4.25. Upon 
complex formation with Raf-RBD the line width increases by a factor of 1.9, 1.53 and for 
the α- and  β- phosphate peak compared to the reference peak and by a factor of 1.42 for 
and the γ-phosphate representing conformational state (2). Stepwise addition of Zn2+-BPA 
to the complex leads to an increase of the population of conformational state (1) and at the 
same time to a decrease of state (2). No significant shift changes are observed for either 
resonances representing state (1) or (2), respectively. The poor data quality did not allow 
for accurate evaluation of the line widths and chemical shifts for every resonance, 
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especially the α-phosphate resonances. The results obtained for the γ- and β-phosphorus 
resonances are given in Table 4.9. Increasing concentrations of Zn2+-BPA lead to a 
decrease of the line width for the β-phosphate resonance. The signal from the γ-phosphorus 
in conformational (1) state is not broadened significantly during the titration.  
 
 
 
 
 
Figure 4.25: Displacement of Raf-RBD from Ras(T35S)·Mg2+·GppNHp by Zn2+-BPA. 
Ras(T35S)·Mg2+·GppNHp in the absence (A) and presence of a 1.5-fold excess of Raf-RBD (B) and 
subsequent addition of a 4-fold (C), 7-fold (D), and 11-fold (E) excess of Zn2+-BPA, respectively. The 
sample initially contained 0.98 mM Ras(T35S)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 
2 mM DTE, 0.2 mM DSS and 5% D2O. All spectra have been recorded at 278 K. Experimental data have 
been filtered exponentially leading to an additional line broadening of 15 Hz. 
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Table 4.9 Chemical shift changes and line widths observed in Ras(T35S)·Mg2+·GppNHp in the   
 presence of Raf-RBD and after subsequent addition of Zn2+-cyclen and Zn2+-BPA, respectively. 
  Ras(T35S) + Raf-RBD + Zn2+-cyclen 
molar excess  1.5 32 48 
α(1) -11.01 -11.02 -10.82 -10.80 
α(2)  -11.60 -11.62 n.d.a 
β(1) -0.32 -0.81 -0.90 
β(2)  -0.34
b 
-0.14 n.d.a 
γ(1) -2.56 -2.59 -1.73 -1.66 
δ [ppm] 
γ(2)  -3.44 -3.49 n.d.a 
 α(1) 101 92 112 
 α(2)  132 n.d.
d
 
n.d.a 
β(1) 78 66 
β(2) 69 104
b 
128 n.d.a 
γ(1) 54 50 74 74 ∆ν1/2 [Hz]
c 
γ(2)  80 116 n.d.a 
 
 
Ras(T35S) + Raf-RBD + Zn2+-BPA 
molar excess  1.5 7 11 
α(1) -10.93 -11.05 -11.00 
α(2)  
-11.55b 
-11.72 -11.66 
β(1) -0.36 
β(2)  -0.32
b 
-0.31b -0.27b 
γ(1) -2.55 -2.55 -2.51 -2.41 
δ [ppm] 
γ(2)  -3.43 -3.40 -3.40 
α(1) 91 
α(2)  
173b n.d.d n.d.d 
β(1) 64 
β(2)  107
b 97b 89b 
γ(1) 50 53 50 61 
∆ν1/2 [Hz]c 
γ(2)  78 100 n.d.d 
 a
 peaks representing conformational state (2) are not observed at this molar excess of Zn2+-cyclen 
 b
 the signals representing the two conformational states are not separated 
 c
 the line width was corrected with respect to the exponential filter used during data processing 
 d
 could not be determined accurately 
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4.3.3 Competitive 31P NMR Titrations of Ras(T35A)·Mg2+·GppNHp with 
Raf-RBD and Zn2+-Cyclen 
The titration studies with Ras(T35S)·Mg2+·GppNHp complexed to Ras clearly reveal that 
the effector can be displaced from its complex with Ras in state (2). The question remains, 
whether Raf-RBD is afterwards bound to state (1), which is stabilized by Zn2+-cyclen. For 
that reason displacement studies have also been carried out with the T35A mutant (see 
Figure 4.26). This mutant cannot be shifted towards conformational state (2) in the 
presence of Raf-RBD (Spoerner et al. 2001) and exists in conformational state (1) during 
the whole titration. Binding of Raf-RBD to Ras(T35A)·Mg2+·GppNHp is accompanied by 
a broadening of the signals due to the enhanced molecular mass.  
 
 
 
 
Figure 4.26: Displacement of Raf-RBD from Ras(T35A)·Mg2+·GppNHp by Zn2+-cyclen. 
Ras(T35A)·Mg2+·GppNHp in the absence (A) and presence of a 2-fold excess of Raf-RBD (B) and 
subsequent addition of a 4-fold (C), 8-fold (D), 12-fold (E) and 24-fold (F) excess of Zn2+-cyclen, 
respectively. The sample initially contained 1.1 mM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O. All spectra have been recorded at 278 K. 
Experimental data have been filtered exponentially leading to an additional line broadening of 15 Hz. 
 
 
Upon binding of Zn2+-cyclen to this mutant chemical shift changes can be observed for 
each signal. As soon as Raf-RBD and Zn2+-cyclen bind simultaneously to the weak binding 
state one would expect the existence of only one signal for each phosphate group during 
the whole titration. These signals should be broadened since the effector is complexed to 
Ras and additionally shift because of the presence of Zn2+-cyclen. If both compounds can 
only bind separately to Ras a different behaviour is expected. Two distinct resonances 
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representing Ras(T35A)·Mg2+·GppNHp with Raf-RBD or Zn2+-cyclen bound should be 
observed. The signal representing the Ras-Raf-RBD complex should decrease in the 
presence of increasing amounts of Zn2+-cyclen without significant shift changes, while the 
other one should gain in population accompanied by the shift changes commonly observed 
in Ras in the presence of the compound. Ras(T35A)·Mg2+·GppNHp was complexed with 
Raf-RBD followed by addition of increasing concentrations of Zn2+-cyclen up to a molar 
excess over Ras of 24-fold. The obtained spectra are depicted in Figure 4.26. Addition of 
Raf-RBD to Ras leads to line broadening of the signals representing the effector-bound 
conformational state of Ras(T35A)·Mg2+·GppNHp. With increasing amounts of  
Zn2+-cyclen two lines can be observed for the α- and γ-phosphate group, of which one 
increases, while the other one is decreasing. For the increasing signal of the γ-phosphate 
group also a downfield shift can be observed. For the β-phosphate resonance only one 
signal shifting upfield is observed over the whole titration. The results are summarized in 
Table 4.10. 
  
 
Table 4.10 Chemical shift changes and line widths observed in Ras(T35A)·Mg2+·GppNHp in the 
presence of Raf-RBD and upon subsequent addition of Zn2+-cyclen. 
  Ras(T35A) + Raf-RBD + Zn2+-cyclen 
molar excess  2 12 24 
α(1) -11.08 -11.17 
α(2)  -10.78 
-10.98a -10.99a 
β(1) -0.29 -0.68 
β(2)  -0.34
a 
-0.52a 
 
γ(1) -2.49 -2.51 -2.14 -1.9 
δ [ppm] 
γ(2)  -2.79 -2.69  
α(1) 67 67 
α(2)  113 
87a 118c 
β(1) 50 
β(2)  77
a
 75a 57a 
γ(1) 34 40 48 45 
∆ν1/2 [Hz]b 
γ(2)  77 83  
a
 the signals representing the two conformational states are not separated 
b
 the line width was corrected with respect to the exponential filter used during data processing 
c
 could not be determined accurately 
 
 
If the experiment is carried out the other way around, i.e. first Zn2+-cyclen is complexed to 
Ras and than Raf-RBD is added with increasing concentrations the same results should be 
observed. Upon addition of Raf-RBD the population of the Ras-Zn2+-cyclen complex 
should be diminished while the one representing the effector-bound complex should 
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increase. Additionally the resonances belonging to the Ras-Zn2+-cyclen complex should 
shift in the opposite direction due to the decreased concentration of the complex.  
Consequently Ras(T35A)·Mg2+·GppNHp was pre-complexed with Zn2+-cyclen and  
Raf-RBD was added stepwise. The obtained spectra are given in Figure 4.27.  
 
 
 
 
Figure 4.27: Displacement of Zn2+-cyclen from Ras(T35A)·Mg2+·GppNHp Raf-RBD. 
Ras(T35A)·Mg2+·GppNHp in the absence (A) and presence of a 30-fold excess of Zn2+-cyclen (B) and 
subsequent addition of a 1-fold (C), 4-fold (D) and 7-fold (E) of Raf-RBD, respectively. All spectra have 
been recorded at 278 K. Experimental data have been filtered exponentially leading to an additional line 
broadening of 15 Hz. The sample initially contained 0.99 mM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl 
pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O. 
 
 
At a 1-fold molar excess of Raf-RBD over Ras and higher precipitation was observed in 
the NMR sample. Additionally signals characteristic for Mg2+·GppNHp are observed in the 
31P NMR spectra. The precipitant was subject to SDS-Page analysis, which revealed Ras as 
precipitant. In the final spectrum a peak probably representing inorganic phosphate is 
coming up. Surprisingly the shift direction of the Pi-peak is opposite to the one commonly 
observed for inorganic phosphate in the presence of Zn2+-cyclen. Due to the poor data 
quality the effects observed are not quantified. Qualitatively the expected results are 
obtained. Addition of Zn2+-cyclen lead to the above described shift of the β- and  
γ-phosphate. Upon addition of Raf signals representing the Raf-Ras complex show up and 
increase in population compared to the signals of the Ras-Zn2+-cyclen-complex. 
Additionally the signals representing the latter complex shift upfield for the γ- and 
downfield for the β-phosphate group. 
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4.4 Localization of the Binding Sites of the Metal(II)-Chelates 
in Ras(T35A)·Mg2+·GppNHp  
4.4.1 General Procedure 
31P NMR spectroscopic investigations clearly revealed an effect of the substances in the 
active centre of the protein (see section 4.2). Additionally it could be shown that at least 
one binding position must be located in proximity to the active site close to the bound 
nucleotide by paramagnetic relaxation enhancement studies. The question remaining is 
about the exact position and the residues affected by binding. Likewise it can be possible 
that additional binding sites beside the one in the active centre might exist, which is the 
case for metal(II)-cyclen (T. Graf 2006). 
The location and number of the binding sites was determined in [1H, 15N]-HSQC titrations. 
Experiments have been carried out with both a paramagnetic and a diamagnetic derivative 
of the chelate complexes. The presence of a paramagnetic centre as represented by Cu2+ 
has a strong effect on the relaxation of NMR active nuclei leading to the bleaching of the 
corresponding NMR signal depending on the distance to the paramagnetic centre as 
described in section 1.2.4. Also exchange phenomena can give rise to line broadening and 
must not be neglected. For that reason each study for the investigation of the binding 
positions of the compounds has been carried out with both the paramagnetic Cu2+- and the 
diamagnetic Zn2+-derivative and the results have been directly compared.  
 
4.4.2 Backbone Assignment of Ras(T35A)·Mg2+·GppNHp at pH 7.5 
The backbone of Ras(T35A)·Mg2+·GppNHp has not been assigned sequentially until 
present. For that reason the assignment of Ras(T35S)·Mg2+·GppNHp at pH 5.5 has been 
transferred to the T35A mutant with the aid of additional triple resonance spectra (F. 
Schumann, University of Regensburg). Any studies concerning the Ras protein and its 
possible ligands have been carried out at pH 7.4. For that reason 
Ras(T35A)·Mg2+·GppNHp was titrated from pH 5.5 to 7.4 and the resonances of the 
individual peaks have been followed by [1H, 15N]-HSQC spectroscopy (T. Graf 2006). The 
correct assignment of the backbone resonances is of high importance since it is the basis 
for several titration studies within this work. For that reason the obtained spectra have been 
evaluated again in order to minimize errors. Figure 4.28 (A) shows the combined chemical 
shift changes observed between pH 5.5 and 7.4. Not surprisingly the largest differences are 
observed for histidine residues, e.g. His27 and His94 and aspartate residues like Asp54 and 
residues in their close proximity. During titration studies peak overlapping complicates the 
assignment of the chemical shifts after each titration step. In order to ensure that the 
titration was followed in the right way the chemical shift changes were plotted against the 
pH value and it was checked, whether the curves resembles the common pH dependence. 
An example is given in Figure 4.28 (B) for histidine94 .  
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Figure 4.28: Combined Chemical Shifts Changes ∆δcombined observed in Ras(T35A)·Mg2+·GppNHp 
between pH 5.5 and pH 7.4 (A) and exemplarily for the proton signals for histidine94 plotted against 
the pH value (B). The corrected standard deviation to zero (σ0corr) is given by the blue line. 
 
4.4.3 Results Obtained for Metal(II)-Cyclen 
As described in paragraph 1.1.6.4 31P NMR spectroscopy directly revealed the binding 
position of the metal(II)-cyclens to be in close proximity to the γ-phosphate group in the 
active centre of the protein. Three binding sites for the metal(II)-cyclens have been 
determined in the partial loss-of-function mutant Ras(T35A)·Mg2+·GppNHp by  
[1H, 15N]-HSQC titrations, whereby one is close to the active centre in good agreement 
with the results from the 31P NMR measurements (T. Graf 2006). However, during data 
evaluation of the titrations carried out slow exchange processes have not been taken under 
consideration. For that reason the obtained data have been re-evaluated and compared with 
the analogues experiments with the diamagnetic derivative. Cu2+-cyclen was titrated  
to 15N Ras(T35A)·Mg2+·GppNHp up to a molar ratio of  5:1 (T. Graf, University of 
Regensburg).In Figure 4.29 a small section of the HSQC-spectrum of 15N Ras(T35A) 
complexed to Mg2+·GppNHp in the absence and presence of Cu2+-cyclen is shown. The 
signal intensities of the resonances of Gly13, located in the P-loop, and of Gly60, located in 
switch II are decreased substantially whereas those of other resonances are not perturbed. 
The titration with the diamagnetic derivative was carried out up to a 50-fold excess of the 
ligand. The corresponding 1H spectra clearly reveal that the protein starts to precipitate at a 
ligand excess of 20-fold. For that reason only the data obtained up to a 15-fold excess of 
Zn2+-cyclen over Ras(T35A)·Mg2+·GppNHp have been evaluated. Several residues also 
show a significant decrease in cross peak volume, when Zn2+-cyclen is titrated to Ras due 
to exchange processes, which can be intermediate or slow compared to the NMR time 
scale. Slow exchange is accompanied by the appearance of a novel peak for a given amino 
acid, while the intensity of the original one is decreasing. An example is given by 
isoleucine24 and glycine115 in Figure 4.30 If a residue exchanges between two chemical 
environments in an intermediate manner compared to the NMR time scale, its cross peak 
volume is decreased without the appearance of a novel one. This can for example be 
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observed for phenylalanine28 and is depicted in Figure 4.31 This residue was considered to 
be part of the third binding site in Ras(T35A)·Mg2+·GppNHp together with histidine27 due 
to the loss of signal intensity in the presence of Cu2+-cyclen. Both residues are also 
bleached out in the titration with Zn2+-cyclen. 
 
 
 
 
Figure 4.29: Effect of Cu2+-cyclen on [1H, 15N]-HSQC NMR spectra of Ras(T35A)·Mg2+·GppNHp. 
Section of the [1H, 15N]-HSQC NMR spectra of 1.3 mM Ras(T35A)·Mg2+·GppNHp in 40 mM Hepes/NaOH, 
pH 7.5, 10 mM MgCl2, 2 mM DTE, and 5% D2O at 293 K in the absence (green) and presence of  
6.5 mM Cu2+-cyclen (red) at the same conditions. 
 
 
 
 
 
Figure 4.30: Exchange processes observed in Ras(T35A)·Mg2+·GppNHp upon addition of Zn2+-cyclen. 
Section of the [1H, 15N]-TROSY-HSQC NMR spectra of 0.78 mM Ras(T35A)·Mg2+·GppNHp in  
40 mM Hepes/NaOH, pH 7.4, 10 mM MgCl2, 2 mM DTE, and 10% D2O at 293 K in the absence (green) and 
presence of 11.66 mM Zn2+-cyclen (red) at the same conditions. 
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Figure 4.31: Exchange processes observed for phenylalanine28 in the presence of Zn2+-cyclen. 
Section of the [1H, 15N]-TROSY-HSQC NMR spectra of 0.78 mM Ras(T35A)·Mg2+·GppNHp in  
40 mM Hepes/NaOH, pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 10% D2O at 293 K in the 
absence (green) and presence of increasing concentrations of Zn2+-cyclen (red, blue and orange) at the same 
conditions. 
 
 
It is possible that His27 and Phe28 are in slow exchange, but the new peak is not be 
identified and clearly assigned. Likewise for these residues intermediate exchange may 
happen. However, residues exhibiting significant signal reduction in both titrations cannot 
be clearly related to the paramagnetic distance-dependent effect of the Cu2+ ion. For that 
reason one has to compare the results from both titrations. In Table 4.11 those residues, 
exhibiting a signal reduction I(j)/I0(j) < 1-σ0 in the presence of Cu2+-cyclen definitely 
caused by paramagnetic relaxation enhancement are listed.  
 
Table 4.11: Residues clearly affected by the paramagnetic central Cu2+-ion chelated by cyclen assigned 
to the two binding sites identified. 
 Site 1 Site 2 
(I-I0)/I0 > σ0 13, 32, 59-61 105-109, 111, 165, 166 
not assigned         1, 4, 30, 34, 53, 57, 66, 73, 79, 100, 110, 140, 163 
 
 
These residues give two spatially well separated binding sites, when mapped onto the 
surface of the crystal structure of Ras(wt)·Mg2+·GppNHp (Figure 4.33). Binding site 1 
(Figure 4.33(A)) is close to the γ-phosphate group of the bound nucleotide in accordance to 
the 31P NMR data and the previous results. Residues most affected are Gly13, Tyr32, Ala59, 
Gly60 and Gln61 (Table 4.11), located in the P-loop (amino acid 10-18), the PM3-motif  
(57-61) and in switch II (60-72), respectively. The second binding site (Figure 4.33 (B)) 
centres in the negatively charged loop L7 comprising Asp105, Ser106, Asp107, Asp108, Val109, 
Met111 and at the C-terminal residues Gln165 and His166. The third binding site identified by 
T. Graf (2006) is not supported by this evaluation. If fast exchange processes compared to 
the NMR time scale prevail only a single cross peak is observed representing both 
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chemical environments with a chemical shift at the population averaged position. Figure 
4.32 shows the combined chemical shift changes observed in Ras(T35A)·Mg2+·GppNHp in 
the presence of Zn2+-cyclen. Table 4.12 summarizes the effects observed in the [1H, 15N]-
HSQC spectrum of Ras(T35A)·Mg2+·GppNHp in the presence of Zn2+-cyclen. Large shift 
perturbations are observed for Ala35, Ile36 and Asp38, which are part of the switch I region, 
Ile163 from the C-terminal end of the protein and Asp108 and Met111 from loop L7. This 
agrees very well with the results obtained in the titration with Cu2+-cyclen. Most of these 
residues become significantly broadened in the latter experiment. Residues, which are 
significantly perturbed in their chemical shift upon addition of Zn2+-cyclen have mapped 
onto the surface of the wild type crystal structure (Figure 4.33).  
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Figure 4.32: Combined chemical shift changes observed in Ras(T35A)·Mg2+·GppNHp in the presence 
of Zn2+-cyclen with a molar excess of 15.  The corrected standard deviation to zero (σ0corr) is represented by 
the blue line (Schumann et al. 2007). 
 
 
Table 4.12: Exchange processes and combined chemical shift changes observed in 
Ras(T35A)·Mg2+·GppNHp in the presence of Zn2+-cyclen. 
 Site 1 Site 2 
k >> δA - δBb 
13, 16, 21, 23, 25, 26, 29, 31, 35, 36, 
37, 38, 58, 59, 60, 61, 63, 64, 68, 76, 
89, 98, 147 
104, 105, 106, 108, 111, 139, 162, 
163, 164, 166 
k << δA - δBc 
8, 11-13, 17-21, 24-26, 31, 39, 46, 56, 58, 80, 83, 84, 85, 87, 88, 91, 112, 114, 
115, 117, 119-121, 124, 125, 127-134, 139, 141, 142, 147, 148, 151-154, 157, 
158, 159, 160, 162, 166  
a
 fast exchange processes 
b
 slow exchange processes 
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Figure 4.33: Binding sites of metal(II)-cyclen in active Ras. (A) and (B) amino acids clearly affected by 
the paramagnetic distance-dependent Cu(II)-effect mapped onto the surface of the crystal structure of 
Ras(wt)·Mg2+·GppNHp (pdb 5p21). Residues exhibiting a significant relative signal reduction I(j)/I0(j) < 1-σ0 
are colored red, not clearly assignable residues are shown in gray. (C) and (D) amino acids showing 
significant shift perturbations in the presence of Zn2+-cyclen mapped onto the surface of the crystal structure 
of Ras(wt)·Mg2+·GppNHp (pdb 5p21). Residues with a significant combined chemical shift change  
∆δcomb  > σ0 are colored green, residues showing a line splitting by binding of Zn2+-cyclen typical for a slow 
exchange process are shown in light green, not clearly assignable residues are shown in gray.    
 
 
4.4.4 Results Obtained for Metal(II)-BPA 
31P NMR investigations with Zn2+-BPA already revealed that at least one binding position 
should be in close proximity to the bound nucleotide in the active centre. The compound 
selectively recognizes conformational state (1) in active Ras as shown for different mutants 
by NMR spectroscopy. This stabilization is not accompanied by large chemical shift 
changes for the phosphorus resonances, which would be expected if a compound like BPA 
carrying two aromatic rings is in binding distance. Consequently [1H, 15N]-HSQC titration 
studies with both the paramagnetic and diamagnetic derivative of BPA were carried out.  
Initially Cu2+-BPA was titrated to Ras(T35A)·Mg2+·GppNHp up to a molar excess of 1.2 
and its effect was followed by [1H, 15N]-HSQC-spectroscopy. In contrast to the 
corresponding titration with Cu2+-cyclen the bleaching of several residues is already 
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observed at a molar ratio of Ras:Cu(II)-BPA of 1:0.2. In order to allow for proper 
information about the relative effect of single amino acid residues in the protein, the data 
obtained at that molar ration have been used for the determination of the binding sites. In 
Figure 4.34 the relative signal intensity of the reference intensity observed upon addition of 
a 0.2-fold excess of Cu(II)-BPA is plotted against the amino acid sequence of Ras(T35A).  
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Figure 4.34:  Relative signal intensities observed in the [1H, 15N]-HSQC spectrum of Ras(T35A) 
complexed to Mg2+·GppNHp in the presence of a 0.2-fold excess of Cu2+-BPA. The mean value is given 
by the blue line. The line colored cyan represents the mean value plus the standard deviation. 
 
 
The cross peaks of residues Tyr38, Asp40, Asp107, Asp108, Val109 and Met111 are already 
bleached and cannot be detected anymore. Strong effects are also observed for residues  
52-55, which are part of the PM3 motif and the C-terminal residues 162-165 as well as 
residues 103-105, which are part of loop L7. Residues exhibiting a relative signal reduction 
larger than the mean value have been color coded according to their effect and mapped 
onto the surface of the structure of Ras(T35S)·Mg2+·GppNHp, which was solved by NMR 
spectroscopy at the department (F. Schumann, unpublished results). Two binding sites can 
be identified for metal(II)-BPA. One of the binding sites is located at the C-terminal end of 
Ras and loop L7 and was also found for metal(II)-cyclen both by NMR spectroscopy and 
by X-ray crystallography (Rosnizeck et al., accepted). The second one is located close to 
the active centre, which is presumably the one responsible for the stabilization of 
conformational state (1) in active Ras. However, its position differs from the binding site 
obtained for metal(II)-cyclen. Metal(II)-BPA is located on the other site of the nucleotide 
binding pocket compared to metal(II)-cyclen. The binding sites identified are depicted in 
Figure 4.36. 
In the next step Ras(T35A)·Mg2+·GppNHp was also titrated with the diamagnetic 
derivative Zn2+-BPA. At a molar ratio of Ras:BPA of 1:16 the protein started to precipitate, 
which was already observed in the 31P NMR experiments. Consequently further titration 
steps have not been carried out and the change of the chemical shift values was evaluated 
with the results obtained with an 8-fold molar excess of Zn2+-BPA over Ras. During the 
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titration slow exchange processes have not been observed. Consequently the results 
derived from the Cu2+-titration need not to be corrected. Figure 4.35 shows the combined 
chemical shift changes observed in the presence of the diamagnetic derivative.  
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Figure 4.35: Combined chemical shift changes observed in the [1H, 15N]-HSQC spectrum of 
Ras(T35A)·Mg2+·GppNHp in the presence of  an 8-fold excess of Zn2+-BPA. The corrected standard 
deviation to zero (σ0corr) is given by the blue line. 
 
The strongest effects are observed for residues Asp38, Ser39 and Tyr40, which are part of the 
binding position in proximity to the active centre as well as the C-terminal residues Ile163, 
Gln165 and His166. Additionally large changes can be found for Ile139, which is in close 
proximity to the C-terminal end and loop L7 and thus part of the second binding position 
and for Lys147, which supports nucleotide binding by the G1 motif. Phe28, which represents 
the G1 motif and forms strong hydrophobic interaction with the guanine base is also 
affected significantly together with residues in its neighbourhood.  
Residues showing chemical shift changes ∆δcombined > σ0corr have been normalized to the 
value calculated for Arg41, which shows the strongest effect, color-coded and mapped onto 
the surface of Ras(T35S)·Mg2+·GppNHp. As one can see very clearly in Figure 4.36 the 
results obtained with both derivatives agree very well. Significant effects are observed in 
both cases for residues around the C-terminus and loop L7, which compromise one binding 
position and residues of switch I and the PM3 motif. 
A summary of the results obtained from the [1H, 15N]-HSQC titrations with metal(II)-BPA 
is given in Table 4.13. The affected residues are assigned to the binding sites identified. 
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Table 4.13: Relative signal intensities and combined chemical shift changes observed in 
Ras(T35A)·Mg2+·GppNHp in the presence of Cu2+-BPA and Zn2+-BPA, respectively. 
  Site 1 Site 2 
0.00 < (I-I0)/I0< 0.25a   
0.25 < (I-I0)/I0< 0.50a 5, 8, 26, 29, 32, 42, 46, 62, 74-76, 78 
94, 95, 105, 112,137, 
161 
0.50 < (I-I0)/I0< 0.75a 3, 27, 28, 41, 52  106, 138, 162, 164 
Cu2+-BPAb 
0.75 < (I-I0)/I0< 1.00a 39, 40, 53-58  107-111, 165, 166 
0.00 < ∆δcomb< 0.25c 20, 41 112 
0.25 < ∆δcomb< 0.50c 3, 5, 18, 54, 59, 73, 75  
91, 95, 98, 106, 111, 
147, 160, 165 
0.50 < ∆δcomb< 0.75c 
25, 28, 31, 38, 39, 49, 
52 96, 139, 162, 166 
Zn2+-BPAd 
0.75 < ∆δcomb< 1.00c 40 108 
a
 combined chemical shift changes observed for the residues have been normalized for the residue giving the  
   biggest response and subgrouped according to the  relative shift effect 
b
 the results listed are obtained at a molar ratio of  Ras:Cu2+-BPA = 1:0.2 
c
 relative signal intensities have been subgrouped according to the  maximum relative signal loss of 1 
d
 the results listed are obtained at a molar of  Ras:Zn2+-BPA = 1:8 
 
 
 
 
Figure 4.36: Intensity loss and chemical shift changes observed in Ras(T35A)·Mg2+·GppNHp in the 
presence of Cu2+- and Zn2+-BPA, respectively.  (A), (B) Binding site 1. (C), (D) Binding site 2. The effects 
in the presence of Cu2+-BPA ((A), (C)) and Zn2+-BPA ((B), (D)) are colored according to the subgroups 
listed in Table 4.13. The stronger the observed effect the darker the residues are colored. Prolines and not 
assigned residues are shown in gray. The NMR structure of Ras(T35S)·Mg2+·GppNHp is shown  
(F. Schumann, unpublished results). 
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4.5 Development of Bivalent Ras Ligands 
4.5.1 Linkage of Zn2+-Cyclen and Zn2+-BPA to a Peptide with a 
Consensus Ras Binding Sequence 
The metal(II)-chelates Zn2+-cyclen and Zn2+-BPA influence the dynamic equilibrium of 
active Ras by selectively stabilizing conformational state (1). Additionally it was shown by 
31P NMR spectroscopy that it is possible to influence the Ras-effector interaction by these 
compounds. Their application is limited by their low affinity, which has been determined 
to be in the millimolar range and the fact, that more than one binding position is present in 
Ras for both compounds. In order to increase both the affinity and the selectivity of  
Zn2+-cyclen and Zn2+-BPA at the binding site in the active centre of Ras, which is 
responsible for the stabilization of conformational state (1) bivalent Ras ligands have been 
designed. State (1) is assumed to be close related to the conformation of Ras found in 
complex with its exchange factor SOS (Ford et al. 2005, Kalbitzer et al. 2009). 
Consequently the crystal structure of the Ras-SOS complex (Boriack-Sjodin et al. 1998) 
was used as basis for the design of a peptide possibly interacting with Ras and bivalent Ras 
ligands have been designed. The peptide consists of amino acids from the sequence of the 
exchange factor SOS directly interacting with Ras close to the active centre. Single amino 
acids in between, not contributing to the interaction with Ras have been displaced by 
glycines in order to allow for more flexibility. Figure 4.37 illustrates the structural basis for 
the design of the peptide with the sequence LGGIR.  
 
 
 
Figure 4.37: Part of the crystal structure of Ras in complex with SOS (1bkd). Direct contacts with Ras 
switch II residues Glu62, Glu63 and Tyr64 are provided by Arg826, Ile825 and Leu822 from SOS. Residues Lys823 
and Met824 do not contribute to the interaction. 
 
 
The short peptide LGGIR was synthesized at the chair of Prof. B. König and investigated 
in terms of its binding position using [1H, 15N]-HSQC titration studies with 
Ras(T35A)·Mg2+·GppNHp at our department. Figure 4.38 shows the histrogram of the 
observed chemical shift changes induced by binding of the small peptide. 
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The largest chemical shift changes are observed for residues 62-65 (switch II), which are at 
the desired binding position of the peptide. Figure 4.39 shows the binding curve for the 
peptide obtained for residues Glu62 and Glu63. The binding affinity has been determined to 
be 3.66 ± 1.3 mM according to Equation 3.4. 
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Figure 4.38: Combined chemical shift changes observed in Ras(T35A)·Mg2+·GppNHp in the presence 
of LGGIR.  Given are the chemical shift changes observed in the [1H, 15N]-TROSY-HSQC spectrum of a 
sample originally containing 0.8 mM 15N c´Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O upon addition of a 32-fold excess of the peptide 
LGGIR dissolved in the same buffer. The spectra have been recorded at 293 K at a spectrometer operating at 
800 MHz proton frequency. The corrected standard deviation to zero (σ0corr) is given by the blue line 
(Schumann et al. 2007). 
 
 
 
 
 
Figure 4.39: Plot of the chemical shift changes obtained for Ras residues Glu62 (black squares) and 
Glu63 (red dots) against the excess of the peptide LGGIR. The data have been fitted by a one-site binding 
model according to Equation 3.4 giving a KD-value of 3.66 mM. The obtained fit is given by the black and 
the blue line for Glu62 and Glu63, respectively. 
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Consequently the distance between the binding position of the metal(II)-chelates at the 
active centre and the peptide was estimated and the peptide was thereupon linked to both 
metal(II)-chelates at the chair of Prof. König. Figure 4.40 shows the designed bivalent 
ligands. 
 
 
 
 
  
Figure 4.40: Designed bivalent ligands for Ras. Both Zn2+-chelates have been linked to the small peptide 
LGGIR giving the hybride ligands H181 (above) and RHC-5-1 (bottom, n = 3) and RHC-6-1 (bottom, n = 2). 
 
 
4.5.2 Determination of the Affinity of the Bivalent Ligands by STD NMR 
The designed hybride ligands carry a peptide moiety and consequently the on-resonance 
irradiation frequency in the STD experiment has to be chosen carefully as already 
described in section 4.1.2. It has been shown that it is possible to saturate Ras entirely and 
selectively at -2 ppm. This frequency should be far enough from the signals from the 
peptides. However to make sure that reliable results are obtained the compounds were 
initially measured without Ras being present. In the next step Ras(T35A)·Mg2+·GppNHp 
was added to the sample and the same experiment was carried out followed by the titration 
with H181, RHC-5-1 and RHC-6-1 up to a molar excess of 333, 480 and 190, respectively.  
Peaks representative for the metal(II)-chelate moiety of the molecule have been used for 
evaluation. Figure 4.41 and 4.42 show the obtained plot of the amplification factor against 
the concentration of the hybride ligand carrying either a Zn2+-cyclen or a Zn2+-BPA 
moiety. The binding curve does not reach saturation at molar ratios between Ras and the 
hybride ligands of 333, 480 and 190. From these data is it clear that the designed hybride 
ligands do not have higher affinity for Ras than the metal(II)-chelates alone.  
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Figure 4.41: Plot of the STD amplification factor against the molar excess of Zn2+-cyclen and the 
hybrid ligands RHC-5-1 and RHC-6-1. Shown are the amplification factors obtained from a STD titration 
with a sample originally containing 50 µM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4 and  
10 mM MgCl2 with Zn2+-cyclen (red dots), RHC-5-1 (blue dots) and RHC-6-1 (black dots), respectively. In 
each experiment on-resonance irradiation was performed at -2 ppm and a spinlock filter was implemented 
(50 ms at 15 dB). In the titration of RHC-5-1 the on-resonance irradiation was performed with an attenuation 
of 30 dB resulting in higher ASTD-values compared to the titrations with Zn2+-cyclen and RHC-6-1  
(the attenuation was set to 40 dB) due to the more effective saturation of the protein. The obtained values for 
ASTD have been multiplied by a factor of 0.1 in the case of RHC-5-1 in order to allow for a better comparison 
with the data obtained for Zn2+-cyclen and RHC-6-1. All spectra were recorded at 278 K at 600 MHz proton 
frequency. In each case the signals representing the Zn2+-cyclen moiety have been used for evaluation. The 
data have been fitted according to Equation 3.2. The corresponding fits are represented by the red  
(Zn2+-cyclen) and the black line (RHC-6-1). For Zn2+-cyclen a KD-value of 9.65 ± 1 mM is derived. For the  
RHC-6-1 the KD-value can be estimated to be larger than 40 mM. The data for RHC-5-1 do not allow for an 
estimation or quantification of the KD-value. 
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Figure 4.42: Plot of the STD amplification factor against the molar excess of Zn2+-BPA and the hybrid 
ligand H181. Shown are the amplification factors obtained from a STD titration with a sample originally 
containing 50 µM Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4 and 10 mM MgCl2 with Zn2+-BPA 
(red dots), RHH 181 (black dots), respectively. The on-resonance irradiation was set to -2 ppm with an 
attenuation of 30 dB (H181) and 0.3 ppm with an attenuation of 40 dB (Zn2+-BPA). A spinlock filter was 
implemented (50 ms at 15 dB) in order to suppress protein proton resonances potentially overlapping with 
the ligand signals. The data obtained in the titration with Zn2+-BPA have been fitted according to  
Equation 3.2 giving a KD-value of 2.07 ± 0.25 mM. The corresponding fit is represented by the red line. The 
data for H181 do not allow for an estimation or quantification of the KD-value. The liner regression of the 
data is shown by the dashed black line. 
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4.6 Characterization of the Interaction between Ras and 
Peptides Derived from Raf-RBD 
4.6.1 Localization of the Binding Site in Ras(wt)·Mg2+·GppNHp and 
          Ras(T35A)·Mg2+·GppNHp 
In section 1.1.6.3 peptides derived from the Ras binding domain of the Ras effector Raf 
and their modified analogues have been described, which potently interfere with the  
Ras-Raf association (Barnard at al.1995 1998). The peptide CCAVFRL compromising 
Raf-RBD residues 95-101 and the peptide CCFFFRRL obtained from computational 
design were investigated in more detail by NMR spectroscopy since the binding position of 
these peptides and also their mode of inhibition have not been elucidated so far. For that 
reason the two peptides have been subject to chemical shift perturbation studies with both 
wild type Ras and the T35A mutant complexed to Mg2+·GppNHp. For the wild type mutant 
an assignment was only available for pH 5.5 at this point of time (Ito et al. 1997). In order 
to allow for a good comparison all investigations have been carried out at this pH value. 
CCAVFRL and CCFFFRRL were first titrated to wild type Ras complexed to 
Mg2+·GppNHp up to a molar excess of 4 and 3.2, respectively and the effect was followed 
by [1H, 15N]-HSQC spectroscopy. Figure 4.43 shows the combined chemical shift changes 
observed in wild type Ras·Mg2+·GppNHp in the presence of the two peptides.  
 
 
 
Figure 4.43: Combined chemical shift changes observed in wild type Ras·Mg2+·GppNHp in the 
presence of the peptide CCAVFRL (left panel) and CCFFFRRL (right panel). Given are the chemical 
shift changes observed in a sample originally containing 1.2 mM 15N c´Ras(wt)·Mg2+·GppNHp in  
20 mM Na2HPO4-NaH2PO4 pH 5.5, 10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O upon addition of 
a 4-fold and 4.8-fold excess of the peptides CCAVFRL and CCFFFRRL dissolved in the same buffer, 
respectively. All spectra have been recorded at 293 K at 800 MHz proton frequency. The corrected standard 
deviation to zero (σ0corr) is given by the blue line (Schumann et al. 2007).  
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The largest changes are observed for residues Lys5, Leu53 and Ile55 in both cases. A strong 
effect is also observed for residues Ser65, Arg68, Asp69 and Met72, which are part of the 
switch II region and the C-terminal residues Arg161 and Glu162. The residues affected are 
normalized with regard to the residue exhibiting the strongest combined chemical shift 
change and listed in Table 4.14. They do not cluster at one position of the protein. Either 
more than one binding position is present in the protein for the peptides or structural 
changes happening upon binding of the peptide might be the case.   
Due to the lack of HN cross peaks of the switch regions in active wild type Ras the titration 
was also carried out with the partial loss-of-function mutant Ras(T35A)·Mg2+·GppNHp, 
which gives signals for all backbone residues in the protein. CCAVFRL and CCFFRRL 
were titrated to Ras(T35A)·Mg2+·GppNHp up to a molar excess of 4.8 and 4, respectively. 
Figure 4.44 shows the combined chemical shift changes. Again residues 52 to 54 of the 
PM3 motif show the largest perturbation similar to the results in wild type Ras. In the 
presence of the peptide CCFFFRRL the effects observed in that region are larger relative to 
the other residues affected. Additionally the absolute values for the chemical shift changes 
are greater, when CCFFFRRL is present. At a molar excess of 4 the effect observed for 
Leu53 is higher by a factor of 1.25 compared to the results obtained with CCAVFRL at a 
molar excess of 4.8. Residues most affected in both titrations are listed in Table 4.14. They 
are again normalized relative to the residue showing the strongest shift change. In Figure 
4.45 the effect of the peptide CCAVFRL observed in the [1H, 15N]-HSQC spectrum of 
Ras(T35A)·Mg2+·GppNHp is shown graphically.  
 
 
 
Figure 4.44: Combined chemical shift changes observed in Ras(T35A)·Mg2+·GppNHp in the presence 
of the peptide CCAVFRL (left panel) and CCFFFRRL (right panel). Given are the chemical shift 
changes observed in a sample originally containing 0.6 mM (left panel) and 0.7 mM (right panel)  
15N c´Ras(T35A)·Mg2+·GppNHp in 20 mM Na2HPO4-NaH2PO4 pH 5.5, 10 mM MgCl2, 2 mM DTE,  
0.2 mM DSS and 5% D2O upon addition of a 3.2-fold and 4-fold excess of the peptides CCAVFRL and 
CCFFFRRL dissolved in the same buffer, respectively. All spectra have been recorded at 293 K at 800 MHz 
proton frequency. The corrected standard deviation to zero (σ0corr) is given by the blue line (Schumann et al. 
2007).  
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Figure 4.45: Combined chemical shift changes observed in Ras(T35A)·Mg2+·GppNHp in the presence 
of the peptide CCAVFRL. Residues exhibiting combined chemical shift changes ∆δcomb > σ0corr have been 
color-coded according to Table 4.14 and mapped on the structure of Ras(T35A)·Mg2+·GppNHp calculated 
when complexed to Cu2+-cyclen (T. Graf 2006). Shown is the surface representation (A) and the ribbon plot 
(B). The stronger the observed effect the darker the residues are colored. Prolines and not assigned residues 
are shown in gray. 
 
 
Table 4.14: Combined chemical shift changes observed in wild type Ras and Ras(T35A) complexed to 
Mg2+·GppNHp in the presence of the peptides CCAVFRL and CCFFFRRL, respectively. 
   Ras(wt)·Mg2+·GppNHp Ras(T35A)·Mg2+·GppNHp 
CCAFVRL p:l 1:4 1:4.8 
0.00 < ∆δcomb< 0.25a 
3, 8, 15, 19, 22, 54-56, 66, 78, 
80, 81, 88, 89, 93, 94, 101, 
107, 108, 114, 115, 126, 132, 
137, 143, 153, 155, 156, 158, 
160, 163-165,  
8, 15, 27, 42, 55, 56, 74, 79, 
80, 91, 100, 107, 108, 136, 
142, 143, 145, 151, 153, 155, 
163 
0.25 < ∆δcomb< 0.50a 91, 95, 100, 111, 161, 166 
65, 68, 72, 76, 95, 111, 112, 
132, 159, 161, 164, 166  
0.50 < ∆δcomb< 0.75a 65, 68, 69, 112, 162  52, 69, 162 
0.75 < ∆δcomb< 1.00a 5, 52, 53, 72 5, 53 
CCFFFRRL p:l 1:3.2 1:4 
0.00 < ∆δcomb< 0.25a 
3, 12, 15, 18, 29, 35, 58, 63, 
67, 69, 71, 72, 78, 79, 80, 89, 
96, 97, 98, 101, 107, 108, 
126, 144, 149, 155, 156, 158, 
163-165 
3, 7, 16, 35-38, 62, 63, 70, 72, 
79, 89, 91, 95, 96, 98, 107, 
108, 132, 145, 149, 155, 156, 
158, 161, 165,  
0.25 < ∆δcomb< 0.50a 
8, 13, 31, 32, 38, 41, 60, 62, 
70, 92, 95, 105, 111, 159, 
161, 166 
13, 19, 31, 32, 41, 54, 57, 60, 
92, 94, 112, 159, 162 
0.50 < ∆δcomb< 0.75a 52, 54, 57, 94, 162  52 
0.75 < ∆δcomb< 1.00a 53 53 
a
 combined chemical shift changes observed for the signals residues have been normalized for the residue 
   giving  the biggest response and subgrouped according to the  relative shift effect. 
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4.6.2 31P NMR Titration of Ras(wt)·Mg2+·GppNHp with CCAVFRL 
The [1H, 15N]-HSQC titration studies of the peptide CCAVFRL reveals its binding to 
Ras(T35A)·Mg2+·GppNHp. Since the latter mutant predominantly exists in the weak 
effector-binding state (1) a possible influence on the dynamic equilibrium in active Ras 
was checked. For that purpose the peptide CCAVFRL was titrated to 
Ras(wt)·Mg2+·GppNHp up to a molar excess of 2. At this ratio effects should be observed 
in the 31P NMR spectra since the compound has been shown to bind to 
Ras(wt)·Mg2+·GppNHp in the micromolar range (D. Filchtinski, personal communication). 
Figure 4.46 shows the spectra in the absence and presence of the peptide. Neither the 
chemical shift nor the line width or the relative populations of the two conformational 
states are affected significantly. At this ratio already strong effects are observed in the 
corresponding [1H, 15N]-HSQC spectra. 
 
 
 
Figure  4.46: Influence of the peptide CCAVFRL on the dynamic equilibrium in 
Ras(wt)·Mg2+·GppNHp. 31P NMR Spectra of 0.8 mM Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O in the absence and presence of CCAVFRL. The molar 
ratios are indicated. All spectra have been recorded at 278 K. Experimental data have been filtered 
exponentially leading to an additional line broadening of 15 Hz.  
 
 
4.7 Comparison of the [1H, 15N]-TROSY-HSQC Spectra of the 
Ras Mutants T35S and T35A Complexed to Mg2+·GppNHp 
The NMR structure of Ras(T35S)·Mg2+·GppNHp was solved at the department  
(F. Schumann, unpublished results). It is assumed that the partial loss-of-function Ras 
mutants T35A and T35S share the same structural principles and most probably differ in 
their dynamics. Changes in the chemical environment are very sensitively sensed by the 
chemical shifts of corresponding residue. In order to obtain detailed information about 
region with a different chemical environment between the two Ras mutants  
[1H, 15N]-HSQC spectra of both mutants have been measured under identical conditions. 
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The identical buffer solution was used for the sample, the data were recorded at the same 
spectrometer at the same temperature and the same settings for the experiments  
(M. Spoerner, Regensburg). Subsequently the chemical shifts have been directly compared. 
Figure 4.47 shows the chemical shift differences between Ras(T35S) and Ras(T35A) 
complexed to Mg2+·GppNHp as a function of the primary sequence. Not surprisingly the 
largest differences can be observed for residue 35, which is the mutated one and residues in 
its close proximity. Residues with an observed combined differences between the chemical 
shifts ∆δcomb > σ0corr are given in Table 4.16. Residues affected by the mutation can be 
found in both switch regions and around helix α3. In Figure 4.48 these residues are 
mapped on the NMR structure of Ras(T35S)·Mg2+·GppNHp (F. Schumann, unpublished 
results). 
 
 
Figure 4.47: Chemical shift differences observed between the [1H, 15N]-TROSY-HSQC spectra of the 
Ras mutants T35S and T35A complexed to Mg2+·GppNHp. Data have been obtained from experiments 
under identical conditions. (M. Spörner, University of Regensburg). The samples contained  
0.75 mM Ras(T35S)·Mg2+·GppNHp and 0.7 mM Ras(T35A)·Mg2+·GppNHp in 20 mM NaPi pH 5.5,  
10 mM MgCl2, 2 mM DTE, 0.2 mM DSS and 5% D2O. All spectra have been recorded at 293 K. The 
corrected standard deviation to zero (σ0corr) is given by the blue line. 
 
 
Table 4.16: Residues exhibiting a significant difference in the combined chemical shifts between the 
[1H, 15N]-HSQC spectra of the Ras mutants T35A and T35S complexed to Mg2+·GppNHp. The mutated 
residue is given in bold letters. 
∆δcomb > σ0corr 
3, 5, 8, 12, 13, 16, 21, 29, 32, 33, 35, 36, 38, 39, 40, 41, 46, 52, 53, 54, 57, 58, 59, 60, 62, 63, 64, 
66, 68, 69, 70, 71, 72, 76, 79, 92, 93, 94, 95, 97, 105, 111, 112, 159, 161, 162 
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Figure 4.48: Residues showing significant combined chemical changes in the [1H, 15N]-HSQC-spectra 
of Ras(T35A) and Ras(T35S) complexed to Mg2+·GppNHp. Residues exhibiting  a combined chemical 
shift difference ∆δcomb larger than the standard deviation to zero are shown in red. Ser35 is shown in green. 
Prolines and not assigned residues are shown in gray.  
 
 
4.8 High Pressure NMR Spectroscopic Investigations on  
       Ras(wt)·Mg2+·GppNHp 
As described in section 1.1.5.3 under high pressure the dynamic equilibrium in wild type 
Ras·Mg2+·GppNHp is shifted from the strong effector-binding substate (2) towards 
conformational state (1), which is recognized by GEFs (Kalbitzer et al. 2009). The 
functional cycle of Ras as described in section 1.1.1 requires the coexistence of more than 
the two conformational substates (1) and (2), which are sensed by 31P NMR spectroscopy 
by different chemical shifts for the α- and γ-phosphate group (Geyer et al. 1996, Spoerner 
et al. 2004 2005a 2007). The GAP-binding conformation has not been detected so far and 
additionally local unfolding states and the completely unfolded state have not been 
investigated. In order to obtain information about the different conformational substates 
coexisting in the Ras protein in solution at atomic resolution, the pressure effect was 
followed using [1H, 15N]-HSQC spectroscopy. For a better comparison the 2D experiments 
have first been carried out at the same experimental conditions with regard to the  
31P pressure series, i.e. at a pH value of 7.4 and a temperature of 278 K. Additionally a 
pressure series at 303 K was recorded. Due to the poor signal to noise ratio achieved in the 
pressure series at 278 K mainly the experimental data from the pressure series recorded at 
303 K have been used for evaluation. [1H, 15N]-HSQC spectra have been recorded at  
0.3 MPa and up to 200 MPa and 180 MPa, respectively. The pressure series recorded at 
303 K was only performed up to a pressure of 180 MPa due to the “explosion” of the 
ceramic cell at a pressure of 200 MPa. The results are given in the following paragraphs. 
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4.8.1 Pressure Dependence of the Chemical Shifts 
Increasing pressure results in chemical shift changes of all resonances at both 
temperatures. The observed shift directions are qualitatively the same at both temperatures. 
Figure 4.49 shows the overlay of the [1H, 15N]-HSQC spectra of Ras(wt)·Mg2+·GppNHp 
under different pressures at both temperatures.  
 
 
 
 
Figure 4.49: Pressure dependent shifts in Ras(wt)·Mg2+·GppNHp: (A) Overlay of the [1H, 15N]-HSQC 
spectra of 1.05 mM Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE,  
0.1 mM DSS and 12% D2O recorded at 278 K under different pressures between 3 and 200 MPa.  
(B) Overlay of the [1H, 15N]-HSQC spectra of 1.84 mM Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 
10 mM MgCl2, 2 mM DTE and 12% D2O recorded at 303 K under increasing pressures of 3 MPa and 
180 MPa. The direction of chemical shift with increasing pressure is indicated by the arrows. All spectra 
have been recorded at 800 MHz proton frequency. 
 
In general the chemical shift changes induced by the local and global conformational 
changes are a non-linear function of the pressure. The chemical shift changes induced by 
pressure can be described by a 2nd order Taylor expansion according to Equation 3.4 (see 
section 3.3.4.3). The pressure effects are composed of two contributions, an unspecific 
effect, which is also observed in random coil peptides and a specific effect, characteristic 
for a certain protein. Consequently the chemical shifts of the amide protons were corrected 
by the known pressure response of random-coil peptides (Arnold et al. 2002) and fitted 
according to Equation 3.4. Unfortunately the corresponding information for the correction 
of the nitrogen shifts in random-coil peptides is missing, but work is currently going on at 
the department. The first order conformation dependent pressure coefficients |B1* (HN)| 
and |B1 (N)| determined for the single residues in wild type Ras complexed to 
Mg2+·GppNHp at 303 K are depicted in Figure 4.50 as a function of the sequence position. 
Figure 4.51 shows the second order coefficients |B2*(HN)| and |B2 (N)|, respectively. 
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Figure 4.50:  First order pressure coefficients of wild type Ras·Mg2+·GppNHp derived from a pressure 
series at 303 K. Shown are the absolute values of the first order pressure coefficients of HN (corrected by the 
standard values derived from model peptides) (A) and N (B) as a function of the primary sequence. The mean 
value (straight line) and the mean value plus /minus the standard deviation (dashed lines) are shown. Prolines 
are marked with P, not assigned or not assignable residues, respectively with * and residues, for which the 
coefficients could not be determined due the loss of signal intensity within the pressure series are marked 
with I. 
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Figure 4.51: Second order pressure coefficients of wild type Ras·Mg2+·GppNHp derived from a 
pressure series at 303 K. Shown are the absolute values of the second order pressure coefficients of  
HN (corrected by the standard values derived from model peptides) (A) and N (B) as a function of the 
primary sequence. The mean value (straight line) and the mean value plus / minus the standard deviation 
(dashed lines) are shown. Prolines are marked with P, not assigned or not assignable residues, respectively 
with * and residues, for which the coefficients could not be determined due the loss of signal intensity within 
the pressure series are marked with I. 
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From the pressure series recorded at 278 K the derived mean first order and second order 
pressure coefficients are 0.45 ppm/GPa (|B1*(HN)|), 0.46 ppm/GPa2 (|B2*(HN)|), 
3.50 ppm/GPa (|B1 (N)|) and 3.42 ppm/GPa2 (|B2 (N)|), respectively. At a temperature of 
303 K the mean first order and second order pressure coefficients are  
0.50 ppm/GPa (|B1*(HN)|), 0.65 ppm/GPa2 (|B2*(HN)|), 3.02 ppm/GPa (|B1 (N)|) and  
3.58 ppm/GPa2 (|B2 (N)|), respectively. These data agree very well and are summarized in 
Table 4.16. 
 
 
Table 4.16: Mean absolute values of the first and second order pressure coefficients for the chemical 
shifts determined according to equation 3.4 in Ras(wt)·Mg2+·GppNHp from a pressure series recorded 
at 278 K and 303 K, respectively. 
 
|B1* (HN)| 
[ppm /GPa] 
|B1 (N)| 
[ppm /GPa] 
|B2*(HN)| 
[ppm /GPa2] 
|B2 (N)| 
[ppm /GPa2] 
278 K 0.45 ± 0.25 3.50 ± 1.96 0.50 ± 0.42 3.42 ± 2.70 
303 K 0.46 ± 0.33 3.02 ± 2.18 0.65 ± 0.59 3.58 ± 2.89 
 
 
The pressure-dependent chemical shift changes observed in wild type Ras·Mg2+·GppNHp 
are of different magnitude within the single residues. Since chemical shift changes reflect 
local changes in the environment of a given residue they strongly correlate with structural 
rearrangements. Hence residues with pressure coefficients significantly larger than the 
mean value are likely to sense a conformational change happening under increased 
pressure. In Table 4.17 those residues, for which pressure coefficients between the mean 
value and the mean value plus the standard deviation or even larger than the mean value 
plus the standard deviation have been determined are listed. Within these residues a lot 
participate in the binding of the nucleotide in the active centre, such as Lys117, Ser118, 
Asp119 from the KKXD-motif or residues Ala146 and Lys147, which are part of the SAK-
motif and residues in their close proximity. The same is true for residues like Val14 and 
Ala18, which are located within or close to the PM1 motif or P loop, which is involved in 
the binding of the β- and γ-phosphate group of the bound nucleotide (Pai et al. 1990). 
Although most of the residues belonging to the both switch regions in Ras do not give 
cross peaks signals in the [1H, 15N]-HSQC-spectrum of Ras(wt)·Mg2+·GppNHp (Ito et al. 
1997) residues in their close proximity exhibit large pressure coefficients, such as Ala66, 
Gly75 and Gly77, respectively. Additionally residues Asp105, Asp107, Val109 and Met111 
building the negatively charged loop L7 show high pressure sensitivities and also residues 
at the N- and C-terminal part of the protein like Glu3, Arg164 and Gln165. Figure 4.52 gives 
a graphical view of the residues exhibiting large pressure coefficients around the active 
centre of Ras.  
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Table 4.17: Residues in Ras(wt)·Mg2+·GppNHp exhibiting significant large pressure coefficients 
determined from the pressure series performed at 303 K. 
 |B1* (HN)| |B2* (HN)| 
Group 1a 
Glu3, Ala18, Gln25, Ile46, Ser65, Arg73, 
Arg97, Gln129, Tyr141, Glu143, Ala146, 
Lys147, Arg161 
Glu3, Ala18, Leu23, Ile24, Ser65, Arg97, 
Asp107, Ser127, Glu153 
Group 2b 
Val14, Leu53, Ala66, Gly75, Gly77, Ile84, 
Asp105, Asp107, Val109, Met111, Leu113, 
Gly115, Asp119, Ala121, Ala122, Ser127, 
Ala134, Tyr137, Ile142, Ser145, Val152, 
Phe156, Tyr157, Leu159, Arg164, Gln165 
Phe28, Val29, Lys42, Ile46, Glu49, Cys51, 
Asp56, Arg73, Gly77, Ile84, Asn85, 
Arg102, Ser106, Val109, Gly115, Lys117, 
Ser118, Ala122, Val125, Leu133, Ala134, 
Tyr137, Tyr141, Ile142, Glu143, Lys147, 
Gly151, Val152, Thr158 
 |B1 (N)| |B2 (N)| 
Group 1a 
Leu23, His27, Ser39, Leu52, Gly75, Phe90, 
Asp107, Val109, Val112, Lys117, Ala121, 
Thr124, Thr144  
Val9, Val14, Leu23, Val45, Arg73, Gly75, 
Phe90, Asp107, Val109, Val112, Val114, 
Lys117, Arg123, Thr124, Gln165 
Group 2b 
Tyr4, Ala11, Leu19, Val29, Val44, Leu53, 
Gly77, Phe78, Ile84, Asn86, Lys88, Arg97, 
Ile100, Asp105, Ser106, Val114, Arg123, 
Val125, Ser127, Gln129, Leu133, Ser136, 
Ile142, Glu143, Arg149, Gln150, Gly151, 
Tyr157, Thr158 
Tyr4, Ser17, Ala18, Ile24, His27, Val29, 
Ser39, Ile46, Asp56, Phe78, Arg97, Ile100, 
Arg102, Ser106, Asp108, Leu113, Val125, 
Asp132, Leu133, Ser136, Tyr137, ,Ile142, 
Thr144, Arg149 
a
 residues exhibiting a pressure coefficient larger than the mean value plus the standard deviation. 
b
 residues exhibiting a pressure coefficient in between the mean value and the mean value plus the standard  
   deviation. 
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Figure 4.52: Pressure-sensitive residues in Ras(wt)·Mg2+·GppNHp.  Residues exhibiting significant large 
first and second order pressure coefficients for the amide protons (A, B) and amide nitrogen atoms (C, D) 
mapped onto the surface of the crystal structure of Ras(wt)·Mg2+·GppNHp (Pai et al. 1990, pdb 5p21). 
Residues with a value for the pressure coefficient from group 1 (as defined in Table 4.16) and group 2 are 
colored red and orange, respectively. Amino acids, which are not assigned in the [1H, 15N]-HSQC-spectrum 
of Ras(wt)·Mg2+·GppNHp or could not been followed within the pressure series are shown in gray. The other 
parts of the protein are colored blue. 
 
 
4.8.2 Pressure Response of the Chemical Shifts and Related Gibbs Free 
          Energies  
For some of the residues a strong non-linear pressure dependence of the chemical shift 
together with an asymptotic behaviour can be observed. This is typical for a two-state 
transition in fast exchange on the NMR time scale. In this model, at ambient pressure 
either one main conformational state N1 exists, which is shifted towards conformation N2 
with increasing pressure. Likewise the two conformational states N1 and N2 coexist at 
ambient pressure and one certain conformation is preferred at higher pressures. Both types 
can be differentiated by the shape of the curve obtained by plotting the chemical shift 
against the applied pressure. The molar free energy (∆G0) for this local transition can be 
derived from the chemical shift change by Equation 3.9. As already stated above, prior to 
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the calculation of the Gibbs free energies ∆G0 the observed pressure-induced chemical 
shift was corrected according to random coil standard peptides (Arnold et al. 2002). Since 
this is only possible for the proton shifts, the pressure dependence of the nitrogen chemical 
shifts have not been evaluated. Figure 4.53 gives an example for residues exhibiting 
pressure dependent shift changes characteristic for a two-state model at both temperatures.  
 
 
 
 
Figure 4.53: Pressure dependent chemical shift changes observed in Ras(wt)·Mg2+·GppNHp.  Given are 
the corrected proton chemical shifts δ* H of Gly115 observed at 278 K (A) and Val14 observed at 303 K (B) as 
a function of pressure. The fits of the data according to Equation 3.9 are represented by the red line.  
 
 
Concerning the transition from conformational substate (2) into substate (1) as investigated 
by 31P NMR spectroscopy two facts are known. First, at ambient pressure both 
conformations are already populated with an equilibrium constant K12 of 1.9 for 
Ras(wt)·Mg2+·GppNHp (Geyer et al. 1996, Spoerner et al. 2001). Secondly the 31P NMR 
pressure series on Ras(wt)·Mg2+·GppNHp showed that at a pressure of 200 MPa the 
equilibrium is not completely shifted towards the weak effector-binding state. Hence the 
detection of this transition via the chemical shifts is quite cumbersome since the expected 
curve does neither have a plateau at ambient pressure nor at 200 or 180 MPa, respectively. 
However molar free energy ∆G0 for this transition of 1.48 kJ mol-1 (Spoerner et al. 2005a) 
and the difference in the molar volume ∆V0 = 17.2 mL mol-1 derived from the 31P NMR 
pressure series (Kalbitzer et al. 2009) might allow for the identification of residues 
participating in this transition. Consequently the pressure response of the chemical shift 
has been fitted according to Equation 3.9 with a constant value for ∆G0 of 1.48 kJ mol-1. As 
soon as the obtained fit gives a difference in the specific volume ∆V0 in agreement with the 
one obtained from the 31P NMR experiments within the range of error the corresponding 
residues is likely to sense the transition from the strong effector-binding state (2) to the 
weak effector-binding state (1). Doing so amino acid residues Asn26, Tyr96, Gly138 and 
Ile139 (278 K) and Val9, Val14, Gln25 and Ala66 (T = 303 K) could be identified to take part 
in the described process, which is subsequently defined by the transition from 
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conformation C(1) to conformation C(2). The obtained values for ∆V0 are given in Table 
4.18. 
 
Table 4.18: Residues giving a value for ∆V0 in agreement with the one obtained from the 31P NMR 
pressure series by fitting the pressure response of their chemical shifts according to Equation 3.9 with 
a value for ∆G0 of 1.48 kJ mol-1 (Spoerner et al 2005a). 
278 K 303 K 
Residue ∆V0 [mL mol-1] Residue ∆V0 [mL mol-1] 
Asn26 
Tyr96 
Gly138 
Ile139 
-17.0 ± 4.0 
-14.9 ± 2.7 
-18.0 ± 6.4 
-17.4 ± 3.1 
Val9 
Val14 
Gln25 
Ala66 
His94 
-18.1 ± 7.2 
-18.6 ± 8.8 
-19.2 ± 6.4 
-19.0 ± 7.2 
-19.4 ± 4.2 
 
 
Figure 4.54 shows the residues with fast exchange processes describing a two-state 
transition under increasing pressure for both temperatures, which have not been identified 
to sense the transition from C(1) to C(2). Fitting these data simultaneously according to 
Equation 3.9 one derives a molar free energy ∆G0 for this transition, of 3.9 ± 0.8 kJ mol-1 
from the data obtained at 278 K. The difference in the specific volume between the two 
conformations is -37 ± 8 mL mol-1. 
 
 
 
 
Figure 4.54: Residues exhibiting a chemical shift dependence on pressure typical for a two-state 
transition with a fast exchange regime on the NMR time scale. Residues from the pressure series recorded 
at 278 K (A) and 303 K (B) have been fitted according to Equation 3.9. The corresponding results are given 
in Table 4.18. 
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The data obtained from the pressure series at 303 K give a molar free energy ∆G0 for the 
transition of 3.9 ± 0.8 kJ mol-1. The difference in the specific volume between the two 
conformations is -35 ± 10 mL mol-1. This transition will subsequently be defined as the 
transition from C(1) to C(3). The results derived from the pressure series at the two 
different temperatures agree very well and are summarized in Table 4.19. 
 
 
Table 4.19: Molar free energies and specific volumes determined from the pressure-response of the 
chemical shifts describing a two-state model in the fast exchange regime according to Equation 3.9. 
 ∆G0 [kJ mol-1] ∆V0 [mL mol-1] 
278 Κ 3.9 ± 0.8 -37 ± 8 
303 Κ 3.9 ± 0.8 -35 ± 10 
mean 3.9 ± 0.8 -36 ± 9 
 
 
Additionally some of the peaks, namely Leu19, Val45, Ser89, Lys117, Val125 and Ala130 
(278 K) and Cys51, Val125, Leu133 and Glu153 (303 K) exhibit a pressure dependence 
regarding their chemical shift, which cannot sufficiently be described by a simple two-state 
model. An example is given by Lys117 and Cys51 in Figure 4.55. These residues obviously 
sense two different transitions with increasing pressure and by taking a closer look at the 
corresponding plot it becomes clear that neither at ambient pressure nor at the end of the 
pressure series one main conformation is present. 
 
 
 
 
Figure 4.55: Pressure dependent chemical shift changes indicating more than one conformational 
transition in Ras(wt)·Mg2+·GppNHp. Given are the corrected proton chemical shifts δ* H for Lys117 
observed at 278 K (A) and Cys51 obtained at 303 K (B) as a function of the pressure. The data have been 
fitted according to Equation 3.9 with n = 3. The data known for the transition from conformational state (2) 
to state (1) (Spoerner et al. 2005a, Kalbitzer et al. 2009) have been taken as values for one of the processes 
described. The data obtained from the fit described above (see Table 4.17) have been taken as values for the 
second process sensed. 
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Consequently it is likely that again one of the transitions sensed by these residues might be 
the one from the strong effector-binding substate (2) to the weak effector-binding substate 
(1), i.e. from C(1) to C(2) and other one equals the transition from C(1) to C(3) identified 
above with a molar free energy of 3.9 kJ mol-1 and a mean change in specific volume of  
-36 mL mol-1. In order to proof that assumption the data have evaluated in two different 
ways either by using 012G∆ , 012V∆ , 013G∆  and 
0
13V∆ free fit parameter or by fixing the values 
for 012G∆ , 
0
12V∆ , 
0
13G∆  and 
0
13V∆  with the ones obtained from the 
31P NMR pressure series 
and the results from the analysis of the pressure-dependent chemical shift changes from the 
transition from C(1) to C(3) (see Table 4.18). Only the latter method enabled a sufficient 
fit of the residues sensing two transitions. Examples are given Figure 4.55. 
 
 
 
 
 
Figure 4.56: Residues participating in two different transitions in Ras(wt)·Mg2+·GppNHp derived from 
analysis of the chemical shifts at 278 K and 303 K. Surface (A) and ribbon plot (B) of the crystal structure 
of Ras(wt)·Mg2+·GppNHp (Pai et al. 1990, pdb 5p21). Residues participating in transition C(1)→C(2) in 
Ras(wt)·Mg2+·GppNHp are colored orange, residues taking part in transition C(1)→C(3) are shown in green. 
Residues sensing both transitions are colored red. The results shown here graphically are summarized in 
Table 4.18. 
 
The results obtained from the evaluation of the pressure response of the chemical shifts at 
both temperatures are summarized in Table 4.20. In Figure 4.56 the residues participating 
in the two different transitions are mapped onto the surface of the crystal structure of 
Ras(wt)·Mg2+·GppNHp (Pai et al. 1990). 
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Table 4.20: Conformational transitions observed in Ras(wt)·Mg2+·GppNHp by analysis of the pressure-
dependent chemical shift changes. 
transition C(1) → C(2) C(1) → C(3) 
∆G0  
[kJ mol-1] 
1.48a  3.9 ± 0.8 
∆V0  
[mL mol-1] 
-18.0 ± 1.4 -36 ± 9 
Val9, Val14, Gln25, Asn26, Ala66, 
His94,Tyr96, Gly138, Ile139 
Gly77, Asn85, Asn86, Val112, Gly115, 
Asn116,  Arg123, Thr124, Asp132, 
Gln165, His166 
residues 
involved 
Leu19, Val45,Cys51, Ser89, Lys117, Val125, Ala130, Leu133, Glu153 
 a
 data taken from Spoerner et al. (2005a) 
 
 
4.8.3 Pressure Response of the Signal Intensities and Related Gibbs Free 
Energies 
Another possible pressure response is a change in signal intensity caused by exchange 
processes. Increasing pressure leads to a compression of the sample and thus to an increase 
of the effective protein concentration observable within the active volume in the probe 
head. Consequently the observed intensities are higher and have to be corrected before 
evaluating their pressure response. The pressure dependent increase of the peak integral of 
the buffer signal of Tris has been used for the determination of an internal correction 
factor. In Figure 4.57 the relative peak area of the signal is shown as a function of the 
pressure.  
 
 
 
Figure 4.57: Pressure dependent peak area of the signal for Tris buffer at 278 K (A) and 303 K (B). 
The linear fits according to Equation 3.10 (red line) give the parameters for the correction of the signal 
intensities in the corresponding [1H, 15N]-HSQC-spectra. The isothermal compressibility of the sample can 
be derived to be 0.35 ± 0.01 GPa-1 and 0.51 ± 0.02 GPa-1 at 278 K and 303 K, respectively. 
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Linear regression according to Equation 3.10 of the data allows for the correction of the 
signal intensities in the corresponding [1H, 15N]-HSQC spectra following Equation 3.11. In 
order to obtain reliable results additionally long time experiments have been carried out at 
3 MPa and 200 MPa at the end of the pressure series at 278 K. Due to the explosion of the 
ceramic cell at a pressure of 200 MPa long term experiments are missing for the pressure 
series recorded at 303 K. At 278 K almost each residue shows a change in signal intensity 
with increasing pressure, which is either a loss or an increase as shown schematically in 
Figure 4.58. New peaks can be observed in the [1H, 15N]-HSQC spectrum of 
Ras(wt)·Mg2+·GppNHp at 200 MPa in the case of the long time experiment recorded at 
278 K. Comparison with the [1H, 15N]-HSQC spectrum of Ras(T35A)·Mg2+·GppNHp, 
which gives cross peaks signals for each amino acid in the protein (except prolines) allows 
for the assignment of these residues to represent Gly10, Gly12 and Gly13, which are all part 
of the phosphate binding loop. An example is given in Figure 4.59. Unfortunately these 
peaks are not observed in the pressure series recorded with 8 scans per increment due to 
the poor signal to noise ratio and thus quantification is not possible. 
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Figure 4.58: Observed changes in signal intensity at high pressure in Ras(wt)·Mg2+·GppNHp at 278 K.  
Shown is the change of the signal intensities observed in the [1H, 15N]-HSQC spectrum of  
1.05 mM 15N Ras(wt)·Mg2+·GppNHp in 40 mM Tris/HCl pH 7.4, 10 mM MgCl2, 2 mM DTE, 0.1 mM DSS 
and 12% D2O at 200 MPa relative to the reference spectrum recorded at 3 MPa as a function of the residue 
position. Both spectra have been recorded at 278 K at 800 MHz proton frequency. The change of the 
concentration of Ras in the active probe volume caused by the compression of the sample was corrected 
using the signal of Tris as an internal standard (see section 3.3.4.4). 
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Figure 4.59: New cross peak signals observed in Ras(wt)·Mg2+·GppNHp at 278 K at high pressure. 
(A) Overlay of the [1H, 15N]-HSQC spectra of 1.05 mM Ras(wt)·GppNHp in 40 mM Tris/HCl pH 7.4,  
10 mM MgCl2, 2 mM DTE, 0.1 mM DSS and 12% D2O recorded at 3 MPa (blue) and 200 MPa (green), 
respectively. The experiments have been performed at 278 K at 800 MHz proton frequency with 32 scans per 
increment. (B) New cross peaks for Gly12 and Gly13 observed at 200 MPa mapped onto the surface of the 
crystal structure of Ras(wt)·Mg2+·GppNHp (Pai et al. 1990, pdb 5p21).  
 
 
Comparing the cross peak intensities between 3 MPa and 180 MPa from the pressure series 
recorded at 303 K gives a different picture. The only observed effect is a loss in signal 
intensity. As already stated above it was not possible to record a spectrum at higher 
pressures than 180 MPa at 303 K for technical reasons. Additionally long time experiments 
are missing. Due to signal overlap within the pressure series not each assigned residue can 
be evaluated according its pressure-dependent signal intensity. A plot of the intensity 
against the applied pressure gives three different types of curves, which are depicted in 
Figure 4.60.  
1) At ambient pressure one certain conformation of the protein is sensed by the residue, 
which looses population with increasing pressure. The conformation favoured at higher 
pressures is not completely stabilized at a pressure of 180 MPa (Figure 4.60 (A)). 
2) Two conformations are already present at ambient pressure with favour of one certain 
conformational state (Figure 4.60 (B)). 
3) At ambient pressure an equilibrium between two conformations is sensed by the residue. 
In contrary to the case described in 2) the favour for a certain conformational state is not 
the case and the conformation preferred at higher pressures becomes almost completely 
stabilized at 180 MPa (Figure 4.60 (C)).  
 
The residues have been subgrouped according to the examples given in Figure 4.59. In 
order to ensure that the observed effects are caused by slow exchange processes 
additionally the pressure-response of the line widths of these residues have been evaluated. 
In the fast exchange regime with |ω2 –ω1|<< 1/τex the cross peak volumes should not be 
dependent on the relative populations of the two states. However, when the exchange 
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correlation time gets larger additional line broadening proportional to N1N2(ω2 –ω1)2 
occurs. This leads to a possible loss of intensity during the INEPT polarization transfer, 
and when only peak amplitudes A not volumes are measured to a more pronounced 
decrease in A. A maximum additional line broadening is expected for N1 = N2 = 0.5, i.e. 
when both conformations involved in the transition are equally populated. In addition, 
pressure may modify the exchange correlation times themselfes and thus also the exchange 
line broadening. An increase in 1/τex leads in the fast exchange regime to a decrease of line 
broadening, in the slow exchange regime to an increase of line broadening.    
 
 
 
 
Figure 4.60: Pressure response of the signal intensities observed in Ras(wt)·Mg2+·GppNHp at 303 K for 
leucine53 (A), alanine18 (B) and threonine20 (C). The data have been fitted according to Equation 3.13. The 
corresponding fits are given by the red lines. The change of the concentration of Ras in the active probe 
volume caused by the compression of the sample was corrected using the signal of Tris as an internal 
standard (see section 3.3.4.4). 
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Group A covers the largest number of residues. Concerning residues assigned to this group 
a significant change in the line widths of 1H or 15N, respectively cannot be observed. The 
maximum increase of the line width is 16% for 1H and 15% for 15N with a mean value for 
the relative line witdhs LB/LBRef of 0.89 ± 0.14 for 1H and 0.99 ± 0.11 for 15N. 
Consequently the loss in signal intensity reflects a loss in signal volume and thus a reduced 
population of the conformation sensed by these residues at ambient pressure. Thus the 
pressure response of the signal intensities of these residues can be fitted by Equation 3.13 
assuming a two-state transition in the slow exchange regime. Figure 4.61 shows the 
distribution of the values for ∆G0 and ∆V0 obtained from the corresponding fits. As one can 
see very nicely amino acids belonging to group A describe one certain process with a 
molar free energy of ∆G0 = 8.6 ± 1.8  kJ mol-1 and a change in the specific volumes ∆V0 
between the two conformations of  -43.7 ± 8.4 mL mol-1. 
 
 
 
 
Figure 4.61: Distribution of the molar free energies ∆G0 and the changes in the specific volumes ∆V0 
determined by Equation 3.13 from the pressure response of residues assigned to group A. 
 
 
For the residues assigned to group B at higher pressures the loss of intensity or volume is 
almost 100% and thus the determination of the line widths is afflicted with higher errors. 
Consequently the line widths of the signals obtained at 80 MPa have been evaluated. At 
this pressure the loss in signal intensity for these residues is about 50%. If this was caused 
by strong line broadening effects this should also be observed at 80 MPa. A mean value for 
the relative line witdhs LB/LBRef of 1.05 ± 0.15 for 1H and 0.97 ± 0.06 for 15N is observed. 
As described above for the residues assigned to group A this again reveals a two state 
transition in the slow exchange regime. Five residues have been found exhibiting a 
pressure response according their signal intensity as shown in Figure 4.60 (B). They have 
been fitted simultaneously by Equation 3.13 (Figure 4.62). For the process sensed by these 
residues a value of 4.4 ± 0.6 kJ mol-1 for ∆G0 and of -48.4 ± 3.3 mL mol-1 for ∆V0 has been 
determined. 
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Figure 4.62: Residues in Ras(wt)·Mg2+·GppNHp exhibiting a pressure-dependence of their signal 
intensities as described for group B.  The data have been fitted simultaneously according to Equation 3.13 
giving a value for ∆G0 of 4.4 ± 0.6 kJ mol-1 and for ∆V0 of -48.4 ± 3.3 mL mol-1 for the sensed transition. 
 
 
Group C covers nine amino acids. Due to the poor signal to noise ratio for these residues 
neither the signal volume nor the line width can be determined automatically with 
sufficient accuracy. The line width might be constant over the pressure range studied and 
thus the data can be fitted by Equation 3.13 just like it was done with the data derived from 
the residues assigned to group A and B, respectively. Likewise the volume of the peak 
might be constant and the lines get broadened due to fast exchange. In the latter case 
quantification with Equation 3.13 is not possible. However for completeness the data have 
been fitted simultaneously by Equation 3.13 (Figure 4.63) deriving a value of  
-28.9 ± 2.4 mL mol-1 for ∆V0. 
 
 
 
 
Figure 4.63: Residues in Ras(wt)·Mg2+·GppNHp exhibiting a pressure-dependence of their signal 
intensities as described for group B.  The data have been fitted simultaneously according to Equation 3.13 
giving a value for ∆V0 of -28.9 ± 2.4 mL mol-1 for the sensed transition. Due to the shape of the curves ∆G0 
could not be determined with sufficient accuracy. 
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A quantification of ∆G0 was not possible with the data available. Also the determination of 
the peak volume was not possible with enough accuracy. 
 
Comparing the results obtained from both analyses the values obtained for ∆G0 and ∆V0 
obtained from analysis of the pressure response of the signal intensity from residues 
assigned to group B agree within the range of error with the transition from conformation 
C(1) to C(3) obtained from the analysis of the chemical shifts.  
Table 4.21 gives a summary about the single transitions determined in 
Ras(wt)·Mg2+·GppNHp and the residues involved. 
 
 
Table 4.21 Conformational transitions and corresponding molar free energies ∆G0 and molar volumes 
∆V0 in Ras(wt)·Mg2+·GppNHp determined by analysis of pressure NMR series performed at 278 K and 
303 K.  
 
∆G0 
[kJ mol-1] 
∆V0 
[mL mol-1] residues involved
a 
C(1) → C(2)c 1.48b -18.0 ± 1.4 
Val9, Val14, Leu19, Gln25, Asn26, 
Val45,  Cys51, Ala66, Ser89, His94, 
Tyr96, Lys117, Val125, Ala130, Leu133, 
Gly138, Ile139, Glu153 
C(1) → C(3)c 3.9 ± 0.8 -36.0 ± 9.0 
Leu19, Val45, Cys51, Gly77, Asn85, 
Asn86, Ser89, Val112, Gly115, Asn116, 
Lys117, Arg123, Thr124, Val125,  
Ala130, Asp132, Leu133, Glu153, 
Gln165, His166 
C(1) → C(3)d 4.4 ± 0.6 -48.4 ± 3.3 Ala18, His27, Phe28, Val44, Asp56 
C(1) → C(4)d 8.6 ± 1.8 -43.7 ± 8.4 
Glu3, Gly15, Lys17, Ser39, Lys42, 
Val45, Glu49, Leu53, Gly77, Phe82, 
Ile84, Asn85, Met111, Leu120, Ala130, 
Leu133, Ala134, Arg135, Ser136, Gly138, 
Tyr141, Glu143, Ala146, Lys147, Arg161 
a
 residues sensing two transitions are given in bold letters. 
b taken from Spoerner et al. (2005a) 
c
 determined by analysis of the pressure-dependent chemical shift changes according to Equation 3.9 
d
 determined by analysis of the pressure-dependent changes in signal intensity according to Equation 3.13 
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5 DISCUSSION 
5.1 Saturation Transfer Difference Spectroscopy 
Ras is a quite interesting target in medicinal chemistry due to its involvement in the 
development of about 30% of all human tumors (Barbacid 1987). Several approaches are 
followed for the inhibition of its signaling (see e.g. Wittinghofer 2000). A novel promising 
strategy is the stabilization of a conformational substate in active Ras with decreased 
effector affinity. The small organic compound Zn2+-cyclen is capable of doing so 
(Spoerner et al. 2005c) and to date no other substance has been reported. A structure of the 
binding site of Zn2+-cyclen in the partial loss-of-function mutant Ras(T35A) in its active 
GppNHp-bound conformation is available (Rosnizeck et al., accepted). This can be taken 
as basis for the structure-based virtual screening at our department following two 
approaches: first, the de novo design for compounds binding at the same position as does 
the Zn2+-cyclen and secondly, the screening for fragments binding in a defined distance to 
the active centre. Potential hits derived from the screening will subsequently be 
investigated using NMR-based screening for their actual binding activity. Both binding 
positions shall further be linked in order to give high affinity ligands.  
 
A diverse array of methods is reported for the detection of ligand binding via NMR (see 
e.g. Peng et al. 2004, Pellechia et al. 2008). Within the ligand-based methods, 
INPHARMA (Sánchez-Pedregal et al. 2005) for example utilizes protein-mediated 
interligand NOEs for the identification of compounds competing for the identical binding 
pocket in the protein. This would represent an interesting approach for the detection of 
ligands binding at the same position as does Zn2+-cyclen. However, small fragments are 
also screened for binding in a defined distance to the binding site of Zn2+-cyclen. 
Additionally it was shown that Zn2+-cyclen binds at two distinct positions in Ras 
(Rosnizeck et al., accepted) and hence the obtained results will not exclusively reflect the 
competition for the desired position at the active centre. In the WaterLOGSY method 
magnetization is transferred from bulk water (Dalvit et al. 2000 2002, Shimotakahara et al. 
2005) within the protein-ligand surface. Irradiation is either realized by the direct 
saturation of the water resonances or by inverting the water resonance signal using for 
example the NOE-ePHOGSY scheme (Bertini et al. 1997). The overlap of the water 
resonance with for example Hα protons can lead to cumulative effects limiting the 
selectivity of the method. Additionally signals from binding and non-binding compounds, 
which have different signs in the resulting spectrum, can cancel each other out. In general 
the method is recommended for targets exhibiting a low proton density and systems with 
the ligand or receptor being strongly hydrated, e. g. RNA-ligand complexes  
(Peng et al. 2004). For the screening of potential Ras ligands in this work saturation 
transfer difference spectroscopy (Mayer and Meyer 1999) was the method of choice. It is 
adequate for the identification of ligands with affinities ranging from 10-3 and 10-8 M. 
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Additionally competitive experiments also allow for the identification of compounds 
binding at a desired position for which a ligand is already known (Jahnke et al. 2002). 
Moreover STD NMR is capable for the characterization of the binding epitope of the 
ligand molecule (Mayer and Meyer 2001, Peikert et al. 2004). The latter feature can be 
utilized for the further optimization of the identified Ras ligands, which has already been 
reported for sugar-derived Ras ligands (Peri et al. 2005, Airoldi et al. 2007). Such 
information is in principle also provided by the WaterLOGSY method (Dalvit et al. 2000 
2002, Shimotakahara et al. 2005), but primary reflects the water contact surface of the 
ligand and not its interaction pattern with the target molecule. STD NMR can in principle 
be combined with any NMR pulse sequence (Vogtherr and Peters 2000, Nagaraja 2006). 
One of the major advantages of STD NMR spectroscopy are the smaller amount of protein 
needed, which is very low with 0.1 nmol compared to 25 nmol in WaterLOGSY or inverse 
NOE pumping and of course compared to receptor-based methods like SAR by NMR or 
diffusion editing, which require 25 nmol and 100 nmol, respectively (Meyer and Peters 
2003). In general receptor-based methods are usually limited by the size of the 
macromolecule. This is not the case in STD NMR spectroscopy since the saturation is even 
more efficient for large proteins and even membrane-bound or immobilized proteins have 
been successfully investigated (Klein et al. 1999, Meinecke and Meyer 2001). 
 
As described in section 1.2.2.2 the STD experiment consists of a reference spectrum and 
an on-resonance spectrum, which ensures the selective irradiation of the protein signals. 
Binding ligands appear with decreased intensity in the on-resonance spectrum. A T1ρ-filter 
was implemented in the pulse sequence (Mayer and Meyer 2001). With the use of this 
spinlock relaxation filter the protein proton resonances are filtered out from the spectrum, 
which eases the evaluation of the difference spectra due to less overlap of protein signals 
with potential ligand signals. In this work different on-resonance irradiation frequencies 
have been tested and used. During the experiments with the different on-resonance 
irradiation frequencies it became apparent that the reference standard DSS present in the 
sample binds to Ras(T35A)·Mg2+·GppNHp. When irradiating at -2 ppm the signal of the 
nine methyl protons of DSS at 0 ppm show up in the difference spectrum only when Ras is 
present in the sample. It has been reported that the compound does bind to hydrophobic 
cavities in proteins (Laurents et al. 2005). DSS might also tend to aggregate and is for that 
reason directly saturated when irradiating at -2 ppm. In the active centre of the Ras protein 
a lot of charges are present due to the strong polar interactions between the active centre 
and the nucleotide (Pai et al. 1990). Thus it is less probable that DSS competes against the 
ligands used within this work and would thus falsify the obtained results. Even if this 
would be case it will still be possible to detect appropriate ligands since they are present in 
a much higher excess than DSS. In each NMR experiment carried out with Ras at the 
department DSS is used as internal reference and hence this substance was further used in 
the STD experiments allowing for better comparison. However, before starting new 
screening experiments one might consider to use a reference standard, which has been 
tested according to its potential binding to Ras before. An example can be given by 
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dioxane (Wishart et al. 1995). Alternatively the water signal can be used for referencing 
the spectra as reported for the STD experiments carried out by Peikert et al. (2004).  
STD spectroscopy has been successfully applied for the identification of the Ras ligand 
Zn2+-BPA in this work by irradiating at 0.3 ppm, which is in a distance of more than 
3.3 ppm from the closest BPA-resonance and guaranteed the selective irradiation of the 
protein resonances over the ligand resonances. The signals of the compound appear in the 
corresponding difference spectrum only upon addition of Ras. Peri et al. (2005) and 
Airoldi et al. (2007) selectively saturated Ras·GDP by irradiating in the aliphatic region 
around 1 ppm in their studies on inhibitors for the nucleotide exchange reaction mediated 
by GEFs. The identification of Zn2+-BPA by STD NMR does not give any information 
about the binding position in the protein. If one is interested, whether the compound does 
bind towards the protein at the same site as another known ligand, competition experiments 
can be carried out (Jahnke et al. 2002). This was not done in this case, since Zn2+-cyclen 
binds to more than one position in active Ras (Rosnizeck et al., accepted). Whenever it is 
possible to displace Zn2+-cyclen from Ras in STD NMR one will not obtain explicit 
information according the binding position. Dissociation constants were determined using 
the so-called STD amplification factor introduced by Mayer and Meyer (1999) giving a 
KD-value of 9.65 mM and 2.07 mM for Zn2+-cyclen and Zn2+-BPA, respectively.  
Bivalent Ras ligands have been investigated according their binding activity towards 
Ras(T35A)·Mg2+·GppNHp. These ligands carry a peptide moiety and thus the on-
irradiation frequency was set to -2 ppm in order to avoid direct saturation of the ligand and 
thus wrong positive results. Preliminary experiments with Ras(T35A)·Mg2+·GppNHp in 
the absence and presence of the known Ras ligand Zn2+-cyclen proofed the efficacy and 
selectivity of the method when irradiating at -2 ppm. This frequency is also recommended 
for primary NMR screening with a large number of potential ligands covering a large 
spectral window.  
 
The above described experiments and results show that Ras can be successfully applied for 
the identification of binding ligands using STD NMR spectroscopy. In future screening 
experiments with potential ligands the on-resonance irradiation frequency can be set to  
-2 ppm, which will be sufficient for the detection of ligands giving signals in the common 
spectral window. However, it is suggested to perform a negative control with a sample 
without the protein being present in order to avoid false positive results, since some 
compounds might tend to aggregate and can thus also be saturated directly since their 
spectral window can be widened due to line broadening effects caused by an increased 
molecular mass upon aggregation. Additionally it was shown that the reference standard 
DSS does bind to Ras. One should be aware that this might influence the results obtained 
in the screening as soon as the potential ligands competes with DSS for the same binding 
position.  
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5.2 Modulation of the Conformational Equilibrium in Active 
Ras by Metal(II)-Chelates  
31P NMR spectroscopy reveals the existence of at least two distinct conformational states 
in active wild type Ras, which are in dynamic equilibrium (Geyer et al. 1996, Spoerner et 
al. 2001). The equilibrium constant strongly depends on the nature of the bound nucleotide 
and mutations in the protein (Spoerner et al. 2004 2005a 2007). One of these states, namely 
state (1) shows drastically reduced affinity towards effector molecules (Spoerner et al. 
2001) and hence its stabilization by suitable ligands represents a promising approach in the 
disruption of aberrant Ras signalling. To date one compound, Zn2+-cyclen has been 
reported to selectively bind to this weak-effector binding state and thus shifts the dynamic 
equilibrium completely to state (1) (Spoerner et al. 2005c). Using STD NMR spectroscopy 
Zn2+-BPA has been identified as a ligand for active Ras in this work. 31P NMR titration 
studies clearly reveal that this compound also selectively recognizes the weak effector-
binding conformation in active Ras. In doing so no significant chemical shift changes can 
be observed for the phosphorus resonances of the bound nucleotide in 
Ras(wt)·Mg2+·GppNHp, which is the case in the corresponding experiment with  
Zn2+-cyclen. In the latter titration each signal shifts by more than 1 ppm (Spoerner et al. 
2005c). At increasing concentrations of Zn2+-BPA the protein starts to precipitate and 
resonances of Mg2+·GppNHp show up in the respective 31P NMR spectrum accompanied 
by an upfield shift for the β-phosphate group of the free nucleotide. The latter observation 
is likely to be caused by the complex formation between Zn2+-BPA and the free nucleotide. 
A comparable shift response is observed in the titration of free Mg2+·GppNHp with  
Zn2+-BPA. In principle different explanations can be given for the precipitation of Ras and 
the resulting appearance of signals representing free Mg2+·GppNHp in the 31P NMR 
spectra. Zn2+-BPA might pull the nucleotide out of its active site in the protein by directly 
binding to the latter. Likewise the compound could also stabilize the Ras protein in a 
conformation, which weakens nucleotide binding and thus facilitates the dissociation of 
Mg2+·GppNHp from the active site in Ras. Additionally impurities in the stock solution of 
Zn2+-BPA such as free ZnCl2 left from the complexation of BPA with Zn2+ might cause 
protein denaturation and consequently the observed release of free nucleotide. It is not 
likely that the nucleotide is pulled out of its binding position in the active centre of Ras. 
The 31P NMR titration of Mg2+·GppNHp with Zn2+-BPA indicates only a weak complex 
formation with an affinity in the millimolar range, whereas the protein binds the nucleotide 
very tightly with picomolar affinity (John et al. 1990). A possible participitation of 
impurities like ZnCl2 in the precipitation of Ras can be excluded. The corresponding 31P 
NMR tirations of Ras(T35A)·Mg2+·GppNHp with ZnCl2 show that concentrations as high 
as 6.5 mM of ZnCl2 are tolerated. At this concentration neither significant chemical shift 
changes of the resonances of the bound nucleotide nor the appearance of signals 
representing free Mg2+·GppNHp can be observed (M. Spoerner, personal communication). 
The most probable mechanism leading to the above described effects in the 31P NMR 
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spectra of Ras(wt)·Mg2+·GppNHp the presence of Zn2+-BPA can be given by the 
stabilization of the weak effector-binding conformational state (1) by the compound, which 
does not proceed via a direct coordination of the bound nucleotide in state (1) as it is the 
case for Zn2+-cyclen. This assumption is supported by the fact that no significant shift 
changes can be observed for the single phosphorus resonances of the bound nucleotide, 
while the relative peak areas of the signals representing the single phosphorus resonances 
clearly reveal an increase of the population of state (1) in the presence of Zn2+-BPA. It is 
known that the dissociation of the nucleotide is enhanced in conformational state (1) of 
active Ras (Spoerner et al. 2001). The same observation can be made when 
Ras(wt)·Mg2+·GppNHp is titrated with the chaotropic compound GdmCl in an unfolding 
experiment: the dynamic equilibrium is shifted towards the weak effector-binding state (1) 
accompanied by the denaturation of the protein and the observation of resonances 
representing Mg2+·GppNHp in the corresponding 31P NMR spectra (Kalbitzer et al. 2009).  
 
A good explanation for the different effects of Zn2+-cyclen and  Zn2+-BPA observed in the 
31P NMR experiments can be derived when looking at their binding positions in the partial 
loss-of-function mutant Ras(T35A)·Mg2+·GppNHp. Both compounds bind at two distinct 
positions in the protein, which can be deduced from [1H, 15N]-HSQC titrations with both a 
paramagnetic and a diamagnetic derivative of the metal(II)-complexes. One of the binding 
positions is identical for both compounds. It centres between the negatively charged loop 
L7 and the C-terminal end of Ras. The driving force for this interaction is assumable a 
strong ionic attraction between the central metal ion of the complexes and the negatively 
charged amino acids within loop L7 (Asp105, Asp107 and Asp108). This binding position was 
also identified in crystals of the complex between Ras(wt)·Mg2+·GppNHp and Zn2+-cyclen  
(Rosnizeck et al. accepted). The second binding position accountable for the stabilization 
of conformational state (1) differs for Zn2+-cyclen and Zn2+-BPA. Zn2+-cyclen binds in 
close proximity of the γ-phosphate group of the bound nucleotide, which is so to say 
sandwiched between the protein and the compound. This binding position is only 
accessible for Ras in conformational state (1) probably for steric reasons. In Ras proteins, 
which predominantly exist in conformation (1) from the spectroscopic view like the 
Mg2+·GppNHp-complexes of the Ras mutants G60A (Ford et al. 2005), T35S  
(F. Schumann, unpublished results) and M-Ras (Ye et al. 2005) the switch I region adopts 
a more opened conformation similar to the one of nucleotide-free Ras in complex with its 
exchange factor SOS (Boriack-Sjodin et al. 1998). 
In contrary, the second binding position of Zn2+-BPA is located at the PM3 motif of Ras 
with residues 53 to 58 giving the strongest response in the titration with Cu2+-BPA, thus 
revealing the closest proximity of this region to the paramagnetic metal centre. This 
binding position of Zn2+-BPA is composed of several hydrophobic amino acids like Leu53 
and Ile55, which can interact with the aromatic rings of BPA. Additionally negative charges 
are present (Asp56 and Asp57) possibly interacting with the central metal ion of the chelate 
complex. The compound approaches the nucleotide binding site from the opposite 
direction compared to metal(II)-cyclen. The nucleotide is not sandwiched between its 
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binding pocket in the active Ras and the compound, which is the case, when looking at the 
calculated HADDOCK structure for the binding site of metal(II)-cyclen  
(Rosnizeck et al., accepted). In the corresponding titration with Zn2+-BPA large chemical 
shift changes are observed within switch I indicating structural rearrangements in this 
region. Obviously metal(II)-BPA stabilizes conformational state (1) by fixing the switch I 
region in its more opened conformation, which results in a weakened binding of the 
nucleotide. Additionally residues, which take part in the coordination of the nucleotide in 
active Ras are strongly affected in the presence of both metal(II)-BPAs, e.g. Phe28 and 
Lys147 which form strong stabilizing interactions with the guanine base of the bound 
nucleotide in active wild type Ras (Wittinghofer and Waldmann 2000). Phe28 also 
drastically changes its position in complex with SOS easing the exchange of the nucleotide 
(Boriack-Sjodin et al. 1998). Measuring the dissociation rate of the nucleotide in the 
presence of Zn2+-BPA might be an appropriate approach to study the influence of the 
compound on the affinity of Ras towards the nucleotide. Additionally the determination of 
the distance of the Cu2+-ion to the phosphorus nuclei by measuring the T1 relaxation in the 
presence of Cu2+-BPA might provide further information about the binding position of the 
compound. 
 
These discriminative binding positions close to the active centre of 
Ras(T35A)·Mg2+·GppNHp also explain very nicely the different effects of Zn2+-cyclen and 
Zn2+-BPA, respectively on the dynamic equilibrium of the oncogenic Ras mutant G12V 
complexed to Mg2+·GppNHp. In the latter mutant the dynamic equilibrium is slightly 
shifted towards the weak binding conformation with a K12 value of 0.9 compared to 1.9 for 
the wild type protein (Spoerner et al 2005a). Consequently one would expect a stronger 
influence of both compounds on the dynamic equilibrium in the oncogenic mutant. This is 
indeed the case for Zn2+-BPA. At a molar ratio of Ras:Zn2+-BPA of 1:10 the dynamic 
equilibrium is almost completely shifted towards the weak effector-binding state  
(K12 = 0.29), whereas such a shift is not achieved at the same excess in the wild type 
protein. The situation is vice versa for Zn2+-cyclen. A 20-fold molar excess is sufficient for 
a complete shift of the equilibrium towards the weak effector-binding state in the wild type 
protein (Spoerner et al. 2005c), whereas K12 equals 0.4 in the presence of a 32-fold excess 
of Zn2+-cyclen in the oncogenic mutant. In contrast to the titration with the wild type 
protein large chemical shift changes are not observed, when Zn2+-cyclen is titrated to 
Ras(G12V)·Mg2+·GppNHp indicating a perturbed interaction with the active site of the 
protein and the nucleotide bound. Additionally the bleaching of the 31P NMR resonance of 
the γ-phosphate group in Ras(G12V)·Mg2+·GppNHp requires a very high excess of  
Cu2+-cyclen over the protein of 30-fold compared to 5-fold in Ras(wt)·Mg2+·GppNHp  
(T. Graf 2006). The mutation of Gly12 to Val also influences the 31P chemical shifts of the 
bound nucleotide. The resonance signal of the γ-phosphate group representing state (1) is 
shifted downfield by 0.23 ppm and the one corresponding to state (2) is shifted highfield 
by 0.76 ppm compared to the wild type protein. For the β-phosphorus resonance an upfield 
shift of 0.24 ppm is observed (Spoerner et al. 2005a). This strongly indicates a perturbation 
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of the chemical environment of the β- and γ-phosphate group both in conformational state 
(1) and (2), respectively. Comparison of the crystal structure of Ras(G12V)·Mg2+·GppNHp 
and Ras(wt)·Mg2+·GppNHp shows that structural differences can be found in the phosphate 
binding loop around amino acids Gly12 and Gly13 and additionally for residues Gly60 and 
Gln61, which are slightly pushed away from the nucleotide binding site, whereas the overall 
topology of the protein is maintained (Krengel et al. 1990). Thus the mainly affected 
residues correspond for the most part with the residues involved in binding of the 
metal(II)-cyclen and hence the binding position for the compound in the 
Ras(G12V)·Mg2+·GppNHp might be less attractive to the small compound even though 
switch I opens up somewhat. In contrast the binding position of metal(II)-BPA is not 
affected by this mutation and the latter compound can bind without any difficulties.  
 
Both compounds are also capable of stabilizing conformational state (1) in the oncogenic 
mutant complexed to its physiological nucleotide GTP. The 31P NMR spectrum of Ras(wt) 
complexed to Mg2+·GTP shows one peak for each phosphorus signal, which can be 
assigned to conformational state (2). By 31P NMR saturation transfer spectroscopy it could 
be shown that this state is in equilibrium with a second one assigned to conformational 
state (1). The latter one is very little populated and thus only sparely visible  
(Spoerner et al., unpublished results). The same is true for Ras(G12V)·Mg2+·GTP. Upon 
addition of a high excess of the Zn2+-chelates a second set of resonances shows up in the 
corresponding spectra for the γ- and β-phosphate group, which have been assigned to 
conformational state (1). The effect is again stronger in the presence of Zn2+-BPA probably 
again for the above described reasons.  
 
Besides the conformational equilibrium between conformational states (1) and (2) as 
described above a slow conformational exchange between two substates of conformational 
state (1) is found in the mutants Ras(T35A) and Ras(T35S) in complex with Mg2+·GTPγS 
(Spoerner et al. 2007). The equilibrium constant K1a1b equals 0.5. Three different 
coordination spheres are possible for GTPγS, when complexed to the protein. The sulphur 
is either not coordinated or by the Mg2+-ion and the main chain NH of Thr35 or  by the 
main chain NH of Gly60 and Lys16 (Spoerner et al. 2007). A schematic representation is 
given in Figure 5.1. The side chain coordination of the Mg2+-ion cannot take place, when 
Thr35 is replaced by alanine. It is suggested that the loss of this coordination is 
accompanied by a break of the hydrogen bond between the main chain NH of amino acid 
at position 35 and the γ-phosphate group of the bound nucleotide (Allin et al. 2001). All 
three coordination spheres are possible for the state (1) mutant Ras(T35A). It is assumed 
by Spoerner et al. (2007) that arrangement A and B are preferred since the side chain of 
lysine16 can coordinate an oxygen in each case. Within both, structure A is preferred since 
additionally the Mg2+-ion is coordinated to an oxygen instead of an sulphur, which is 
preferred following the hard soft [Lewis] acid base (HSAB) principle (Pearson 1963). For 
that reason conformational substate (1a), which is populated to a higher extend most 
probably resembles structure A and in turn substate (1b) is reflected by the coordination 
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pattern B. Metal(II)-cyclens represent an attractive tool in order to obtain additional insight 
into the coordination pattern in the active centre since it binds to the γ-phosphate group. 
Titration studies with both the paramagnetic and the diamagnetic metal(II)-cyclen 
derivative clearly reveal that substate (1a) is selectively recognized. This is not surprising 
since the sulphur atom is available for coordination in structure A, whereas the electron 
pairs of the non coordinated oxygen of the thiophosphate group in structure B are not 
available for coordination due their delocalization strongly supporting the proposed 
interaction pattern assigned to the two substates by Spoerner et al. (2007). 
 
 
 
Figure 5.1: Schematic representation of the coordination sphere of the phosphate groups and the 
thiophosphate of GTPγS complexed to wild type and mutant Ras.  Bonds that probably exists only in 
state (1) or are weakened or abolished in the thiophosphate group are represented by broken lines (taken from 
Spoerner et al. 2007). 
 
The present coordination pattern also gives an explanation for the observed stronger effect 
of Cu2+-cyclen compared to Zn2+-cyclen, which is observed in the respective 31P NMR 
titrations. Following the HSAB theory Zn2+ and Cu2+ differ in their Lewis acidity. While 
Zn2+ is an intermediate acid, Cu2+ is a weak acid. Consequently the latter one is stronger 
coordinated by sulphur, which is a weak Lewis base. Both compounds affect the  
γ-phosphorus resonance in the corresponding 31P NMR titration the strongest. When  
Cu2+-cyclen is present additionally strong effects are observed for the β-phosphate group in 
terms of both its chemical shift and its line width for electronic reasons caused by the 
stronger influence on the coordination sphere of the β-phosphate group. A direct 
coordination of the β-phosphate hardly is the reason for the latter effect since it is less 
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accessible for the metal(II)-cyclen and effects in the presence of both derivatives should be 
observed as it is the case in the corresponding titration with free Mg2+·GTPγS. 
The preference of Zn2+-cyclen for substate (1a) was also shown in the mutant 
Ras(G12V)·GTPγS, which predominantly exists in conformational state (2). In the 
presence of Zn2+-cyclen a second set of resonances shows up in the corresponding spectra 
for the γ- and β-phosphate group, which can be assigned to conformational state (1a). 
However, the affinity towards this mutant is much lower as already described.  
GTPγS is a less stable analogue of GTP compared to GppNHp and GppCH2p. An 
abnormal hydrolysis mechanism was observed for GTPγS in the presence of Ras giving 
protein bound GDP as expected and inorganic phosphate and H2S instead of thiophosphate 
(Spoerner et al. 2007). In the titration with Zn2+-cyclen the expected hydrolysis product is 
obtained and shifts due to the complex formation with Zn2+-cyclen, which might avoid the 
hydrolysis of thiophosphate. Additionally a high intensity peak representing inorganic 
phosphate is observed, which is not likely to be a hydrolysis product of thiophosphate 
since the amount of the latter matches quite well with the protein bound GDP and H2S was 
not detected by its smell at the end of the experiment. 
In the above described titrations of different Ras mutants such a high intensity peak 
representing inorganic phosphate appears only in the presence of Zn2+-cylen, not  
Zn2+-BPA independent from the bound nucleotide. This observation has been made before 
in experiments with Ras and its effectors and regulators such as SOS and NF1  
(M. Spoerner, personal communication) or with Arf1 and ArnoSec7 (Kremer et al. 2004). 
Interestingly the signal for Pi is not observed in each sample itself, but can be detected after 
adding them together. To date no explanation can be given. It is possible that the Ras 
protein carries an additional phosphate molecule, which is not detectable due to 
intermediate exchange between the free and the protein-bound state, but released in the 
presence of certain regulators. Probably Zn2+-cyclen can also do so. It does bind to 
inorganic phosphate leading to a downfield shift of the resonance of the latter, as derived 
from several experiments. Since this effect is not observed in the presence of Zn2+-BPA it 
is strongly suggested that this potential additional phosphate molecule is positioned close 
to the binding site of Zn2+-cylcen at the active centre. 
 
High field EPR and 31P NMR studies also indicate the existence of two different 
conformational states in the Ras·Mg2+·GDP complex (Rohrer et al. 2001). 31P NMR 
titrations of Ras·Mg2+·GDP with metal(II)-cyclen do not reveal any significant effects of 
the compound. A different picture is obtained for the α-phosphate signal in the presence of 
metal(II)-BPA. In the presence of Cu2+-BPA the line width of the α-resonance signal is not 
affected, but significant downfield shifts can be observed in wild type Ras, Ras(G12V) and 
Ras(T35A). Ras(wt)·Mg2+·GDP was also titrated with Zn2+-BPA. A slight downfield shift 
is observed for the α-phosphate signal, whereas the β-phosphorus signal remains 
unperturbed. This observation strongly indicates that there is a binding position for 
metal(II)-BPA in inactive Ras·Mg2+·GDP, which perturbs the chemical environment of the 
α-phosphate group but does not influence the β-phosphate group considerable.  
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It can be deduced from the 31P NMR experiments that both metal(II)-cyclen and metal(II)-
BPA bind to Ras with millimolar affinity. Hybride ligands composed of a chelate moiety 
and a peptide with a consensus Ras binding sequence have been designed with the aim to 
enhance both the selectivity and the affinity of the compounds in cooperation with 
G. Dirscherl and F. Schmidt from the chair of Prof. König (Institute for Organic 
Chemistry, University of Regensburg). The peptide was derived from the interaction 
surface of the guanine nucleotide exchange factor SOS (Boriack-Sjodin et al. 1998) since 
conformational state (1) of Ras is structurally closer related to the conformation of Ras in 
its complex with SOS (Ford et al. 2005). [1H, 15N]-HSQC titration revealed the binding of 
the peptide at the desired position, namely around Glu62 and Glu63 and hence both metal 
chelates have been connected to the peptide by an appropriate linker at the chair of Prof. 
König. STD NMR titrations clearly show that the compounds still bind towards Ras but 
with reduced affinity. In the case of the hybride ligand carrying Zn2+-cyclen as chelate 
moiety the reason for the reduced binding affinity can be of steric origin. As described 
above for the oncogenic mutant Ras(G12V)·Mg2+·GppNHp the binding position of the 
metal(II)-cyclen reacts very sensitively on changes in its environment. The additional 
binding module obviously enlarges the ligand spatially such that is not able to enter its 
binding pocket. Probably only the binding position at loop L7 is recognized accompanied 
by a reduced affinity due to the attached second site ligand. It is also likely for both 
hybride ligands that the linker length was not chosen appropriately, i.e. the peptide does 
not reach its binding position in the desired way. Likewise the linker might affect the 
binding potential of the hybride ligands. Additionally the peptide part of the designed 
bivalent ligands might be orientated the other way around than expected from the Ras-SOS 
complex structure.  
 
Both metal(II)-chelates represent attractive lead compounds for the development of Ras 
inhibitors following the novel strategy of stabilizing the weak effector-binding 
conformation of active Ras. The compounds differ in their binding position responsible for 
this stabilization, which widens the range of the design for novel ligands with increased 
affinity. Advancements in the binding site of Zn2+-cyclen are most probably achieved by 
the modification of known phosphate sensing compound, such as linear and bismacrocyclic 
octaamines (Le Bris et al. 2007). One has to be aware of the fact that any compound, which 
is known to bind towards triphosphates is not necessarily able to do so, when the 
nucleotide is bound to the protein. The application of the Zn2+-cylens is limited for steric 
reasons as shown by its decreased affinity towards the oncogenic mutant 
Ras(G12V)·Mg2+·GppNHp. This is not the case for metal(II)-BPAs. Taking all the NMR 
results with the metal(II)-BPA into account one could calculate a HADDOCK structure of 
the Ras-ligand complex for the subsequent structure-based design of a second class of 
compounds stabilizing conformational state (1) via a different mechanism as it was done 
with the ligand Zn2+-cyclen (Rosnizeck et al., accepted). 
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The existence of a conformational equilibrium seems to be a common feature of Ras 
family GTPases and has been reported for Ran (Geyer et al. 1999), Rho (Dias and 
Cerione 2007), Rap and Ral (Liao et al. 2008). Due to their involvement in the 
development of several diseases (Lu et al. 2009, Minato and Hattori 2009, Smith and 
Theodorescu 2009, Abe et al. 2008) their interaction with effectors or regulators might also 
be controlled by the stabilization of a certain conformational states. 
 
5.3 Perturbation of the Ras-Effector Interaction by Zn2+-
Cyclen and Zn2+-BPA 
31P NMR spectroscopy clearly revealed that metal(II)-cyclen and metal(II)-BPA 
selectively bind to conformational state (1) of active Ras as described in the previous 
paragraph. Conformational state (1) is also known as weak effector-binding state due to its 
reduced affinity towards effector molecules (Spoerner et al. 2001) and hence its 
stabilization by suitable ligands represents a promising approach in the inhibition of  
Ras-Raf signaling. Isothermal calorimetric titration studies showed that the binding affinity 
of Raf-RBD to wild type Ras·Mg2+·GppNHp is decreased in the presence of Zn2+- and  
Cu2+-cyclen, respectively (Rosnizeck et al., accepted).  
In this work it was shown by 31P NMR spectroscopy that both Zn2+-cyclen and Zn2+-BPA, 
respectively are capable of shifting the dynamic equilibrium back towards conformational 
state (1), when Raf-RBD is present. This becomes apparent by the analysis of the peak 
areas in the experiment with Ras(T35S)·Mg2+·GppNHp. In this mutant the resonance 
signals representing state (1) and state (2), respectively are very well separated by 0.5 ppm 
and 0.84 ppm for the α- and the γ-phosphorus resonance allowing the accurate 
determination of the peak areas, which are a direct measure of the population of each state. 
Upon addition of increasing concentrations of Zn2+-cyclen or Zn2+-BPA, respectively an 
increase of the population of conformational state (1) accompanied by the decrease of the 
population of conformational state (2) is observed. Only the signals assigned to 
conformational state (1) shift in the presence of Zn2+-cyclen. The shift directions are 
identical to the ones found for the signals representing the weak effector-binding state in 
the titration of Ras(wt)·Mg2+·GppNHp with Zn2+-cyclen without Raf-RBD being present 
(Spoerner et al. 2005c). Significant shift changes are not observed for the resonances 
representing conformational state (2) as expected since it has been shown that Zn2+-cyclen 
does not bind towards the latter conformation. 
From suitable experiments it was also possible to deduce that the mode of inhibition does 
not proceed via the formation of a heterotrimeric complex consisting of Ras in 
conformational state (1), Raf-RBD and Zn2+-cylen, which was expected since Raf-RBD 
can also bind the weak binding state (Spoerner et al. 2001). Evidence for the separate 
binding of Zn2+-cyclen and Zn2+-BPA is derived from analysis of the line widths of the 
resonances assigned to both conformational states in the experiment with 
Ras(T35S)·Mg2+·GppNHp. The signals representing conformational state (2) are 
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significantly broadened compared to the ones assigned to conformational state (1) during 
the titration with the compounds. This directly reflects the larger mass of Ras in 
conformational state (2) due to its complex with Raf-RBD. If the above described 
heterotrimeric complex was formed also the lines representing the weak effector-binding 
state should be significantly broadened due to this increased molecular mass.  
Additional data supporting the assumed separated binding of Raf-RBD and the compounds 
is given by experiments with the partial loss-of-function mutant 
Ras(T35A)·Mg2+·GppNHp, which stays in conformational state (1) even in the presence of 
Raf-RBD (Spoerner et al. 2001). Upon addition of Zn2+-cyclen to the complex between 
this Ras mutant and Raf-RBD the fractions of Ras in conformational state (1) with  
Raf-RBD and Zn2+-cyclen, respectively are represented by distinct resonances for the  
α- and γ-phosphate group. From the analysis of the line width and the chemical shifts one 
can exclude the formation of a heterotrimeric complex. First, within the whole titration the 
α- and γ-phosphorus resonances reflecting the effector-bound fraction are broadened by a 
factor of about 1.8 compared to the ones representing the Zn2+-cyclen-bound fraction. The 
latter line widths correspond very well with the ones observed for the signals of 
Ras(T35A)·Mg2+·GppNHp in absence of Raf-RBD within the whole titration. Secondly, a 
significant shift can only be observed for the resonances assigned to the Zn2+-cyclen-bound 
fraction. At a molar ratio of Ras:cyclen of 1:24 the resonances of the effector-bound 
fraction can no longer be detected. The signals representing both fractions cannot be 
separated at the magnetic field used for the β-phosphate group. Nevertheless they also 
point out that a formation of a heterotrimeric complex does not occur. A shift of the signal 
is observed with increasing concentrations of Zn2+-cyclen and additionally the line width 
decreases, which directly reflects the decrease of the effector-bound fraction. Again, at the 
endpoint of the titration the β-phosphate resonance appears with a line width comparable 
to free Ras(T35A)·Mg2+·GppNHp. 
From the experiment carried out the other way around, i.e. the displacement of Zn2+-cyclen 
by Raf-RBD the same conclusions can be drawn. Both fractions are again represented by 
two sets of resonances for the α- and γ-phosphate group and only the signals representing 
the Zn2+-cyclen-bound fraction shift. The direction is opposite compared to the 
contrariwise titration as expected and directly reflects the decrease of the Zn2+-cyclen-
bound fraction upon addition of increasing concentrations of Raf-RBD. An increase in 
signal volume of the resonance representing Ras(T35A)·Mg2+·GppNHp complexed to the 
effector is observed, whereas the Zn2+-cyclen-bound fraction decreases as deduced from 
the loss of the corresponding peak areas. Unfortunately the results can only be consulted 
qualitatively due to the observed precipitation of Ras.  
The experiments with Ras(T35A)·Mg2+·GppNHp have not been carried out with Zn2+-BPA 
due to the observed precipitation of Ras in the presence of the compound. However, it is 
very likely that this compound follows the same mode of inhibition. This can already be 
explained by the results obtained in the competitive titration of Ras(T35S)·Mg2+·GppNHp 
with Raf-RBD and Zn2+-BPA, which agree very well with the respective experiment with 
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Zn2+-cyclen, i.e. the increased line width of resonances representing conformational state 
(2) compared to the ones assigned to state (1).  
The 31P NMR data are in good agreement with the results obtained from D. Filchtinski 
using fluorescence titration. In the presence of Raf-RBD the relative fluorescence of the 
Ras mutant Y32C/C118S which the IEDANS fluorophore attached at position 32 increases 
by a factor of 2.5. Upon addition of both Zn2+-cyclen and Zn2+-BPA a decrease in 
fluorescence is observed due to the release of the effector (D. Flichtinski, personal 
communication). 
 
5.4 Peptide Ligands for Ras·Mg2+·GppNHp Derived from the 
Primary Sequence of Raf-RBD 
The small peptide CCAVFRL has been found to inhibit the Ras-Raf-RBD interaction 
(Barnard et al. 1998). It represents the truncated version of a peptide sequence derived 
from the primary sequence of Raf-RBD which is capable of interfering with Ras-Raf-RBD 
association (Barnard et al. 1995). This peptide compromises Raf-RBD residues 95 to 101 
and is located about 15 Å away from the binding interface between Raps and Raf-RBD in 
the crystal structure (Nassar et al. 1996, Zeng et al. 1999). Since the interaction with the 
RBD of RalGDS is also influenced by the peptide it is strongly suggested that its mode of 
action is caused by binding towards Ras (Barnard et al. 1998). In cooperation with  
D. Filchtinski from the group of Prof. Herrmann (Ruhr University Bochum) this peptide 
was studied using ITC, fluorescence titration and  [1H, 15N]-HSQC NMR. Additionally the 
peptide CCFFFRRL, which has been designed by Zeng et al. (2001) using a computational 
combinatorial algorithm was subject to investigations. A KD-value of 12 µM was obtained 
for CCAVFRL by ITC. In competitive titrations with Raf-RBD a KD- value of 6.5 µM and 
3.5 µM was extracted for the peptides CCAVFRL and CCFFFRRL, respectively  
(D. Filchtinski, unpublished results).  
 
Both peptides have been investigated further at our department according to their binding 
sites using [1H, 15N]-HSQC-titrations. Since in the [1H, 15N]-HSQC spectrum of the wild 
type protein not every residue of the switch regions is represented by a cross peak the 
investigations have additionally been carried out with the mutant Ras(T35A). Significant 
chemical shift changes are observed for several residues, which do not clearly reveal one 
distinct binding position in the protein. Two explanations can be suggested. Either the 
small peptides do bind at more than one position in active Ras or large structural changes 
are induced by the binding of the small peptides in the protein, which are reflected by the 
chemical shift perturbations. In each titration the residues most affected are Leu52 and 
Leu53. In the wild type protein also Lys5 is strongly affected by the presence of both 
peptides. These residues are part of the so-called interaction surface in Ras compromising 
residues Lys5-Val8 and Leu52-Asp56, bridging the effector loop and switch II (Zeng and 
Treutlein 1999). In the crystal structure the Raps-Raf-RBD complex Raf residues Lys84 
Chapter 5                                                                                                               Discussion 
 
 
- 120 - 
and Arg89 form salt bridges with Glu33 and Asp38 of the effector loop (Nassar et al 1996). 
Consequently Zeng et al. (2001) extended the Ras binding helix in a computational 
approach for peptide design by taking potential interactions with the effector region, switch 
II and the interaction surface of Ras as a basis yielding the peptide CCFFFRRL among 
others. The relative shift effect on residues of the interaction surface is stronger in both 
mutants when CCFFFRRL is present. Barnard et al. (1998) could show that the 
replacement of the arginine in CCAVFRL against a hydrophobic residue strongly enhances 
the inhibitory effect. In the CCFFFRRL this position is occupied by a phenylalanine. They 
also showed that mutations of residues 98-100 (with respect to the primary sequence of 
Raf-RBD) are tolerated. Obviously the introduced phenylalanine strongly contributes to 
the interaction with Leu53 in Ras since the absolute effect for this residue is stronger in the 
presence of CCFFFRRL compared to CCAVFRL.  
 
The incorporation of a paramagnetic label in the peptide might ease the identification of 
the exact binding position(s) of the peptide. Detailed analysis of the peptide by Barnard et 
al. (1998) exclude a direct participation of the thiol groups of both cysteine residues for the 
interaction, even though they are indispensable for the inhibitory effect of the peptide. 
However a covalently attached label might largely influence the interaction pattern of such 
a small peptide and thus the incorporation of a paramagnetic module into the peptide 
sequence represents are more promising approach. Several unnatural amino acids carrying 
a nitroxide paramagnetic moiety, which can be readily used in the solid phase synthesis of 
the peptide are reported in literature (Toniolo et al. 1998, Tominga et al. 2001, Balog et al. 
2003, Lindfors et al. 2008). The major drawback of these labels is the need of their 
synthesis. Carboxy-PROXYL in contrast is commercially available, but can only be 
attached at the N-terminal end of the peptide due to the lack of an amine group. Since this 
does not limit our application the latter compound might be appropriate for the desired 
investigations concerning the binding position of CCAVFRL in active Ras. Figure 5.2 
shows the designed paramagnetic labelled peptide. 
 
Another question remaining is, whether the peptide sequence is also in binding contact 
with Ras, when part of the effector. To date no crystal structure is available for the Ras-
Raf-RBD complex. A widely accepted model is given by the Raps-Raf-RBD complex 
(Nassar et al. 1996). The sequence homology within the effector region forming an 
intermolecular β-sheet with Raf β2 is 95% with Ras. However, the overall sequence 
homology is only 50% and additional contributions from other parts in Ras for the 
interaction with Raf-RBD can not be excluded. Mutations in the switch II regions of Ras, 
e.g. D57A and A59T have been found to abolish the interaction with Raf-RBD  
(Shirouzo et al. 1994). These residues are close to the interaction surface of Ras. 
Additionally the so-called cysteine rich region of Raf-RBD requires an intact switch II 
region for its binding activity (Drugan et al. 1996). Recently Stieglitz et al. (2008) solved 
the crystal structure of Ras and the RBD of the Ras effector NORE 1. Strong hydrophobic 
interaction between an N-terminal extension of the RBD and Ras switch II are necessary 
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for the association. Information about a possible contact of the region in Raf containing the 
peptide sequence CCAVFRL can for example be obtained by introducing a paramagnetic 
label into Raf-RBD at one of the cysteine residues. Mutagenesis analysis showed that free 
SH- groups of the cysteine residues in the peptides are not necessary for the inhibitory 
effect (Barnard et al. 1998) and consequently a covalently attached label might not disturb 
the interaction, when part of the complete RBD. Likewise alanine scanning within Raf 
residues 95 to 101 represents an alternative. If this sequence is contributing to the 
interaction with Ras the overall affinity should drop, when certain residues are mutated to 
alanine. 
 
 
 
 
Figure 5.2: The small peptide CCAVFRL with a paramagnetic label covalently attached to the N-
terminus. 
 
5.5 High Pressure NMR Spectroscopy on Wild Type Ras 
Complexed to Mg2+·GppNHp 
The active wild type Ras protein complexed to Mg2+·GppNHp exists in at least two distinct 
conformational states as sensed by different chemical shifts for the α- and γ-phosphorus 
resonance of the bound nucleotide in 31P NMR spectroscopy (Geyer et al. 1996, Spoerner 
et al. 2005a). Both conformations are in dynamic equilibrium with exchange rates in the 
millisecond time scale at room temperature. As described in section 1.1.5.2 state (2) 
becomes stabilized by the interaction with the Ras binding domains of Ras effectors, such 
as Raf-RBD. State (1) represents a conformation, which is recognized by guanine 
nucleotide exchange factors, such as SOS (Kalbitzer et al. 2009).  
High pressure NMR spectroscopy represents a powerful tool for the investigation of 
conformational processes in biomolecules at atomic resolution (Akasaka 2006,  
Kremer 2006). In general conformations with a smaller specific volume become stabilized 
when high pressure is applied to the protein sample. The structure of the Ras-SOS complex 
reveals a more opened switch I region in Ras and thus a smaller specific volume of the 
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protein (Boriack-Sjodin et al. 1998). 31P NMR investigations on Ras(wt)·Mg2+·GppNHp 
show that conformational state (1) of Ras indeed becomes stabilized at higher pressures 
giving a difference in the specific volume ∆V0 between state (2) and state (1) of  
-17.2 mL mol-1 (Kalbitzer et al. 2009). Since state (1) also represents an interesting target 
for drugs interfering with aberrant Ras signaling (see section 1.1.6.4) knowledge of the 
residues involved in the transition from conformational state (2) to state (1) can aid 
structure-based inhibitor design. When looking at the functional cycle of Ras as shown in 
Figure 1.1 (section 1.1.1) one can deduce that Ras necessarily requires at least one other 
conformational state, which is recognized by GTPase activating proteins. 
For these reasons the pressure response of Ras(wt)·Mg2+·GppNHp was investigated using 
[1H, 15N]-HSQC spectroscopy. Pressure series have been recorded at 278 K and 303 K 
from 3 MPa to 200 MPa and 180 MPa, respectively. Both the changes in the chemical 
shifts induced by pressure as well as the signal intensities of the cross peaks have been 
subject to evaluation. In Ras(wt)·Mg2+·GppNHp large parts of both switch regions and the 
P loop are not represented by cross peaks in the corresponding [1H, 15N]-HSQC spectrum. 
At 278 K and a pressure of 200 MPa new cross peaks appear in the spectrum, namely 
Gly10, Gly12 and Gly13, which are all part of the phosphate binding loop. It is likely that 
these residues sense the same transition as the phosphate groups do in the corresponding 
31P NMR pressure studies (Kalbitzer et al. 2009). Unfortunately these peaks only become 
detectable, when collecting a respective number of scans. Since only the reference 
spectrum and the one at the highest pressure applied have been repeated with more scans 
per increment quantification of the effect is not possible.  
Due to the poor signal to noise ratio yielded in the pressure series performed at 278 K only 
the effect on the chemical shifts was followed quantitatively. In the experiments carried out 
at 303 K with more scans/FID and a higher concentrated protein sample the pressure 
response of the signal intensities cannot give information about the transition from the 
strong effector-binding state (2) to the weak effector-binding state (1). At 303 K the 
exchange rate between conformational state (2) and (1) is 1800 s-1 (Spoerner et al. 2005a) 
and consequently the exchange between the two conformations is always fast compared to 
the NMR time scale, when recorded at that temperature and at a spectrometer operating at 
800 MHz proton frequency. Information about the transition from conformational state (2) 
to (1) as described was only derived by the evaluation of the chemical shift data. The 
signal intensities from the data at 278 K, could not be evaluated due to the poor signal to 
noise ratio. 
The chemical shift data could be evaluated by the use of the results reported by Kalbitzer et 
al. (2009) from the 31P NMR pressure series. Amino acids Val14, Leu19, Gln25, Asn26, 
Val45,  Cys51, Ala66, Ser89, His94, Tyr96, Lys117, Val125, Ala130, Leu133, Gly138, Ile139, Glu153 
have been identified to sense the transition from the state (2) to state (1). These residues 
are in close proximity of the active centre of Ras as depicted in Figure 4.56  
(see section 4.8.2). Val14 for example is part of the so-called phosphate binding loop and in 
the neighbourhood of Gly12. Mutating the latter residue to valine gives an oncogenic 
mutant, which has lost the ability to be switched off either intrinsically or by GAPs.  
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31P NMR spectroscopy also reveals that the dynamic equilibrium between state (2) and 
state (1) is directly influenced by this mutation with slight preference of state (1) over state 
(2) (Spoerner et al. 2005a). Lys117 plays a crucial role in the stabilization of nucleotide 
binding (Pai et al. 1990). Unfortunately, as already mentioned residues from both switch 
regions, which are expected to undergo large structural changes during that process do not 
give cross peak signals in the [1H, 15N]-HSQC spectrum of the wild type protein. 
From the chemical shift data a second transition (C(1) to C(3)), which compromises a 
difference in the specific volume ∆V0 of -36 ± 9 mL mol-1 and in the molar free energy 
∆G0 of 3.9 ± 0.8 kJ mol-1 could be identified compromising residues Gly77, Asn85, Asn86, 
Val112, Gly115, Asn116,  Arg123, Thr124, Asp132, Gln165, His166. Out of the analysis of the peak 
intensities additional residues can be found, which are involved in this transition. The 
obtained values for ∆G0 of 4.4 ± 0.6 of kJ mol-1 and for ∆V0 of -48.4 ± 3.3 mL mol-1 agree 
very well within the range of error with the ones obtained by analysis of the chemical shift 
data. Plotting the chemical shifts and the intensities against the applied pressure also gives 
a comparable curve describing a two-state transition. For the latter transition as well as for 
the transition from state (2) to state (1) the equilibrium is not completely in favour of one 
of these states neither at ambient pressure nor at 200 and 180 MPa, respectively. 
Interestingly, several residues, namely Leu19, Val45, Cys51, Ser89, Lys117, Val125, Ala130, 
Leu133 and Glu153 could be identified to sense both transitions as derived from the pressure-
dependence of their chemical shifts. Using the values obtained for the two above described 
transitions enables the fit of these data describing a conformational exchange between 
three conformations. They are located in between the residues sensing either the transition 
from C(1) to C(2) or C(3), respectively.  
Analysis of the peak intensities reveals a third transition (C(1) to C(4)), which differs from 
the one described above. This is already clear when looking at the pressure response 
qualitatively. At ambient pressure one main conformation is clearly sensed by the residues. 
At a pressure of 180 MPa the equilibrium is equally populated by the original 
conformation and the one stabilized by high pressure. A large number of residues sense 
this transition. They are again involved in key interaction patterns of Ras and part of 
important structural motifs. The transition is characterized by a change in the molar 
volume ∆V0 of -43.7 ± 8.4 mL mol-1, which corresponds with the value obtained for the 
transition from C(1) to C(3) within the range of error. However, when looking at the molar 
free energy ∆G0 of 8.6 ± 1.8 of kJ mol-1 describing this transition it is obvious that one 
talks of two different processes. Keeping the functional cycle of Ras in mind one of the 
conformations stabilized at higher pressure is likely to be recognized by GAPs. The GAP 
mechanism involves a transition state, which becomes stabilized by a so-called arginine 
finger provided by GAP (Scheffzek et al. 1997). Consequently there should exist two 
different GAP-binding conformations. Assuming that the molar volumes of these 
conformations should not differ largely the conformations C(3) and C(4) stabilized under 
high pressure might represent two different GAP binding conformations.  
Finally a group of residues exhibiting a completely different pressure response have been 
identified. Unfortunately, quantitative description of their pressure response is not possible 
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accurately for the reasons described in section 4.8.3. The main question remaining is 
whether these residues sense a process, which is slow or fast on the NMR time scale, 
which would in principle both be possible. Adequate data regarding the peak volume and 
the line widths of these residues would give more information. In general two different 
explanations can be given for their pressure response. If the transition sensed is slow on the 
NMR time scale there is already an equilibrium between two conformational states at 
ambient pressure. In this case the line width should not be influenced significantly by the 
applied pressure, but only the peak volume reflecting a change of the populations. This can 
in turn be observed by a loss in signal intensity and the data can be fitted by Equation 3.13 
describing a two-state transition in the slow exchange regime. Likewise the volume of the 
peak does not change significantly but the lines get broadened. This is the case, when the 
exchange is fast on the NMR time scale. As described in section 4.8.3 maximum line 
broadening is expected when both conformations are equally populated. This gives a 
completely different interpretation of the curve observed for these residues. At ambient 
pressure one certain conformation is represented. The lines get broadened until both 
conformations are populated equally and would than get smaller again. In this case 
qualitatively the same pressure dependence is observed as in the transition from 
conformation C(1) to conformation C(4).  
High pressure NMR spectroscopy is also used for the study of protein folding and 
unfolding. At higher pressures the unfolded state of a protein is preferred due to its smaller 
specific volume compared to the folded structure. Likewise folding intermediates or local 
unfolding processes can be detected (Kachel et al. 2006, Inoue et al. 2000). In principle 
each of the transitions described above could also reflect local unfolding of these residues. 
Unfolded protein parts resemble a random-coil structure and give cross peak signals at a 
characteristic chemical shift region of the [1H, 15N]-HSQC spectrum, namely between 7.9 
and 8.6 ppm for 1H and 120 - 128 ppm for 15N. Taking a closer look at the overlay of the 
reference spectrum and the spectrum recorded with the highest pressure in the series one 
cannot find new cross peaks appearing in this region. This is true for the pressure series at 
both temperatures. Since the pressure induced loss in signal intensity for the single residues 
is at least 50% independently from the subgroup according the pressure response these 
residues should be visible. Many of the residues involved in the single transitions observed 
are located in close proximity to the bound nucleotide and the switch regions. If local 
unfolding processes would be the case in these regions one would expect the release of the 
nucleotide. This was not observed in the 31P NMR pressure series (Kalbitzer et al. 2009) 
and is thus also not likely to happen here. 
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6 SUMMARY 
The small guanine nucleotide binding protein Ras is essentially involved in the regulation 
of cell proliferation, differentiation and apoptosis. Alternating between an inactive GDP 
and an active GTP-bound form, Ras acts as molecular switch, whereby two classes of 
regulatory proteins determine the lifetime of these two states: guanine nucleotide exchange 
factors (GEFs) and GTPase activating proteins (GAPs). In about 30% of all human tumors 
Ras exhibits point mutations at either position 12, 13 or 61. These mutants are insensitive 
to GAP activation and are therefore locked in the active GTP-bound form, which 
contributes to tumor formation. Ras is part of a complex signaling network, which requires 
the coexistence of multiple functional states allowing for the fast transition into a certain 
conformation. 31P NMR spectroscopy using the bound nucleotide as probe reveals the 
dynamic equilibrium between at least two distinct conformational substates in active Ras, 
namely state (1) and state (2), which interconvert in the millisecond timescale. State (2) 
becomes stabilized by binding of effectors like Raf kinase. State (1) is recognized by 
guanine nucleotide exchange factors and shows a drastically reduced affinity towards 
effectors. The relative population of the two states is directly influenced by mutations in 
Ras and the nature of the bound nucleotide. Chaotropic compounds, high pressure and 
metal(II)-cyclens shift the dynamic equilibrium towards conformational state (1). Since 
oncogenic Ras is a key player in human malignancies the selective stabilization of 
conformational state (1) by suitable ligands, such as metal(II)-cyclens represents a 
promising approach for the inhibition of aberrant Ras signaling.  
 
Two binding positions could be identified in Ras(T35A)·Mg2+·GppNHp for metal(II)-
cyclen. One binding site centres between loop L7 and the C-terminal part of the protein. 
The second binding site responsible for the stabilization of conformational state (1) is 
located in close proximity of the γ-phosphate group of the bound nucleotide. In this work a 
promising second alternative lead structure for the inhibition of Ras signalling was 
identified. By saturation transfer difference spectroscopy metal(II)-bis(2-picolyl)amine 
(short: metal(II)-BPA) was identified as Ras ligand. Its binding affinity to 
Ras(T35A)·Mg2+·GppNHp was determined to be 2.07 ± 0.25 mM. The compound 
selectively recognizes the weak effector-binding state in active Ras as revealed by 31P 
NMR spectroscopy. Combining paramagnetic relaxation enhancement (PRE) and chemical 
shift perturbation (CSP) mapping two binding sites were identified for this lead structure. 
One binding site is located around loop L7 and the C-terminal end and is also found for the 
metal(II)-cyclens. In contrary, the second binding site differs for the two compound classes 
even though they share the same stabilizing effect regarding conformational state (1) of 
Ras. It is located in the PM3 motif around residues Leu53 to Thr58. In this work it was 
shown that both compound classes differ in their stabilizing efficacy for state (1) in the 
oncogenic mutant Ras(G12V)·Mg2+·GppNHp. The observed effect is stronger for the novel 
ligand metal(II)-BPA, most probably due to its different binding site responsible for 
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stabilization of conformational state (1). This is not influenced sterically by mutations of 
residues such as Gly12 around the bound nucleotide.  
In order to increase both the affinity and the selectivity of metal(II)-cyclen and metal(II)-
BPA for state (1) bivalent ligands have been designed. They consist of a peptide derived 
from the primary sequence of the guanine nucleotide exchange factor SOS and a metal(II)-
chelate moiety. The first hybride ligands did not give the desired results most probably 
because the linker was not chosen appropriately according to its length. However, the 
ligands are synthetically accessible and can be further improved.  
In this work the impact of Zn2+-cyclen and Zn2+-BPA on the Ras-effector interaction was 
studied. Both compounds are capable of replacing Raf-RBD from its complex with 
conformational state (2) of active Ras, which can be attributed to the stabilization of state 
(1) and an associated shift of the equilibrium towards this state. Interestingly 31P NMR 
displacement experiments with suitable Ras mutants reveal at least for Zn2+-cyclen that 
also the binding of the effector towards Ras in state (1) is influenced by the compound. 
Zn2+-cyclen and Raf-RBD cannot bind simultaneously to Ras in conformation (1). 
Additionally to its stabilizing effect regarding conformational state (1) Zn2+-cyclen also 
behaves as an allosteric inhibitor for the binding of Raf-RBD to state (1) since its binding 
site is not located in the interaction surface of Ras for Raf-RBD.  
Additionally peptides directly derived or modified from the primary sequence of Raf-RBD 
have been investigated. They are known to interfere with the Ras-Raf-RBD interaction but 
their binding position was left to be unclear and thus chemical shift perturbation mapping 
was applied in this work with both the active wild type protein and the mutant Ras(T35A). 
The largest chemical shift changes are observed for residues Leu52, Leu53 and Asp54 at the 
PM3 motif strongly indicating the binding of the peptides at this position. However, also 
amino acids elsewhere in the protein are influenced by the addition of the peptides. The 
explanation can be the existence of more than one binding site or a strong structural change 
induced by binding of the peptides at the PM3 motif. The incorporation of a paramagnetic 
labelled amino acid into the sequence of the peptide can give detailed information of the 
binding site by use of paramagnetic relaxation enhancement studies. 
As already mentioned the dynamic equilibrium of active Ras can also be modulated by the 
application of pressure in favour of state (1) as studied by 31P NMR spectroscopy. Within 
this work the influence of pressure on Ras(wt)·Mg2+·GppNHp was investigated at atomic 
resolution by [1H, 15N]-HSQC spectroscopy. Chemical shift analysis of the data obtained 
from pressure series carried out at 278 K and 303 K enabled the identification of residues 
involved in the transition from conformational state (2) to state (1), namely Val9, Val14, 
Leu19, Gln25, Asn26, Val45, Cys51, Ala66, Ser89, His94, Tyr96, Lys117, Val125, Ala130, Leu133, 
Gly138, Ile139, Glu153 which are either directly or indirectly involved in binding of the 
nucleotide or part of the switch regions. At least two further transitions can be derived 
from analysis of the pressure response of both the chemical shifts and the signal intensities. 
For one of the transitions the values derived for ∆G0 are 3.9 ± 0.8 kJ mol-1 and  
4.4 ± 0.6 kJ mol-1 and the difference in the specific volume ∆V0 between the two 
conformations involved in the process is -36.0 ± 9.0 mL mol-1 and -48.4 ± 3.30 mL mol-1 
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as determined from analysis of the chemical shifts and the signal intensities, respectively. 
The other process does not involve a significantly different change in the specific volume, 
which has been determined to be -43.7 ± 8.4 mL mol-1, but is described by a different 
molar free energy of 8.6 ± 1.8 kJ mol-1. It is likely that one of the processes describes the 
stabilization of the GAP-binding conformation at higher pressure, which has not been 
detected so far. Conformational states of Ras, which are not visible under ambient pressure 
become stabilized at high pressure. These states are of special interest for example in the 
above described approach for the inhibition of Ras signaling. Calculating the structure of 
these states from NMR data obtained at higher pressure might offer novel opportunities in 
structure-based drug design. Comparison with the pressure response of different Ras 
mutants, such as T35A or T35S might allow to interpret and discriminate the data obtained 
from the investigations on Ras(wt)·Mg2+·GppNHp more easily.  
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8 APPENDIX 
8.1 List of Abbreviations 
aa   amino acid: alanine (Ala, A), arginine (Arg, R), aspartate (Asp, D), 
asparagine (Asn, N), cysteine (Cys, C), glutamic acid (Glu, E), glutamine 
(Gln, Q), glycine (Gly, G), histidine (His, H), isoleucine (Ile, I), leucine 
(Leu, L), lysine (Lys, K), methionine (Met, M), phenylalanine (Phe, F), 
proline (Pro, P), serine (Ser, S), threonine (Thr, T), tryptophane (Trp, W), 
tyrosine (Tyr, Y), valine (Val, V) 
BSA   bovine serum albumine 
c'  C-terminal truncated 
CSP  chemical shift perturbation 
DNAse desoxyribonuclease 
DSS  3-(trimethylsilyl)-1-propanesulfonic acid 
DTE  1,4-Dithioerythritol 
EDTA  ethylenediaminetetraacetic acid 
fl  full length 
GAP  GTPase activating protein 
GDP  guanosine 5′-diphosphate 
GEF  guanine nucleotide exchange factor 
GppCH2p guanosin-5`-(β,γ-methyleno)triphosphat 
GppNHp guanosine-5′-(β,γ-imido)triphosphate  
GST    gluthation-S-transferase 
GTP  guanosine-5′-triphosphate  
GTPγS guanosine-5`-O-(3-thiotriphosphate) 
HEPES    4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid 
HPLC  high perfomance liquid chromatography 
HQSC  heteronuclear single quantum coherence 
ITC  isothermal titration calorimetry 
IPTG  isopropyl β-D-1-thiogalactopyranoside 
K  Kelvin 
kDa  kilo Dalton 
Tris  2-amino-2-(hydroxymethyl)-1,3-propanediol 
NMR  nuclear magnetic resonance 
OD600  optical density at 600 nm 
PAGE  polyacrylamide gel electrophoresis 
Pi  inorganic phosphate 
PI(3)K   phosphinositol(3)kinase 
PMSF  phenylmethanesulfonyl fluoride 
ppm  parts per million 
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PRE  paramagnetic relation enhancement 
RBD  Ras binding domain 
rpm  rounds per minute 
SDS  sodium dodecyl sulfate 
STD  saturation transfer difference 
TROSY transverse relaxation optimized spectroscopy 
U  Unit 
wt  wild type 
δ  chemical shift 
ε  extinction coefficient 
λ  wave length 
 
8.2 Experimental Data 
Chemical Shifts of the Cross Peaks Assignable in the [1H, 15N]-TROSY HSQC 
Spectrum of c'Ras(T35A)·Mg2+·GppNHp at pH 7.4 and 293 K. 
 
residue 
number 
amino 
acid 
δ
 
1H 
[ppm] 
δ
 
15N 
[ppm] 
residue 
number 
amino 
acid 
δ
 
1H 
[ppm] 
δ
 
15N 
[ppm] 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
31 
32 
33 
35 
36 
37 
38 
39 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
GLU 
CYS 
ASP 
ALA 
ILE 
GLU 
ASP 
SER 
125.368 
127.438 
122.555 
124.274 
126.813 
122.672 
129.548 
121.11 
108.687 
122.477 
107.046 
114.078 
112.984 
108.765 
124.43 
120.602 
125.993 
121.305 
117.672 
121.5 
121.539 
120.875 
114.859 
116.812 
117.32 
113.101 
123.063 
126.462 
119.039 
122.555 
126.383 
119.547 
124.704 
122.75 
121.422 
114.117 
8.804 
8.278 
8.633 
8.933 
9.063 
7.985 
8.599 
8.988 
7.282 
8.913 
8.653 
8.742 
7.309 
8.237 
8.974 
9.404 
8.974 
8.708 
7.377 
8.783 
7.971 
7.609 
8.012 
8.783 
7.855 
6.681 
8.155 
7.582 
7.862 
8.019 
7.964 
7.78 
8.155 
8.06 
7.971 
7.684 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
MET 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
117.75 
119.899 
125.172 
124.938 
115.015 
125.407 
122.438 
118.141 
121.422 
118.062 
116.89 
120.094 
119.625 
117.945 
120.953 
120.953 
118.023 
118.766 
119.156 
116.812 
121.696 
109.859 
122.907 
121.852 
123.532 
123.61 
118.609 
129.509 
128.923 
115.289 
121.852 
112.867 
114.859 
118.141 
121.656 
123.454 
7.759 
7.807 
9.152 
8.353 
7.848 
7.288 
8.333 
8.367 
7.432 
7.671 
7.377 
7.479 
8.285 
7.93 
7.752 
7.752 
7.691 
7.643 
8.183 
8.005 
7.8 
7.432 
8.258 
8.285 
7.602 
8.162 
8.005 
8.804 
9.049 
7.896 
8.64 
7.227 
8.647 
8.469 
7.677 
8.046 
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40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
123.375 
121.461 
123.454 
129.821 
121.735 
121.852 
126.735 
131.775 
103.842 
123.18 
127.126 
124.821 
122.711 
124.743 
126.423 
124.743 
130.681 
126.423 
114.156 
123.141 
111.929 
120.485 
122.516 
121.539 
121.93 
120.133 
128.063 
117.633 
121.031 
119.352 
118.727 
119.195 
119.82 
117.633 
109.312 
108.999 
122.086 
101.967 
122.164 
126.813 
125.133 
126.813 
124.665 
121.813 
113.96 
8.892 
8.21 
8.585 
8.81 
8.981 
7.998 
8.066 
9.527 
8.244 
7.575 
8.838 
9.363 
8.626 
9.049 
8.626 
9.084 
8.865 
8.626 
7.22 
8.326 
9.254 
8.162 
8.681 
8.319 
8.237 
7.766 
8.647 
7.896 
7.534 
7.971 
7.677 
7.985 
8.203 
7.896 
7.602 
7.712 
8.77 
7.07 
8.087 
9.063 
8.599 
8.906 
9.179 
8.572 
8.353 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
122.555 
121.031 
115.172 
125.29 
127.79 
122.516 
118.648 
117.515 
124.352 
118.844 
120.875 
124.391 
122.555 
119.117 
118.609 
120.836 
111.734 
114.078 
120.719 
130.87601 
125.485 
113.257 
113.179 
133.064 
116.5 
106.929 
118.844 
125.016 
115.914 
121.422 
117.633 
117.281 
124.821 
113.335 
120.133 
117.75 
122.438 
119.859 
119.859 
118.805 
122.789 
119.508 
116.265 
126.266 
7.616 
7.889 
9.043 
7.5 
8.626 
9.322 
8.578 
6.66 
6.886 
8.496 
8.101 
7.363 
8.312 
8.326 
7.814 
7.486 
8.196 
7.964 
8.176 
8.367 
7.732 
8.694 
8.674 
8.988 
6.858 
7.596 
7.698 
7.698 
8.831 
6.974 
8.155 
8.08 
8.51 
7.131 
9.466 
8.435 
7.131 
7.391 
7.93 
8.08 
8.039 
8.305 
7.527 
7.561 
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pKa-values Obtained for Single Residues in c'Ras(T35A)·Mg2+·GppNHp from a 
Titration in the pH Range of 5.5 to 7.5 Determined from the Chemical Shifts of 1H 
and 15N, respectively. 
 
residue 
number 
amino 
acid pKa 
1H error pKa 15N error 
2 
3 
4 
7 
8 
9 
10 
12 
13 
14 
17 
18 
22 
25 
27 
28 
29 
32 
35 
38 
39 
40 
46 
52 
55 
70 
72 
74 
76 
77 
78 
92 
93 
94 
95 
106 
108 
116 
117 
162 
166 
Thr 
Glu 
Tyr 
Val 
Val 
Val 
Gly 
Gly 
Gly 
Val 
Ser 
Ala 
Gln 
Gln 
His 
Phe 
Val 
Tyr 
Ala 
Asp 
Ser 
Tyr 
Ile 
Leu 
Ile 
Gln 
-- 
Thr 
Gly 
Gly 
Phe 
Asp 
Ile 
His 
Gln 
Ser 
Asp 
Asn 
Lys 
Glu 
His 
7.33 
-- 
-- 
6.82 
-- 
-- 
-- 
4.92 
-- 
-- 
-- 
6.75 
6.46 
5.72 
5.67 
6.88 
6.72 
6.21 
-- 
6.5 
-- 
5.54 
6.47 
7.09 
5.91 
6.65 
6.32 
-- 
-- 
-- 
6.88 
4.97 
6.51 
6.05 
5.67 
5.48 
7.19 
-- 
-- 
4.31 
-- 
0.28 
-- 
-- 
0.71 
-- 
-- 
-- 
1.26 
-- 
-- 
-- 
0.13 
0.54 
0.25 
0.36 
0.16 
0.1 
0.03 
-- 
0.02 
-- 
0.14 
0.19 
1.66 
0.33 
0.13 
0.08 
-- 
-- 
-- 
0.16 
0.1 
0.16 
0.03 
0.09 
0.15 
0.39 
-- 
-- 
1.1 
-- 
6.59 
5.97 
6.03 
4.66 
5.69 
5.24 
5.1 
5.4 
5.74 
6.36 
6.43 
5.92 
-- 
6.81 
6.76 
6.48 
6.72 
7.05 
6.72 
6.2 
5.98 
6.23 
6.69 
5.23 
6.3 
5 
5.55 
5.29 
5.21 
6.16 
-- 
5.72 
5.94 
6.05 
6.03 
6.28 
7.47 
7.11 
7.07 
-- 
6.93 
0.18 
0.11 
0.24 
1.29 
0.14 
0.1 
0.48 
0.17 
0.08 
0.24 
0.16 
0.1 
-- 
0.09 
0.08 
0.11 
0.1 
0.25 
0.07 
0.17 
0.13 
0.06 
0.07 
0.09 
0.22 
0.16 
-- 
0.02 
0.09 
0.21 
-- 
0.03 
0.04 
0.05 
0.04 
0.08 
0.49 
0.37 
0.23 
-- 
0.12 
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Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(T35A)·Mg2+·GppNHp between pH 5.5 and 7.5 at 293 K. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
ALA 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.118 
0.121 
0.034 
0.012 
- 
0.01 
0.061 
0.044 
0.022 
0.048 
0.026 
0.052 
0.025 
0.012 
0.035 
0.03 
0.081 
0.017 
0.012 
0.012 
0.026 
0.007 
0.04 
0.102 
0.043 
0.283 
0.31 
0.107 
- 
0.036 
0.06 
0.03 
- 
0.057 
0.027 
0.035 
0.1 
0.145 
0.084 
0.082 
0.04 
0.02 
0.04 
0.019 
0.116 
0.036 
0.018 
0.003 
0.017 
0.017 
0.146 
- 
0.223 
0.064 
0.022 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
- 
0.037 
0.063 
0.067 
0.037 
0.041 
0.03 
0.025 
0.047 
0.072 
0.008 
0.019 
0.014 
0.062 
0.088 
0.085 
- 
0.035 
0.016 
0.102 
0.027 
0.035 
0.047 
0.044 
0.011 
0.017 
0.025 
0.017 
0.091 
0.018 
0.178 
0.008 
0.003 
0.048 
0.042 
0.156 
0.117 
0.491 
0.334 
0.043 
0.237 
- 
0.009 
- 
0.102 
0.013 
0.06 
0.019 
0.039 
0.087 
0.072 
0.042 
0.039 
- 
0.082 
 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.051 
0.018 
0.03 
0.022 
0.018 
0.036 
0.017 
0.021 
0.018 
0.013 
0.024 
0.031 
0.013 
0.017 
0.042 
0.025 
0.024 
0.019 
0.037 
0.019 
0.049 
0.043 
0.03 
0.002 
0.036 
0.048 
0.046 
0.045 
- 
0.016 
0.021 
0.019 
0.043 
0.014 
0.003 
0.056 
0.017 
0.019 
0.02 
0.022 
0.025 
0.025 
0.02 
0.063 
0.044 
0.016 
0.054 
0.1 
0.116 
0.023 
0.115 
0.035 
0.03 
0.031 
0.124 
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- 148 - 
Combined Chemical Shift Differences Observed between the [1H, 15N]-TROSY-
HSQC Spectra of c`Ras(T35A) and c'Ras(T35S) Complexed to Mg2+·GppNHp.  
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
ALA/SER 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.017 
0.034 
0.008 
0.056 
0.012 
0.007 
0.053 
0.014 
0.006 
0.009 
0.033 
0.031 
0.004 
0.006 
0.029 
0.005 
0.013 
0.015 
0.01 
0.029 
0.018 
0.013 
0.01 
0.009 
0.009 
0.012 
0.023 
0.031 
- 
0.07 
0.08 
0.231 
- 
0.772 
0.504 
0.016 
0.09 
0.114 
0.031 
0.051 
0.015 
0.005 
0.011 
0.012 
0.042 
0.002 
0.002 
0.009 
0.003 
0.002 
0.074 
0.038 
0.081 
0.005 
0.024 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
0.081 
0.029 
0.062 
0.051 
0.005 
0.064 
0.038 
0.036 
0.02 
0.056 
0.027 
0.029 
0.029 
0.043 
0.048 
0.062 
0.017 
0.022 
0.004 
0.027 
0.004 
0.024 
0.036 
0.019 
0.004 
0.005 
0.002 
0.003 
0.002 
0.002 
0.003 
0.003 
0.006 
0.012 
0.017 
0.053 
0.028 
0.107 
0.059 
0.016 
0.04 
0.022 
0.006 
0.008 
0.02 
0.006 
0.024 
0.005 
0.029 
0.017 
0.025 
0.013 
0.01 
- 
0.036 
 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.051 
0.004 
0.011 
0.011 
0.001 
0.002 
0.005 
0.008 
0.004 
0.002 
0.001 
0.001 
0.002 
0.002 
0.01 
0.002 
0.003 
0.003 
0.004 
0.003 
0.009 
0.005 
0.007 
0.002 
0.011 
0.011 
0.006 
0.004 
- 
0.011 
0.011 
0.011 
0.011 
0.013 
0.007 
0.01 
0.003 
0.02 
0.009 
0.008 
0.006 
0.012 
0.014 
0.024 
0.024 
0.013 
0.022 
0.049 
0.019 
0.028 
0.059 
0.011 
0.022 
0.02 
0.023 
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- 149 - 
Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(T35A)·Mg2+·GppNHp upon Addition of a 15-fold Excess of  
Zn2+-Cyclen. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
ALA 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.011 
0.017 
0.009 
0.006 
0.021 
0.041 
0.029 
0.026 
0.01 
0.033 
0.01 
0.103 
0.014 
0.02 
0.054 
0.044 
0.016 
0.03 
0.01 
0.044 
0.016 
0.041 
0.039 
0.07 
0.097 
- 
- 
- 
- 
0.078 
- 
0.01 
- 
0.108 
0.159 
0.021 
0.119 
0.091 
0.067 
0.044 
0.005 
0.006 
0.004 
0.013 
0.143 
0.038 
0.005 
0.012 
- 
0.014 
0.015 
0.016 
0.015 
0.029 
0.029 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
0.015 
0.049 
0.108 
0.098 
0.05 
0.038 
0.063 
0.072 
- 
- 
0.011 
0.05 
0.043 
0.016 
0.041 
- 
0.016 
0.031 
0.019 
0.012 
0.01 
0.005 
0.021 
0.01 
0.004 
- 
0.011 
0.01 
- 
0.005 
- 
0.017 
0.05 
0.028 
0.05 
0.068 
0.065 
0.019 
0.18 
0.027 
- 
0.045 
0.027 
0.034 
0.005 
0.031 
0.013 
0.042 
0.081 
0.027 
- 
0.106 
0.032 
- 
0.093 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.038 
0.015 
0.009 
0.02 
0.034 
0.01 
0.01 
0.005 
0.005 
0.01 
0.016 
0.032 
0.011 
- 
0.005 
0.016 
0.011 
- 
0.011 
0.005 
0.011 
0.01 
0.006 
0.011 
0.011 
0.027 
0.014 
0.083 
- 
0.018 
0.009 
0.023 
0.015 
0.016 
0.028 
0.071 
0.019 
0.011 
0.012 
- 
0.009 
0.005 
0.011 
0.011 
0.005 
0.014 
0.01 
0.02 
0.008 
0.022 
0.06 
0.157 
- 
0.028 
0.113 
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- 150 - 
Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(T35A)·Mg2+·GppNHp upon Addition of a 8-fold Excess of  
Zn2+-BPA. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
ALA 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
- 
0.079 
- 
0.051 
0.022 
- 
0.035 
0.016 
0.018 
0.012 
0.022 
0.001 
0.009 
0.022 
0.009 
0.045 
0.071 
0.032 
0.047 
0.027 
0.04 
0.027 
0.022 
0.115 
0.034 
0.035 
0.122 
- 
- 
0.128 
0.026 
0.017 
- 
0.044 
0.041 
- 
0.134 
0.099 
0.195 
0.046 
0.02 
0.034 
0.01 
0.004 
- 
- 
0.008 
0.142 
- 
0.03 
0.111 
- 
0.074 
0.023 
- 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
- 
0.044 
0.049 
0.03 
0.029 
0.042 
0.04 
0.011 
- 
0.002 
- 
0.017 
0.027 
- 
0.014 
- 
0.056 
0.022 
0.067 
0.038 
0.029 
0.027 
- 
0.017 
0.01 
0.012 
0.003 
0.007 
0.01 
0.005 
- 
0.014 
0.034 
- 
0.054 
0.031 
0.039 
0.03 
0.069 
0.11 
- 
0.059 
0.02 
- 
0.037 
0.029 
0.008 
0.009 
0.02 
0.069 
0.045 
0.194 
0.036 
- 
0.085 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.047 
0.009 
0.005 
0.022 
0.005 
0.006 
0.003 
0.01 
0.005 
- 
0.012 
0.007 
0.007 
0.006 
- 
0.011 
0.01 
0.005 
0.021 
0.007 
0.004 
0.028 
- 
0.007 
0.011 
0.014 
0.012 
0.116 
- 
0.006 
0.002 
0.014 
0.014 
- 
0.03 
0.082 
0.009 
- 
0.02 
0.01 
0.012 
0.017 
0.005 
0.006 
0.014 
0.022 
0.006 
0.038 
0.073 
0.067 
0.113 
- 
- 
0.072 
0.131 
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- 151 - 
Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(wt)·Mg2+·GppNHp upon Addition of a 4-fold Excess of 
CCAVFRL. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
THR 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.017 
0.034 
0.022 
0.133 
0.005 
0.018 
0.034 
0.012 
- 
0.022 
- 
- 
0.009 
0.028 
- 
0.018 
- 
0.025 
- 
- 
0.038 
0.004 
0.015 
0.017 
0.007 
0.02 
0.009 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0.015 
- 
0.016 
0.016 
0.019 
0.02 
0.012 
0.008 
0.005 
0.016 
0.008 
0.003 
0.133 
0.161 
0.03 
0.026 
0.038 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
- 
- 
- 
- 
- 
- 
- 
- 
0.09 
0.03 
- 
0.084 
0.088 
- 
- 
0.144 
- 
0.008 
0.021 
- 
0.004 
0.038 
0.021 
0.039 
0.024 
0.009 
0.011 
0.013 
0.004 
0.002 
0.019 
0.023 
0.026 
0.008 
0.053 
- 
0.029 
0.031 
0.056 
0.022 
0.009 
- 
0.009 
0.045 
0.034 
0.019 
- 
0.012 
- 
0.016 
0.029 
0.04 
0.014 
- 
0.045 
 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.102 
0.01 
0.023 
0.023 
0.002 
0.008 
0.003 
0.013 
0.003 
0.007 
0.008 
0.009 
0.001 
0.004 
0.031 
0.013 
0.011 
0.006 
0.011 
0.007 
0.024 
0.002 
0.018 
0.008 
0.016 
0.024 
0.004 
0.01 
- 
0.016 
0.019 
0.024 
0.005 
0.021 
0.004 
0.015 
0.009 
0.019 
0.014 
0.011 
0.008 
0.026 
0.021 
0.03 
0.029 
0.017 
0.024 
0.077 
0.023 
0.056 
0.112 
0.025 
0.036 
0.037 
0.054 
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- 152 - 
Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(wt)·Mg2+·GppNHp upon Addition of a 3.2-fold Excess of 
CCFFFRRL. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
THR 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.011 
0.02 
0.013 
0.147 
0.011 
0.012 
0.022 
0.002 
- 
0.021 
- 
- 
0.008 
0.026 
- 
0.01 
- 
0.01 
- 
- 
0.06 
0.012 
0.003 
0.018 
0.001 
0.025 
0.009 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0.014 
- 
0.023 
0.001 
0.017 
0.006 
0.016 
0.015 
0.012 
0.011 
0.006 
0.004 
0.09 
0.133 
0.02 
0.024 
0.023 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
- 
- 
- 
- 
- 
- 
- 
- 
0.049 
0.017 
- 
0.038 
0.077 
- 
- 
0.039 
- 
0.022 
0.019 
0.048 
0.004 
0.019 
0.022 
0.027 
0.02 
0.003 
- 
0.004 
0.004 
0.005 
0.004 
0.007 
0.013 
0.004 
0.036 
- 
0.017 
0.018 
0.04 
0.014 
0.012 
- 
- 
0.021 
0.02 
0.013 
- 
0.005 
0.021 
0.02 
0.031 
0.029 
0.015 
- 
0.049 
 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.059 
0.002 
0.011 
0.012 
0.001 
0.006 
0.011 
0.01 
0.001 
0.008 
0.005 
- 
0.007 
0.001 
0.018 
0.015 
0.01 
0.007 
0.013 
0.016 
0.038 
0.013 
0.019 
0.006 
0.027 
0.011 
0.006 
0.018 
- 
0.014 
0.028 
0.023 
0.002 
0.022 
0.001 
0.006 
0.012 
0.013 
0.004 
0.021 
0.003 
0.021 
0.021 
0.024 
0.019 
0.012 
0.019 
0.058 
- 
0.039 
0.084 
0.026 
0.038 
0.019 
0.042 
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- 153 - 
Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(T35A)·Mg2+·GppNHp upon Addition of a 4.8-fold Excess of 
CCAVFRL. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
ALA 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.02 
0.044 
0.017 
0.017 
0.017 
0.016 
0.053 
0.012 
0.007 
0.016 
0.036 
0.075 
0.003 
0.034 
0.016 
0.026 
0.031 
0.021 
0.013 
0.02 
0.025 
0.008 
0.011 
0.006 
0.012 
0.015 
0.015 
0.032 
- 
0.068 
0.097 
0.009 
- 
0.05 
0.023 
- 
0.051 
0.011 
0.013 
0.096 
0.009 
0.014 
0.022 
0.021 
0.02 
0.006 
0.002 
0.015 
0.01 
0.003 
0.134 
0.202 
0.125 
0.019 
0.027 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
0.125 
0.029 
0.004 
0.095 
0.022 
0.077 
0.044 
0.003 
0.006 
0.031 
0.03 
0.007 
0.037 
0.059 
0.035 
0.031 
0.019 
0.02 
0.011 
0.023 
0.003 
0.041 
0.04 
0.032 
0.009 
0.008 
0.003 
0.005 
0.003 
0.006 
0.014 
0.018 
0.032 
0.011 
0.025 
0.089 
0.023 
0.116 
0.07 
0.04 
0.038 
0.044 
0.004 
0.013 
0.031 
0.006 
0.026 
0.015 
0.062 
0.018 
0.036 
0.038 
0.008 
- 
0.052 
 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.108 
0.003 
0.018 
0.01 
0.01 
0.011 
0.01 
0.015 
0.004 
0.005 
0.007 
0.016 
0.01 
0.002 
0.032 
0.012 
0.005 
0.005 
0.005 
0.006 
0.023 
0.007 
0.01 
0.004 
0.017 
0.011 
0.007 
0.007 
- 
0.014 
0.018 
0.022 
0.036 
0.014 
0.008 
0.02 
0.011 
0.044 
0.011 
0.016 
0.003 
0.022 
0.024 
0.038 
0.037 
0.024 
0.032 
0.082 
0.026 
0.052 
0.109 
0.037 
0.033 
0.038 
0.055 
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- 154 - 
Combined Chemical Shift Changes Observed in the [1H, 15N]-TROSY-HSQC 
Spectrum of c'Ras(T35A)·Mg2+·GppNHp upon Addition of a 4-fold Excess of 
CCFFFRRL. 
 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
residue 
number 
amino 
acid 
∆δcomb 
[ppm] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
MET 
THR 
GLU 
TYR 
LYS 
LEU 
VAL 
VAL 
VAL 
GLY 
ALA 
GLY 
GLY 
VAL 
GLY 
LYS 
SER 
ALA 
LEU 
THR 
ILE 
GLN 
LEU 
ILE 
GLN 
ASN 
HIS 
PHE 
VAL 
ASP 
GLU 
CYS 
ASP 
PRO 
ALA 
ILE 
GLU 
ASP 
SER 
TYR 
ARG 
LYS 
GLN 
VAL 
VAL 
ILE 
ASP 
GLY 
GLU 
THR 
CYS 
LEU 
LEU 
ASP 
ILE 
LEU 
- 
0.009 
0.045 
0.024 
0.022 
0.006 
0.039 
0.049 
0.012 
0.013 
0.027 
0.019 
0.099 
0.003 
0.034 
0.037 
0.03 
0.026 
0.065 
0.019 
0.022 
0.025 
0.011 
0.01 
0.014 
0.016 
0.021 
0.018 
0.035 
- 
0.087 
0.101 
0.008 
- 
0.051 
0.039 
0.028 
0.052 
0.014 
0.013 
0.078 
0.013 
0.016 
0.022 
0.017 
0.033 
0.005 
0.005 
0.015 
0.012 
0.004 
0.141 
0.246 
0.095 
0.03 
0.026 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
ASP 
THR 
ALA 
GLY 
GLN 
GLU 
GLU 
TYR 
SER 
ALA 
MET 
ARG 
ASP 
GLN 
TYR 
MET 
ARG 
THR 
GLY 
GLU 
GLY 
PHE 
LEU 
CYS 
VAL 
PHE 
ALA 
ILE 
ASN 
ASN 
THR 
LYS 
SER 
PHE 
GLU 
ASP 
ILE 
HIS 
GLN 
TYR 
ARG 
GLU 
GLN 
ILE 
LYS 
ARG 
VAL 
LYS 
ASP 
SER 
ASP 
ASP 
VAL 
PRO 
MET 
 
0.095 
0.021 
0.017 
0.1 
0.014 
0.048 
0.055 
0.008 
0.035 
0.015 
0.02 
0.008 
0.026 
0.049 
0.012 
0.02 
0.008 
0.019 
0.013 
0.014 
0.002 
0.035 
0.037 
0.033 
0.007 
0.012 
0.01 
0.014 
0.002 
0.005 
0.019 
0.023 
0.05 
0.009 
0.041 
0.09 
0.014 
0.096 
0.061 
0.038 
0.022 
0.039 
0.01 
0.017 
0.027 
0.006 
0.027 
0.022 
0.072 
0.02 
0.039 
0.05 
0.007 
- 
0.063 
 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
VAL 
LEU 
VAL 
GLY 
ASN 
LYS 
SER 
ASP 
LEU 
ALA 
ALA 
ARG 
THR 
VAL 
GLU 
SER 
ARG 
GLN 
ALA 
GLN 
ASP 
LEU 
ALA 
ARG 
SER 
TYR 
GLY 
ILE 
PRO 
TYR 
ILE 
GLU 
THR 
SER 
ALA 
LYS 
THR 
ARG 
GLN 
GLY 
VAL 
GLU 
ASP 
ALA 
PHE 
TYR 
THR 
LEU 
VAL 
ARG 
GLU 
ILE 
ARG 
GLN 
HIS 
0.122 
0.017 
0.02 
0.01 
0.007 
0.005 
0.008 
0.012 
0.001 
0.006 
0.004 
0.015 
0.016 
0.004 
0.03 
0.02 
0.005 
0.01 
0.001 
0.006 
0.04 
0.013 
0.022 
0.008 
0.027 
0.004 
0.009 
0.012 
- 
0.014 
0.021 
0.023 
0.012 
0.044 
0.012 
0.03 
0.017 
0.037 
0.006 
0.023 
0.007 
0.024 
0.026 
0.039 
0.039 
0.025 
0.037 
0.101 
0.024 
0.05 
0.115 
0.026 
0.041 
0.038 
0.07 
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- 155 - 
Corrected First and Second Order Pressure Coefficients for 1H Derived for 
c'Ras(wt)·Mg2+·GppNHp at 278 K. 
 
residue 
number 
amino 
acid 
B1* (HN) 
[ppm/GPa] error 
B2* (HN) 
[ppm/GPa2] error 
3 
7 
9 
14 
26 
42 
45 
48 
49 
50 
75 
77 
82 
83 
84 
85 
86 
88 
89 
96 
105 
106 
107 
108 
109 
111 
115 
117 
119 
120 
122 
123 
124 
125 
126 
127 
129 
130 
132 
136 
138 
139 
141 
142 
143 
146 
147 
150 
153 
155 
156 
158 
159 
160 
161 
162 
165 
166 
Glu 
Val 
Val 
Val 
Asn 
Lys 
Val 
Gly 
Glu 
Thr 
Gly 
Gly 
Phe 
Ala 
Ile 
Asn 
Asn 
Lys 
Ser 
Tyr 
Asp 
Ser 
Asp 
Asp 
Val 
Met 
Gly 
Lys 
Asp 
Leu 
Ala 
Arg 
Thr 
Val 
Glu 
Ser 
Gln 
Ala 
Asp 
Ser 
Gly 
Ile 
Tyr 
Ile 
Glu 
Ala 
Lys 
Gln 
Glu 
Ala 
Phe 
Thr 
Leu 
Val 
Arg 
Glu 
Gln 
His 
9.7E-4 
5.56E-4 
-3.97E-4 
-2.42E-4 
-4.91E-4 
-5.53E-4 
-3.02E-4 
7.2E-4 
-3.66E-4 
7.57E-4 
4.52E-4 
6.32E-4 
-2.36E-4 
-9.32E-5 
5.21E-4 
-1.45E-4 
2.56E-4 
6.09E-4 
-2.72E-4 
-6.87E-4 
-6.28E-4 
3.31E-4 
6.57E-4 
-2.48E-4 
-7.96E-4 
5.9E-4 
-6.01E-4 
1.51E-4 
-6.74E-4 
-3.59E-4 
4.02E-4 
-2.85E-4 
-1.16E-4 
7.63E-5 
5.62E-5 
2.57E-4 
-6.84E-4 
2.67E-4 
-1.33E-4 
1.17E-4 
-2.79E-4 
-3.57E-4 
7.53E-4 
5.92E-4 
8.65E-4 
-9.87E-4 
-0.00102 
-2.86E-4 
3.84E-4 
-5.81E-4 
-3.68E-4 
-1.85E-4 
-4.19E-4 
-6.72E-4 
-7.66E-4 
-1.68E-4 
-3.12E-4 
-2.3E-4 
2.15E-4 
4.8E-5 
8.32E-5 
2.32E-5 
3.46E-5 
1.21E-4 
3.57E-5 
5.48E-5 
2.3E-5 
4.13E-5 
5.75E-5 
4.93E-5 
4.72E-5 
2.88E-5 
6.43E-5 
1.47E-5 
1.15E-5 
3.48E-5 
2.38E-5 
4.43E-7 
3.64E-5 
2.18E-5 
8.35E-5 
2.8E-5 
1.94E-5 
2.75E-5 
1.11E-4 
1.04E-5 
3.58E-5 
1.63E-5 
2.76E-5 
2.96E-5 
4.24E-5 
8.41E-6 
2.27E-5 
5.96E-5 
4.57E-5 
2.67E-5 
3.12E-5 
2.54E-5 
3.61E-5 
2.55E-5 
5.57E-5 
4.71E-5 
1.44E-5 
7.32E-5 
8.3E-5 
1.23E-7 
2.91E-5 
7.11E-5 
4.4E-5 
6.16E-5 
3.42E-5 
2.79E-5 
5.12E-5 
3.59E-5 
2.88E-5 
2.54E-5 
-8.83E-7 
-8.58E-8 
1.06E-6 
-5.95E-7 
1.05E-7 
-4.6E-7 
1.07E-6 
1.08E-7 
8.25E-7 
-1.3E-6 
2.48E-7 
-2.04E-6 
1.5E-7 
1.92E-8 
-5.91E-7 
-4.02E-7 
-4.62E-7 
-1.16E-7 
8.92E-7 
8.97E-7 
8.81E-7 
-5.44E-7 
-9.63E-7 
3.56E-7 
8.14E-7 
2.37E-7 
5.73E-7 
-9.17E-7 
6.88E-7 
-1.5E-7 
-3.07E-7 
-5.64E-8 
-5.33E-7 
-7.68E-7 
2.2E-7 
-1.23E-7 
3.9E-8 
-1.06E-6 
-4.93E-7 
-3.98E-7 
4.2E-8 
1.48E-8 
9.58E-8 
-5.75E-7 
-6.85E-7 
1.21E-6 
1.28E-7 
2.88E-7 
-2.01E-7 
6.9E-8 
-2.75E-9 
-2.92E-8 
-4.32E-7 
1.18E-6 
3.06E-7 
-4.07E-7 
-3.24E-7 
-6.81E-7 
1.03E-7 
2.3E-7 
3.98E-7 
1.11E-7 
1.65E-7 
5.79E-7 
1.71E-7 
2.62E-7 
1.1E-7 
1.97E-7 
2.75E-7 
2.36E-7 
2.25E-7 
1.53E-7 
3.07E-7 
7.01E-8 
5.5E-8 
1.66E-7 
1.14E-7 
2.12E-7 
1.74E-7 
1.04E-7 
6.58E-7 
1.34E-7 
9.29E-8 
1.31E-7 
5.07E-7 
4.98E-8 
1.9E-7 
7.8E-8 
1.32E-7 
1.41E-7 
2.03E-7 
4.02E-8 
1.08E-7 
2.85E-7 
2.18E-7 
1.28E-7 
1.49E-7 
1.22E-7 
1.73E-7 
1.22E-7 
2.66E-7 
2.25E-7 
6.86E-8 
3.49E-7 
3.98E-7 
5.87E-8 
1.39E-7 
3.4E-7 
2.1E-7 
2.94E-7 
1.63E-7 
1.33E-7 
2.45E-7 
1.72E-7 
1.38E-7 
1.21E-7 
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First and Second Order Pressure Coefficients for 15N Derived for 
c'Ras(wt)·Mg2+·GppNHp at 278 K. 
 
residue 
number 
amino 
acid 
B1 (N) 
[ppm/GPa] error 
B2 (N) 
[ppm/GPa2] error 
3 
4 
7 
9 
14 
19 
26 
42 
45 
48 
50 
75 
77 
78 
82 
83 
84 
85 
86 
88 
89 
96 
105 
106 
107 
108 
109 
111 
115 
116 
117 
120 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
136 
138 
139 
141 
142 
143 
144 
145 
146 
147 
148 
150 
151 
153 
155 
158 
Glu 
Tyr 
Val 
Val 
Val 
Leu 
Asn 
Lys 
Val 
Gly 
Thr 
Gly 
Gly 
Phe 
Phe 
Ala 
Ile 
Asn 
Asn 
Lys 
Ser 
Tyr 
Asp 
Ser 
Asp 
Asp 
Val 
Met 
Gly 
Asn 
Lys 
Leu 
Ala 
Arg 
Thr 
Val 
Glu 
Ser 
Arg 
Gln 
Ala 
Gln 
Asp 
Leu 
Ser 
Gly 
Ile 
Tyr 
Ile 
Glu 
Thr 
Ser 
Ala 
Lys 
Thr 
Gln 
Gly 
Glu 
Ala 
Thr 
1.90544 
5.64042 
5.69335 
5.38397 
7.5519 
4.73599 
3.39208 
0.29332 
-1.03154 
4.20029 
3.69398 
6.25371 
3.63529 
6.4699 
2.00251 
1.94297 
4.9846 
0.75352 
4.62946 
3.77585 
1.91327 
4.55986 
2.42688 
4.53064 
5.64834 
1.42056 
0.90498 
1.85488 
1.43542 
1.44928 
9.73091 
1.47764 
2.22503 
3.75434 
6.66887 
2.71192 
-2.32381 
3.55924 
3.0459 
5.35085 
5.09046 
3.63528 
2.01767 
3.9879 
4.62878 
2.04566 
1.38043 
1.25834 
4.03971 
4.23264 
8.54537 
2.39653 
2.51605 
-2.53959 
6.77998 
2.82753 
3.44022 
3.38834 
-2.21166 
4.36428 
0.16119 
0.37934 
0.27623 
0.50615 
0.19574 
0.68228 
0.22247 
0.56869 
0.2567 
0.64215 
0.41221 
0.14857 
0.39717 
0.42032 
0.23697 
0.14544 
0.17759 
0.12133 
0.18623 
0.21126 
0.45472 
0.18628 
0.21342 
0.20895 
0.60056 
0.24031 
0.17159 
0.34883 
0.25617 
0.17824 
0.13899 
0.18804 
0.15616 
0.11083 
0.40819 
0.16713 
0.25857 
0.21144 
0.15239 
0.50714 
0.18557 
0.17509 
0.14188 
0.20219 
0.19078 
0.26705 
0.22422 
0.1815 
0.29203 
0.21652 
0.30139 
0.62858 
0.30442 
0.23103 
0.52649 
0.18573 
0.24417 
0.17847 
0.22856 
0.20648 
-1.9049 
-10.05164 
-3.28227 
4.889 
-7.70219 
0.92628 
-1.88544 
-9.35359 
3.2336 
-2.97965 
-3.77134 
-9.33667 
-2.92653 
-10.75531 
-1.10501 
-0.74256 
0.3414 
-0.87713 
-0.52625 
-1.57668 
1.07895 
-7.30364 
-1.22225 
-3.55661 
-5.29784 
4.39741 
2.69552 
0.85354 
4.68091 
-2.95077 
-7.17092 
-1.84045 
-1.45938 
-5.73707 
-8.41673 
-3.69909 
4.18494 
0.91485 
-0.3738 
-6.31485 
-3.80719 
-1.53879 
-2.41384 
-3.34398 
-3.00082 
0.69375 
0.21602 
-1.06405 
-4.4678 
-1.23799 
-7.85139 
-0.69678 
-3.79123 
2.30555 
-7.82484 
-0.11904 
-2.98066 
-2.97131 
5.37271 
-4.42782 
0.77969 
1.80505 
1.32067 
2.40842 
0.93585 
3.26204 
1.06363 
2.75083 
1.22728 
3.07015 
1.97081 
0.71031 
1.8989 
2.00956 
1.13297 
0.69538 
0.84907 
0.58006 
0.89038 
1.01006 
2.17406 
0.89063 
1.02038 
0.99899 
2.87132 
1.14893 
0.8204 
1.6678 
1.22479 
0.85216 
0.66454 
0.89903 
0.74663 
0.52989 
1.95159 
0.79907 
1.23625 
1.01093 
0.7286 
2.42467 
0.88723 
0.83713 
0.67832 
0.9667 
0.91213 
1.27679 
1.07199 
0.86778 
1.39619 
1.03519 
1.44095 
3.00528 
1.45543 
1.10939 
2.51717 
0.888 
1.16739 
0.85327 
1.09277 
0.98718 
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159 
160 
162 
165 
166 
Leu 
Val 
Glu 
Gln 
His 
2.64885 
2.61603 
1.90315 
1.50392 
2.46999 
0.20113 
0.14853 
0.31775 
0.13679 
0.1938 
-2.34257 
2.68062 
-2.76617 
-0.8498 
-1.39099 
0.96163 
0.71014 
1.51917 
0.65401 
0.92656 
 
 
Corrected First and Second Order Pressure Coefficients for 1H Derived for 
c'Ras(wt)·Mg2+·GppNHp at 303 K. 
 
residue 
number 
amino 
acid 
B1* (HN) 
[ppm/GPa] error 
B2* (HN) 
[ppm/GPa2] error 
3 
4 
9 
11 
14 
15 
17 
18 
23 
24 
25 
27 
28 
29 
39 
42 
44 
45 
46 
49 
51 
52 
53 
56 
65 
66 
67 
73 
75 
77 
78 
80 
82 
83 
84 
85 
86 
88 
90 
94 
97 
98 
100 
102 
105 
106 
107 
108 
109 
111 
112 
113 
Glu 
Tyr 
Val 
Ala 
Val 
Gly 
Ser 
Ala 
Leu 
Ile 
Gln 
His 
Phe 
Val 
Ser 
Lys 
Val 
Val 
Ile 
Glu 
Cys 
Leu 
Leu 
Asp 
Ser 
Ala 
Met 
Arg 
Gly 
Gly 
Phe 
Cys 
Phe 
Ala 
Ile 
Asn 
Asn 
Lys 
Phe 
His 
Arg 
Glu 
Ile 
Arg 
Asp 
Ser 
Asp 
Asp 
Val 
Met 
Val 
Leu 
0.00101 
-4.54145E-4 
-2.91338E-4 
-2.94833E-4 
-6.17124E-4 
-2.42724E-4 
-1.16408E-4 
-0.0014 
3.35241E-5 
1.06431E-4 
-8.14175E-4 
-4.18356E-5 
1.58311E-4 
4.51047E-4 
-1.38291E-4 
-2.99645E-4 
-3.21115E-4 
-3.44598E-4 
-0.00162 
-4.19456E-4 
1.81104E-4 
4.31337E-4 
-5.86749E-4 
1.29674E-4 
-0.00119 
-4.94914E-4 
-3.1237E-4 
-0.00116 
4.83609E-4 
5.11692E-4 
1.95344E-4 
2.26882E-4 
-2.53853E-4 
-1.43151E-4 
6.68167E-4 
-1.81581E-4 
2.02169E-4 
6.24296E-4 
-2.31374E-4 
-7.49374E-4 
0.00114 
-1.12256E-4 
-3.27282E-4 
-3.57357E-4 
-6.89862E-4 
4.39137E-4 
7.69427E-4 
-1.56373E-4 
6.38478E-4 
5.73134E-4 
-3.83767E-4 
7.53785E-4 
2.59466E-5 
2.22226E-5 
2.92867E-5 
2.3798E-5 
7.99577E-5 
2.96305E-5 
3.56342E-5 
3.47809E-5 
5.0651E-5 
4.39057E-5 
8.21622E-5 
4.31254E-5 
2.59697E-5 
4.5074E-5 
3.20558E-5 
3.78326E-5 
5.59029E-5 
2.15759E-5 
9.15864E-5 
3.17021E-5 
2.1091E-5 
3.20358E-5 
2.58298E-5 
3.93977E-5 
3.64032E-5 
3.31801E-5 
4.2015E-5 
2.24802E-5 
3.75786E-5 
3.76394E-5 
1.67539E-5 
3.04393E-5 
2.93231E-5 
2.30401E-5 
3.17498E-5 
3.00775E-5 
1.50754E-5 
4.35596E-5 
3.04046E-5 
3.68313E-5 
5.97623E-5 
1.82538E-5 
4.18489E-5 
3.49096E-5 
2.17933E-5 
3.99457E-5 
7.82298E-5 
2.30223E-5 
4.47348E-5 
3.56924E-5 
3.46486E-5 
3.67006E-5 
-1.06475E-6 
3.82581E-7 
-1.181E-8 
1.83577E-7 
-6.16583E-8 
-1.30374E-7 
1.20712E-7 
-7.41133E-7 
-3.04413E-6 
-1.70081E-6 
4.96774E-8 
-5.06198E-7 
-1.22917E-6 
-9.32895E-7 
-2.01029E-7 
-6.75343E-7 
-8.05108E-8 
5.10253E-7 
9.54859E-7 
8.26574E-7 
-1.13914E-6 
-5.70986E-7 
5.91159E-7 
1.21223E-6 
1.25366E-6 
8.57099E-8 
-5.01901E-7 
8.13417E-7 
-4.31512E-7 
-8.47383E-7 
-5.76426E-7 
-4.31726E-7 
1.32531E-10 
-2.26856E-8 
-1.17252E-6 
-1.95509E-7 
-5.22996E-7 
-4.49797E-7 
-5.05008E-7 
2.53431E-7 
-2.24658E-6 
-4.0645E-7 
-6.43501E-7 
7.59906E-7 
5.45291E-7 
-1.1517E-6 
-3.86531E-6 
-5.72975E-8 
-7.52209E-7 
1.61241E-7 
2.0874E-7 
-5.23082E-7 
1.37787E-7 
1.18011E-7 
1.53844E-7 
1.25011E-7 
4.20019E-7 
1.5735E-7 
1.89232E-7 
1.847E-7 
3.01972E-7 
2.61758E-7 
4.36313E-7 
2.29013E-7 
1.37909E-7 
2.39361E-7 
1.70229E-7 
2.00906E-7 
3.33283E-7 
1.14576E-7 
4.86359E-7 
1.68351E-7 
1.10791E-7 
1.70122E-7 
1.37166E-7 
2.09217E-7 
2.4721E-7 
1.76199E-7 
2.23116E-7 
1.19379E-7 
1.99557E-7 
1.9988E-7 
9.05162E-8 
1.59898E-7 
1.54035E-7 
1.2103E-7 
1.68604E-7 
1.59723E-7 
8.98768E-8 
2.31318E-7 
1.6146E-7 
1.95588E-7 
3.18429E-7 
9.69347E-8 
2.22234E-7 
1.85384E-7 
1.15731E-7 
2.12127E-7 
6.15817E-7 
1.37255E-7 
2.37559E-7 
1.8954E-7 
1.80038E-7 
1.94895E-7 
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114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
127 
129 
132 
133 
134 
135 
136 
137 
138 
139 
141 
142 
143 
144 
145 
146 
147 
149 
150 
151 
152 
153 
155 
156 
157 
158 
159 
161 
162 
164 
165 
166 
Val 
Gly 
Asn 
Lys 
Ser 
Asp 
Leu 
Ala 
Ala 
Arg 
Thr 
Val 
Ser 
Gln 
Asp 
Leu 
Ala 
Arg 
Ser 
Tyr 
Gly 
Ile 
Tyr 
Ile 
Glu 
Thr 
Ser 
Ala 
Lys 
Arg 
Gln 
Gly 
Val 
Glu 
Ala 
Phe 
Tyr 
Thr 
Leu 
Arg 
Glu 
Arg 
Gln 
His 
-4.33437E-4 
-7.1211E-4 
-5.04298E-5 
-2.59476E-6 
-3.98014E-4 
-6.28315E-4 
-3.57923E-4 
5.21894E-4 
5.25996E-4 
-3.64416E-4 
-1.71186E-4 
1.78541E-4 
4.8738E-4 
-7.96184E-4 
-1.08585E-4 
1.22536E-4 
-6.75294E-4 
-3.41568E-4 
1.02547E-4 
-7.35652E-4 
-1.67295E-4 
-3.08797E-4 
9.19663E-4 
5.81281E-4 
8.81904E-4 
9.30092E-5 
7.09581E-4 
-8.87784E-4 
-0.00119 
1.60493E-4 
-2.54646E-4 
2.45394E-4 
-7.35617E-4 
-3.25452E-4 
-3.84399E-4 
-5.01262E-4 
4.99101E-4 
-3.10387E-5 
-5.01105E-4 
-9.26749E-4 
-1.56495E-4 
-6.97667E-4 
5.50902E-4 
-2.21767E-4 
3.25512E-5 
3.02256E-5 
1.1386E-5 
1.17068E-5 
2.89954E-5 
5.65226E-5 
2.46677E-5 
3.1902E-5 
4.66017E-5 
3.35856E-5 
2.2308E-5 
3.19079E-5 
2.6188E-5 
2.34113E-5 
2.56064E-5 
1.47565E-5 
3.31862E-5 
2.47851E-5 
2.61577E-5 
3.5616E-5 
1.73593E-5 
3.05661E-5 
4.98517E-5 
3.26712E-5 
3.98348E-5 
2.74942E-5 
5.0765E-5 
1.99716E-5 
2.85183E-5 
4.39073E-5 
2.61681E-5 
2.04679E-5 
3.30619E-5 
3.5853E-5 
2.16814E-5 
3.65247E-5 
4.91752E-5 
3.47885E-5 
3.08026E-5 
1.80564E-5 
1.27137E-5 
4.8587E-5 
4.68242E-5 
3.88918E-5 
-4.63106E-7 
1.16628E-6 
-3.65579E-7 
-6.57929E-7 
7.20001E-7 
3.71509E-7 
-2.52114E-7 
-3.10909E-7 
-7.62192E-7 
6.08313E-7 
-3.8351E-7 
-1.17399E-6 
-1.59084E-6 
3.96817E-7 
-4.89291E-7 
-6.57387E-7 
6.67005E-7 
2.98273E-7 
-3.77262E-7 
8.44947E-7 
-3.96442E-7 
-2.91367E-7 
-9.31499E-7 
-1.01723E-6 
-8.99209E-7 
-3.42165E-7 
-3.50644E-7 
5.266E-7 
8.00097E-7 
3.68754E-7 
-2.33257E-7 
-8.16364E-7 
7.30336E-7 
1.94664E-6 
-4.73054E-7 
7.35255E-8 
5.68544E-7 
-7.4629E-7 
1.43349E-7 
5.7095E-7 
1.88603E-7 
4.65418E-7 
2.06558E-7 
-6.16789E-7 
1.72859E-7 
1.6051E-7 
6.04643E-8 
6.21676E-8 
1.53977E-7 
3.10126E-7 
1.30995E-7 
1.69412E-7 
2.47473E-7 
1.78353E-7 
1.17185E-7 
1.90229E-7 
1.56128E-7 
1.24323E-7 
1.3598E-7 
7.83626E-8 
1.76232E-7 
1.30197E-7 
1.38908E-7 
1.89135E-7 
9.21849E-8 
1.62318E-7 
2.64732E-7 
1.73497E-7 
2.11538E-7 
1.44428E-7 
2.69582E-7 
1.06057E-7 
1.51443E-7 
1.96386E-7 
1.38963E-7 
1.22026E-7 
1.75572E-7 
2.13749E-7 
1.15136E-7 
1.9396E-7 
2.6114E-7 
1.87415E-7 
1.63574E-7 
9.58865E-8 
6.67853E-8 
2.61752E-7 
2.48655E-7 
2.06531E-7 
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First and Second Order Pressure Coefficients for 15N Derived for 
c'Ras(wt)·Mg2+·GppNHp at 303 K. 
 
residue 
number 
amino 
acid 
B1 (N) 
[ppm/GPa] error 
B2* (N) 
[ppm/GPa2] error 
3 
4 
5 
9 
11 
14 
15 
17 
18 
19 
23 
24 
25 
27 
28 
29 
39 
42 
44 
45 
46 
49 
51 
52 
53 
56 
65 
66 
67 
73 
75 
77 
78 
80 
82 
83 
84 
85 
86 
88 
90 
94 
97 
98 
100 
102 
105 
106 
107 
108 
109 
111 
112 
113 
114 
115 
116 
117 
118 
120 
Glu 
Tyr 
Lys 
Val 
Ala 
Val 
Gly 
Ser 
Ala 
Leu 
Leu 
Ile 
Gln 
His 
Phe 
Val 
Ser 
Lys 
Val 
Val 
Ile 
Glu 
Cys 
Leu 
Leu 
Asp 
Ser 
Ala 
Met 
Arg 
Gly 
Gly 
Phe 
Cys 
Phe 
Ala 
Ile 
Asn 
Asn 
Lys 
Phe 
His 
Arg 
Glu 
Ile 
Arg 
Asp 
Ser 
Asp 
Asp 
Val 
Met 
Val 
Leu 
Val 
Gly 
Asn 
Lys 
Ser 
Leu 
0.00148 
-0.00348 
0.00282 
0.00216 
0.00348 
0.00132 
-0.00129 
0.0021 
-6.99372E-6 
0.00441 
0.00606 
0.00172 
0.00149 
0.00615 
-2.92092E-4 
0.00403 
0.00957 
-1.81702E-4 
0.00404 
-0.00186 
-3.68836E-4 
7.77514E-4 
0.00121 
0.00536 
0.00359 
0.00288 
8.19594E-4 
-0.00195 
9.0301E-4 
-0.00271 
0.00583 
0.00329 
0.00507 
1.08567E-4 
0.00165 
0.00173 
0.00486 
9.61122E-4 
0.00456 
0.00316 
0.00733 
0.00176 
0.00408 
0.00279 
0.00439 
0.00225 
0.0031 
0.0046 
0.00624 
0.00125 
0.00708 
0.00133 
-0.01116 
-0.00207 
0.00371 
0.00223 
8.47467E-4 
0.008 
0.00137 
0.00158 
8.48466E-5 
1.18143E-4 
1.08469E-4 
8.24846E-5 
1.13449E-4 
5.77778E-4 
9.15206E-5 
1.18129E-4 
1.02009E-4 
1.14054E-4 
1.3978E-4 
5.99262E-5 
1.22512E-4 
1.74759E-4 
1.88665E-4 
1.673E-4 
1.57707E-4 
8.11001E-5 
2.07707E-4 
1.37877E-4 
1.34703E-4 
5.74613E-5 
1.01878E-4 
1.52948E-4 
1.41388E-4 
2.08605E-4 
1.31276E-4 
8.61805E-5 
6.54908E-5 
7.06022E-5 
1.3296E-4 
9.12068E-5 
1.43872E-4 
8.23706E-5 
6.78501E-5 
7.70435E-5 
1.3969E-4 
5.59271E-5 
1.48429E-4 
1.28445E-4 
2.08697E-4 
1.37634E-4 
1.19982E-4 
1.111E-4 
1.57037E-4 
8.95088E-5 
1.39851E-4 
1.13504E-4 
4.124E-4 
8.22474E-5 
2.34618E-4 
1.145E-4 
2.44631E-4 
9.95469E-5 
1.34985E-4 
1.7371E-4 
6.95981E-5 
2.11735E-4 
6.27916E-5 
7.998E-5 
9.35116E-7 
6.33261E-6 
-2.22404E-6 
6.56089E-6 
2.95951E-7 
6.4944E-6 
-8.21609E-7 
-6.40225E-6 
4.55928E-6 
-1.4843E-7 
-9.51708E-6 
-4.24587E-6 
-1.79092E-6 
3.69086E-6 
-2.83542E-6 
-4.66884E-6 
-6.35269E-6 
-3.55174E-6 
7.95808E-7 
7.86781E-6 
4.47469E-6 
1.68181E-6 
-2.48728E-6 
-5.74905E-6 
-2.95794E-6 
4.507E-6 
2.07063E-7 
3.41839E-6 
-5.63455E-8 
1.16505E-5 
-7.324E-6 
-8.60204E-7 
-4.7617E-6 
-2.54713E-6 
2.28781E-7 
-4.17911E-7 
-1.03122E-7 
-8.39043E-7 
-1.96425E-6 
6.60725E-7 
-1.22574E-5 
3.17674E-7 
-5.41288E-6 
-8.69203E-7 
-5.81811E-6 
-4.75459E-6 
-3.52421E-6 
-4.36285E-6 
-6.86355E-6 
3.70996E-6 
-1.0465E-5 
2.58245E-6 
-1.02363E-5 
-6.0674E-6 
-7.37816E-6 
7.10182E-7 
-3.225E-7 
-8.92478E-6 
1.34593E-6 
-1.70075E-6 
4.50569E-7 
6.27387E-7 
5.76015E-7 
4.38025E-7 
6.0246E-7 
3.03508E-6 
4.8601E-7 
6.27312E-7 
5.4171E-7 
6.05669E-7 
8.33342E-7 
3.18232E-7 
6.50585E-7 
9.2804E-7 
1.00189E-6 
8.88428E-7 
8.37484E-7 
4.30673E-7 
1.103E-6 
7.32183E-7 
7.15324E-7 
3.05142E-7 
5.41011E-7 
8.12216E-7 
7.50824E-7 
1.10778E-6 
8.91482E-7 
4.57652E-7 
3.47782E-7 
3.74926E-7 
7.06071E-7 
4.84344E-7 
7.64016E-7 
4.3742E-7 
3.60311E-7 
4.09131E-7 
7.41811E-7 
2.96995E-7 
7.88215E-7 
6.82095E-7 
1.10826E-6 
7.3089E-7 
6.39297E-7 
5.89987E-7 
8.33926E-7 
4.75327E-7 
7.42662E-7 
6.0275E-7 
2.19001E-6 
4.36766E-7 
1.24592E-6 
6.08042E-7 
1.27113E-6 
5.28633E-7 
7.16821E-7 
9.22466E-7 
3.69593E-7 
1.1244E-6 
3.33448E-7 
4.24725E-7 
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121 
122 
123 
124 
125 
127 
129 
132 
133 
134 
135 
136 
137 
138 
139 
141 
142 
143 
144 
145 
146 
147 
149 
150 
151 
152 
153 
155 
157 
158 
159 
161 
162 
164 
165 
166 
Ala 
Ala 
Arg 
Thr 
Val 
Ser 
Gln 
Asp 
Leu 
Ala 
Arg 
Ser 
Tyr 
Gly 
Ile 
Tyr 
Ile 
Glu 
Thr 
Ser 
Ala 
Lys 
Arg 
Gln 
Gly 
Val 
Glu 
Ala 
Tyr 
Thr 
Leu 
Arg 
Glu 
Arg 
Gln 
His 
0.00563 
0.00258 
0.00416 
0.00682 
0.00359 
0.00383 
0.00455 
0.00261 
0.00429 
0.00106 
0.00244 
0.00508 
-3.1046E-4 
0.00147 
0.00101 
4.04108E-4 
0.00429 
0.00376 
0.00793 
0.00264 
0.00201 
-6.98673E-4 
0.00413 
0.00306 
0.00339 
0.00277 
9.08523E-4 
-0.00112 
0.00331 
0.00442 
0.00248 
0.00116 
5.45723E-4 
0.00152 
6.49932E-4 
0.00237 
9.86528E-5 
2.34224E-4 
1.44258E-4 
1.51417E-4 
1.20591E-4 
2.39111E-4 
1.34564E-4 
2.91023E-4 
1.03771E-4 
7.37455E-5 
1.0294E-4 
1.5056E-4 
7.81129E-5 
7.07661E-5 
8.13817E-5 
1.37365E-4 
1.65789E-4 
1.18338E-4 
1.74722E-4 
1.10335E-4 
1.35697E-4 
7.28955E-5 
2.52915E-4 
1.21108E-4 
1.24464E-4 
1.34186E-4 
7.8958E-5 
9.81958E-5 
1.17515E-4 
3.48562E-4 
1.07485E-4 
9.41192E-5 
8.17093E-5 
3.25711E-4 
2.51019E-4 
1.6449E-4 
-2.8641E-6 
-2.88375E-6 
-7.55837E-6 
-6.82088E-6 
-4.3134E-6 
-1.35622E-6 
-2.90296E-6 
-4.74678E-6 
-4.04356E-6 
3.17264E-6 
-1.52472E-6 
-4.2837E-6 
4.39868E-6 
1.26664E-6 
1.49331E-6 
2.44707E-6 
-5.0656E-6 
-9.04618E-7 
-6.46863E-6 
-1.58355E-6 
-1.70979E-6 
-7.03423E-7 
-6.24095E-6 
-1.21538E-6 
-1.66344E-6 
-4.89026E-7 
4.83561E-7 
2.92069E-6 
1.29934E-6 
-2.79346E-6 
-7.57719E-7 
-3.5832E-7 
2.69854E-6 
3.38451E-6 
9.82248E-6 
-1.99048E-6 
5.23885E-7 
1.24382E-6 
7.66066E-7 
8.04084E-7 
6.40386E-7 
1.26977E-6 
7.14585E-7 
1.54545E-6 
5.51062E-7 
3.91618E-7 
5.46653E-7 
7.99534E-7 
4.1481E-7 
3.75796E-7 
4.32169E-7 
7.29464E-7 
8.80407E-7 
6.2842E-7 
9.27844E-7 
5.85921E-7 
7.20606E-7 
3.87104E-7 
1.13122E-6 
6.43129E-7 
6.6095E-7 
7.1258E-7 
4.19298E-7 
5.21458E-7 
6.2405E-7 
1.8778E-6 
5.70787E-7 
4.9981E-7 
4.33908E-7 
1.75469E-6 
1.33301E-6 
8.73507E-7 
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NMR-Assisted Design of a New Type of Ras Inhibitors 
Poster Contributions 
• 3rd Summer School Medicinal Chemistry, University of Regensburg, Germany, 
September 2006 
Inhibition of the Interaction between Oncogenic Ras and Its effectors by Small 
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